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Abstract 
This thesis consists of two separate projects. The first project involved an attempted 
total synthesis of (+)-retronecine A, a poisonous pyrrolizidine alkaloid via a novel 
asymmetric α-lithiation-substitution reaction of N-thiopivaloyl azetidine B, mediated by 
a chiral diamine.  
 
A total synthesis was not possible and our attention turned towards elucidating the 
mechanism of enantioinduction. Of particular note was how the use of carbon dioxide 
and methyl chloroformate as electrophiles gave products with the opposite 
configuration under otherwise identical reaction conditions (using (–)-sparteine C).  
Chapter two consists of work undertaken towards a total synthesis of anthracimycin D, 
a potent marine antibiotic. The development of robust methodology was explored for 
the early stages of the synthesis. In addition, a synthesis of the model decalinone E, was 
developed, via a Sakurai-aldol reaction, followed by ring closing metathesis.  
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Chapter One: Studies Towards the Total Synthesis of (+)-Retronecine 
via an Azetidine Lithiation-Trapping Reaction 
 
1.1 Introduction to Nitrogen Containing Natural Products 
Natural products, assuming that they are chiral, are usually produced as a single 
enantiomer, given that they are typically made via enzymatic catalysis. Despite major 
advances, efficient methods for asymmetric synthesis remains a challenge in natural 
product total synthesis, in terms of matching the enantiomeric excesses achieved by the 
organism that produces it, stepwise efficiency and substrate specificity.  
Nitrogen heterocycles are biologically privileged motifs. Many natural products contain 
at least one substituted nitrogen heterocycle and some selected examples are shown in 
figure 1.1, including Miraziridine A, a protease inhibitor,
1
 Desoxyprosopine, an alkaloid 
isolated from Prosopsis africana,
2 
Penazetidine A, a protein kinase C inhibitor,
3
 and    
(–)-Kainic acid, a mammalian neuroexcitory amino acid.4  
 
Figure 1.1 
Methods for the asymmetric synthesis of α-substituted nitrogen heterocycles are thus 
important for the synthetic chemist. To date, the asymmetric synthesis of functionalised 
organolithium reagents remains one of the best, most conceptually simple and fastest 
ways of accessing enantioenriched α-substituted nitrogen heterocycles.  
12 
 
1.2 α-Lithiation-Substitution of Nitrogen Containing Heterocycles 
Typically, organolithium reagents are formed via three methods: reductive lithiation, 
transmetallation and deprotonation, summarised in Scheme 1.1. 
 
Scheme 1.1 
Ultimately, reductive lithiation remains the only method of generating organolithium 
reagents ab initio but, due to the single electron transfer mechanism of their formation
5
 
which proceeds via an sp
2
 planar radical intermediate, any stereogenic centres 
containing a C–X bond are racemised. Transmetallation also generally suffers from the 
same problem, although tin-lithium exchange provides a method for retaining the 
enantioenrichment of the starting stannane.
6
 Deprotonation, therefore, remains the most 
general and most effective method for the formation of enantioenriched α-functionalised 
organolithium reagents.  
The most well utilised method of carrying out asymmetric deprotonations of a substrate 
is to use a strong base (sBuLi or nBuLi typically) in the presence of a chiral diamine, 
with (–)-sparteine (–)-1, an alkaloid extracted from Cytisus scoparius,7 being the prime 
example. Although (–)-sparteine (–)-1  was used in organometallic chemistry as early as 
1968,
8
 its potential for asymmetric deprotonations was not realised until 1990, when 
Hoppe
9
 treated cyclic carbamate 2 with sBuLi in the presence of (–)-sparteine to form 
enantioenriched carbamate 3, which could then be trapped with a variety of 
electrophiles in high yields and enantioselectivities. The synthesis of α-functionalised 
carbamates (R)-4  and (S)-5 are shown in Scheme 1.2.  
13 
 
 
Scheme 1.2 
Importantly, the carbamate functional group acts as a directing group and coordinates to 
the sBuLi, forming a pre-lithiation complex 6 consisting of diamine, sBuLi and the 
starting carbamate 2. Complex 6 can then undergo deprotonation to give the 
functionalised organolithium. Known as the "complex induced proximity effect", 
evidence for the pre-lithiation complex was first put forwards by Beak
10
 in 1995 and has 
subsequently been directly observed with some N-Boc substrates by in situ IR 
spectroscopy.
11, 12
 It is also worth noting, that chiral base mixtures consisting of an 
alkyllithium and (–)-1 require a non-coordinating solvent such as Et2O, toluene or 
alkanes in order for effective enantioinduction to occur. If THF is used, the product of 
lithiation-trapping is usually racemic
13-20
 which is believed to be due to the solvent out-
competing (–)-1 for ligation to the lithium.13, 21  
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1.2.1 α-Lithiation-Substitution of 5-Membered Nitrogen Containing Heterocycles 
Perhaps the most well utilised substrate for α-lithiation-trapping chemistry is the cyclic 
N-Boc pyrrolidine 7. First reported in 1991,
22
 7 was treated with sBuLi in the presence 
of (–)-1 to form enantioenriched organolithium (S)-8 and was then trapped with a 
variety of electrophiles. Some selected examples are shown in Scheme 1.3. 
 
 
Scheme 1.3 
Crucially, Beak also demonstrated that the mechanism of enantioinduction is an 
enantioselective deprotonation of 7 by the sBuLi/(–)-1 complex, rather than a resolution 
of racemic organolithium 8 and (–)-1. The key experiments are shown in Table 1.1. 
Enantioenriched stannane (S)-9 (97:3 er) was transmetallated to the corresponding 
organolithium (S)-8 in the presence of TMEDA and then trapped with Me3SiCl. The 
product silane had an enantiomeric ratio of 83:17 (Table 1.1, entry 1). In contrast, when 
racemic 9 was transmetallated to (S)-8 in the presence of (–)-1, then trapped with 
Me3SiCl, the corresponding silane was effectively racemic (Table 1.1, entry 2). 
15 
 
 
Table 1.1: Demonstration of Configurational Stability of 8 
The results indicate that organolithium 8 is configurationally stable under the reaction 
conditions ie., it is not able to interconvert to its enantiomer. This means that both the 
sense of induction and the enantioenrichment of the product must be determined during 
the deprotonation step (Scheme 1.4). This also explains why the sense of induction does 
not change and why the overall enantioselectivities do not change significantly with the 
electrophile that is used. 
 
Scheme 1.4 
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Whilst (–)-sparteine  (–)-1 provides excellent enantioselectivities for products of the 
opposite enantiomeric series to (S)-proline, (+)-sparteine (+)-1 has been less available 
commercially. To date, the only enantioselective synthesis of (+)-1 was reported by 
Aubé
23
 using  norbornadione (S,S)-11 as starting material. This route gave (+)-sparteine 
(+)-1 in 15 steps and 15.7% overall yield (Scheme 1.5).  
 
Scheme 1.5 
For this reason, chiral diamines that give the opposite sense of induction to (–)-1 have 
been investigated. Originally developed as ligands to facilitate the asymmetric addition 
of organolithium reagents to aromatic imines,
24, 25
 diamines (S,S)-12 and (R,R)-12 have 
been shown to be effective ligands in the asymmetric α-lithiation-substitution of 7.26 For 
example, N-Boc pyrrolidine 7 was treated with sBuLi in the presence of (R,R)-12 and 
trapped with Me3SiCl to give silane (S)-10 in 72% and 95:5 er (Scheme 1.6), comparing 
favourably to the enantioselectivities obtained with (–)-1.  
 
Scheme 1.6 
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Crucially, racemic trans-1,2-diaminocyclohexane is commercially available. Thus, 
either enantiomer of the desired chiral diamine can be synthesised following  resolution 
with (D)-tartaric acid. (R,R)-12 was synthesised via two successive alkylations in 60% 
overall yield.
27, 28
 To date, the (+)-sparteine surrogate (+)-13, a pseudoenantiomer of    
(–)-1 derived from (–)-cytisine (–)-14, developed within our group,29 has shown the 
greatest promise in terms of matching the yields and enantioselectivities obtained with 
(–)-1. The synthesis of (+)-13 and a comparison of its use in α-lithiation trapping are 
shown in Scheme 1.7.  
 
Scheme 1.7 
The sBuLi/(+)-13 complex has been demonstrated, via a competition experiment, to be 
significantly more reactive than sBuLi/(–)-1 (Scheme 1.8).30 Given that the sBuLi/(+)-
13 complex and the sBuLi/(–)-1 complex give products with the opposite sense of 
induction but at similar levels of enantioenrichment, the rate at which each complex 
lithiates N-Boc pyrrolidine 7 will be proportional to the enantioenrichment of the final 
product. In this case, Me3SiCl as electrophile gave (R)-10 in 62% yield and an 
enantiomeric ratio of 90:10, indicating that the sBuLi/(+)-13 complex lithiates N-Boc 
pyrrolidine 7 approximately twenty times faster than does the sBuLi/(–)-1 complex. 
18 
 
 
 
Scheme 1.8 
Surprisingly, solution phase 
6
Li and 
13
C NMR spectroscopy carried out within our 
group found that the  (+)-sparteine surrogate (+)-13 forms a monomeric iPrLi/diamine 
species 15 (Figure 1.2) in THF.
31
 To the best of our knowledge, no other monomeric 
organolithium species has been directly observed.  
 
Figure 1.2 
Naturally, being able to predictably access both enantiomers of α-substituted 
pyrrolidines is synthetically useful and both (–)-sparteine (–)-1 and the (+)-sparteine 
surrogate (+)-13 have been used in this manner in several total syntheses.
32-34
 
Lithiated N-Boc pyrrolidine 8 is known to become configurationally unstable at 
temperatures above –40 °C.35 However, provided that the temperature of the reaction 
remains below this, the mechanism of enantioinduction must remain an enantioselective 
deprotonation as shown in Scheme 1.4. However, if the temperature is allowed to 
increase beyond –40 °C, the ratio between the enantiomers of the lithiated intermediate 
will be dependent on the equilibrium constant, Keq. In 2006, Coldham
35
 formed the 
racemic organolithium 8 at –78 °C and allowed a resolution by warming the reaction 
to –20 °C in the presence of (S,S)-16, then re-cooling to –78 °C and trapping with  
Me3SiCl (Table 1.2). 
 
19 
 
 
Table 1.2: Results Demonstrating Thermodynamic and Kinetic Resolutions of 8 
The results indicate that chiral diamine (S,S)-16 favours a 58:42 thermodynamic ratio of 
enantiomers, with the (R)-lithio-pyrrolidine 8 being the major diastereoisomer. As 
lithiated pyrrolidine 8 is configurationally stable at –78 °C, the addition of excess 
Me3SiCl preserves the thermodynamic ratio of (R)-8 and (S)-8 in the enantiomeric ratio 
of the product (Scheme 1.9).  
 
Scheme 1.9 
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Conversely, the addition of substoichometric amounts of Me3SiCl gives the silane (S)-
10 as the major product, with higher enantioselectivities but lower yields. This implies 
that the (S)-lithiopyrrolidine (S)-8/(S,S)-16 complex reacts faster with Me3SiCl than its 
diastereoisomer. Coldham was able to optimise the reaction conditions to give silane 
(S)-10 in 57% yield and 95:5 er by the slow addition of excess Me3SiCl at –20 °C 
(Scheme 1.10). The presence of 10 equivalents of nBuLi was required to maximise ers, 
possibly to increase the rate of interconversion of (S)-8 and (R)-8.  
 
Scheme 1.10 
Nonetheless, resolutions of lithiated N-Boc pyrrolidine 8 often lack generality due to the 
poor selectivities offered by thermodynamic resolutions, whilst kinetic resolutions are 
highly electrophile dependent, both for enantioselectivities and for the overall sense of 
induction. In contrast, enantioselective deprotonations always proceed with the same 
sense of induction and enantioselectivities, provided that trapping occurs below the 
temperature at which the organolithium becomes configurationally unstable.  
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1.2.2 α-Lithiation-Substitution of 6-Membered Nitrogen Containing Heterocycles 
Methodology developed for the asymmetric α-lithiation substitution of N-Boc 
pyrrolidine 7 does not produce equivalent results when applied to the 6-membered ring 
equivalent N-Boc piperidine 17. Although N-Boc pyrrolidine 7 fully lithiates at –30 °C 
in THF in 5 min, even in the absence of a diamine, N-Boc piperidine 17 does not lithiate 
at all under the same reaction conditions.
36
 Even in the presence of (–)-sparteine (–)-1, 
N-Boc piperidine 17 only undergoes 10% deprotonation at –78 °C after 6 h using 
sBuLi.
12
 It is known that in the case of N-Boc pyrrolidine 7 and N-Boc piperidine 17, 
the equatorial proton is preferentially removed, irrespective of whether a chiral ligand is 
present.
37, 38
 When (–)-1 is used the chiral diamine, the kinetic energy barrier to 
deprotonation of the pro-(S) proton from 17 is lower than for the pro-(R) proton.
39-41
 In 
contrast to (–)-1, the use of the (+)-sparteine surrogate (+)-13 leads to complete 
deprotonation over 2 h at –78 °C, as confirmed by in situ IR spectroscopy.12 
Enantioselectivities are similar to those obtained with (–)-1 but with the expected 
opposite sense of induction (Scheme 1.11).
12, 42
 As stated previously, (+)-13 has been 
shown to form a monomeric iPrLi/diamine complex in THF. As lower order 
alkyllithium species are typically more reactive than their higher order counterparts,
43
 it 
may simply be that due to the increased binding affinity of (+)-13 relative to (–)-1, it is 
better able to deaggregate the sBuLi to a more reactive species that can more readily 
overcome the kinetic energy barrier of deprotonation.   
 
Scheme 1.11 
Despite the difference in relative kinetic barriers, lithiated N-Boc piperidine 18 has been 
demonstrated to be configurationally stable at –78 °C.12 The mechanism of 
enantioinduction, provided the temperature is kept at –78 °C, must therefore be an 
enantioselective deprotonation as is the case with N-Boc pyrrolidine 7. This was 
formally proven by tin-lithium exchange at –78 °C on racemic stannane 19. After tin-
lithium exchange, (+)-1 was added and the reaction was incubated at –78 °C for 2 h. 
22 
 
The lithiated intermediate was then trapped with methyl chloroformate to give rac-20, 
indicating that enantioinduction does not occur after the deprotonation event (Scheme 
1.12). 
 
Scheme 1.12 
In contrast to N-Boc piperidine 17, N-Boc piperazine 21 lithiates rapidly, even in the 
absence of a diamine (Scheme 1.13).
36
 Although the exact reason for this effect is 
unknown, two possible explanations for this effect can be suggested. It could be that N-
Boc piperazine 21 adopts a different conformation to N-Boc piperidine 17 and thus 
allows more facile deprotonation. Alternatively, the electron withdrawing β-nitrogen 
could lower the pKa of the α-protons in N-Boc piperazine 21.  
 
Scheme 1.13 
 
 
 
 
 
 
 
23 
 
1.2.3 α-Lithiation-Substitution of 3-Membered Nitrogen Containing Heterocycles  
Although α-lithiation-substitution chemistry is well established for N-Boc pyrrolidine 7 
and N-Boc piperidine 17, N-Boc aziridines behave differently under similar conditions. 
In 1994, Beak carried out the first α-lithiation-substitution reaction of N-Boc aziridine 
22 and the 2-methyl 23 and 2-trimethylsilyl derivatives 24 (Scheme 1.14).
44
 
 
Scheme 1.14 
Beak did not comment on the diastereoselectivity of the reaction, although it is likely 
that the two ring substituents are trans to one another, as has been demonstrated on 
similar substrates.
45-48
 It is also worth noting that the substituted aziridine could only be 
accessed with an in situ Me3SiCl trap. In the original reporrt, Beak did not speculate on 
why this was the case, although it is now known that 2-lithio-N-Boc aziridines rapidly 
undergo a 1,2-migration to give the corresponding 2-substituted free amine, as 
demonstrated by Hodgson (Table 1.3).
47
 
 
Table 1.3: Yields of 1,2-Migration Products on a Variety of N-Boc Aziridines 
24 
 
It is unclear why this migration occurs with N-Boc aziridines but not with larger ring 
sizes. A possible reason may be that the nitrogen lone pair does not delocalise into the 
π* C=O  orbital as efficiently in three-membered ring (Figure 1.3). 
 
Figure 1.3 
The extra ring strain of N-Boc aziridine 22 has been exploited by Aggarwal
46
 to 
stereoselectively gain access to 1,2-amino alcohols (Table 1.4): 
 
Table 1.4: Lithiation-Boronate Rearrangements of Isopropyl N-Boc Aziridine 
The reaction proceeds diastereoselectively and enantioenriched starting materials retain 
their original enantioenrichment in the product (Sheme 1.15). 
 
Scheme 1.15 
The tendency of the Boc group to migrate largely restricts the applicability of more 
traditional α-lithiation-substitution chemistry to unreactive electrophiles that can be 
used for in situ trapping ie. Me3SiCl and boronates. 
25 
 
In 2005, Hodgson
49
 reported the first successful directed α-lithiation-substitution 
reaction on racemic aziridine 25 without using utilising an in situ electrophilic trap. The 
Boc group was substituted for a t-butyl sulfone directing group, thus avoiding the 
previously unwanted side reaction of 1,2-migration (Scheme 1.16). 
 
Scheme 1.16 
Lithiation is both regioselective and diastereoselective, with the proton trans to the alkyl 
chain being removed and is compatible with a wide range of electrophiles. However, to 
the best of our knowledge, no asymmetric variant of this reaction has been reported. 
In 1997, Vedejs
45
 reported the first example of an α-lithiation-substitution reaction on 
an aziridine without an internal directing group. TBS protected aziridine 26 was treated 
with borane to give the stable aziridine-borane complex 27 which could then be lithiated 
with sBuLi and trapped with a variety of electrophiles (Scheme 1.17). 
26 
 
 
Scheme 1.17 
Lithiation occurs syn to the boron, although it is likely that this is purely down to sterics, 
rather than any directing effect from the boron. Crucially, Vedejs demonstrated that the 
lithiated intermediate is configurationally stable at –78 °C.  Tin-lithium exchange on a 
77:23 diastereomeric mixture of stannanes rac-28 and rac-29, followed by trapping 
with Bu3SnCl gave re-formed stannanes rac-28 and rac-29 in a largely unchanged 
82:18 diastereomeric ratio (Scheme 1.18). When aziridine 30 was lithiated and trapped 
with Bu3SnCl, stannanes rac-28 and rac-29 were formed in a 98:2 diasteremeric ratio 
(Scheme 1.18). The results imply that diastereoselectivity is not due to a resolution of 
the 2-lithio borane-aziridine, otherwise both experiments would have given an identical 
diastereomeric ratio.  
 
Scheme 1.18 
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In 2002, Vedejs
50
 reported the first asymmetric α-lithiation substitution reaction on a 
veriety of aziridine-boranes. The use of (–)-sparteine (–)-1 as the chiral diamine gave 
access to 2-substituted aziridines in a consistent er of approximately 85:15, although the 
absolute configuration of the products was not assigned (Table 1.5). 
 
Table 1.5: (–)-1 Mediated Lithiation-Trapping of Borane-Aziridine Complexes 
 
1.2.4 α-Lithiation-Substitution of 4-Membered Nitrogen Containing Heterocycles 
In contrast with 3-,5- and 6-membered rings, lithiation-trapping of the corresponding 4-
membered rings, azetidines, has not been as widely explored. Prior to 2010, the only 
known examples of successful lithiation on an azetidine were reported by Seebach
51, 52
 
in 1977 and 1981. Azetidines 31 and 32 were lithiated with tBuLi and LDA, 
respectively, and then trapped with benzaldehyde to give product alcohols rac-33 and 
rac-34 in 62% and 65% yield (Scheme 1.19). The relative stereochemistry of rac-33 
and rac-34 was not proven and the diastereoselectivity was not mentioned in either 
instance. The harsh conditions required to lithiate triphenyl acyl azetidine 31 also mean 
it is unclear as to whether the carbonyl group acts as a true directing group in the 
deprotonation step, or whether it is simply due to the electron withdrawing effect of the 
nitrogen atom.  
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Scheme 1.19 
More recently, Hodgson
20
 reported the first examples of the successful α-lithiation-
substitution reaction on azetidine 35 (Scheme 1.20). 
 
Scheme 1.20 
Yields were good with all the electrophiles tested. Interestingly, using benzaldehyde as 
the electrophile, Hodgson reported that rac-38 was formed as a single diastereoisomer.  
Of greater note is that the use of Boc, SOtBu, SO2tBu and PO(OEt)2 as directing groups 
either led to decomposition, only partial lithiation or no observable lithiation. Of the 
protecting groups tested, only the thiopivalamide, first reported by Seebach
53
 in 1976 
(Scheme 1.21), allowed complete lithiation to occur at the α position.  
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Scheme 1.21 
Use of the thioamide directing group may allow facile deprotonation due to both the 
longer C=S bond length relative to the C=O bond length and the larger, more diffuse sp
2
 
p-orbitals containing the lone pairs on the sulfur atom (Figure 1.4). This may allow the 
reactive carbon centre of sBuLi to come into closer proximity to the α-protons and 
permit efficient deprotonation.
54, 55
 
 
Figure 1.4 
The thioamide group is less synthetically useful than the Boc group. However, some 
useful transformations are possible (Scheme 1.22). For example, the thioamide can  be 
removed with MeLi or refluxing ethylenediamine, oxidised to the corresponding amide 
using hydrogen peroxide or desulfurised by treatment with LiAlH4. 
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Scheme 1.22 
Hodgson also reported the first example of an asymmetric α-lithiation substitution of N-
thiopivaloyl azetidine 35 (Table 1.6). Of the four ligands tested, (R,R)-12 gave the 
highest enantioselectivity, forming methylated (R)-40 in an 80:20 enantiomeric ratio 
(Table 1.6, entry 4). The results were intriguing. For example, (–)-1 which works well 
with N-Boc heterocycles gave low enantioselectivities and no explanation was offered 
on the mechanism of enantioinduction. 
 
Table 1.6: Optimisation of the Asymmetric Lithiation-Trapping of 35 
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Hodgson
56
 has also utilised the thiopivaloyl moiety to lithiate azetidinol 42, under 
similar conditions used to lithiate 35 (scheme 1.23). For all except deuterium, the 
electrophile takes the trans-position to the hydroxyl group. 
 
Scheme 1.23 
More recently, Hodgson
57
 has also reported the use of the t-butoxythiocarbonyl group 
(Botc) to direct lithiation to the α-position of azetidine (Scheme 1.24). 
 
Scheme 1.24 
An interesting difference in regioselectivity between thiopivalamide and Botc was 
observed with methylated azetidines 40 and 44 (Scheme 1.25).
58
 Lithiation-trapping of 
azetidine 40 gives rise to gem-dimethyl compound 45, whereas the analogous reaction 
on azetidine 44 gives rise to the 2,4-dimethyl compounds rac-46 and rac-47. 
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Scheme 1.25 
For 40, the disfavourable steric interaction between the t-butyl and methyl groups would 
be an obvious explanation as to why the trans rotamer is favoured (Scheme 1.26). For 
44, the additional C-O bond increases the distance between the t-butyl and methyl 
groups and would thus decrease the disfavourable interaction, although why the cis 
isomer itself is favoured is unclear.  
 
Scheme 1.26 
As with azetidine 35, 43 proved amenable to asymmetric lithiation-trapping with 
diamine (S,S,S,S)-48, another diamine initially developed by Alexakis
59
 in 2012, 
proving to be the best ligand, with a maximum er of 92:8 obtained with acetone as the 
electrophile (Scheme 1.27). 
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Scheme 1.27 
Although Hodgson has reported the first asymmetric α-lithiation-substitution reactions 
on 35 and 43, no explanation was offered as to how enantioinduction occurs.  
Recently, Luisi
60
 investigated the behaviour of various lithiated 2-aryl-N-Boc azetidines 
(Table 1.7). Given that N-Boc azetidine was previously proven to be resistant to 
lithiation by Hodgson, the aromatic ring must therefore significantly acidify the α-
hydrogens, most likely via delocalisation of the negative charge into the aromatic ring. 
Treatment of a variety of 4-substituted aromatic N-Boc azetidines with sBuLi and 
trapping with acetone gave the self-addition products shown below in Table 1.7. 
Interestingly, when ortho-tolyl-N-Boc azetidine was lithiated, the corresponding self 
addition products were not observed (Scheme 1.28).  
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Table 1.7: Results of Self-Addition Reactions of 2-Aryl N-Boc Azetidines 
 
 
Scheme 1.28 
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1.3 Project Outline 
The starting point in this project was the development of an effective lithiation-trapping 
based synthetic route for the total synthesis of (+)-retronecine (+)-49 (Figure 1.5), a 
hepatotoxic pyrrolizidine alkaloid found in Jacobaea vulgaris.
61
  
 
Figure 1.5 
The earliest total synthesis of racemic retronecine was reported in 1962 by Geissman.
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Starting from carbamate-ester 50, racemic retronecine was synthesised 0.91% yield and 
12 steps (Scheme 1.29).  
 
Scheme 1.29 
Although (+)-retronecine has been successfully synthesised asymmetrically in several 
syntheses,
63-68
  our proposed synthesis would be only eight steps, comparing favourably 
to the most recent synthesis by Roche who synthesised (+)-retronecine in 13 steps.  Our 
proposed synthesis would synthesise azetidine 35 by a two step acylation-thiolation 
reported by Hodgson.
20
 This would be followed by an asymmetric lithiation-trapping 
using an aldehyde such as 51 as the electrophile. If azetidine 35 behaves in a similar 
manner to N-Boc pyrrolidine 7 or N-Boc piperidine 17, then the (+)-sparteine surrogate 
(+)–13 should give the product with the correct configuration. Hodgson also reported 
that when benzaldehyde was used as electrophile, the reaction was completely 
diastereoselective in favour of the syn diastereoisomer 38. Our proposed synthesis 
would make use of this diastereoselectivity to control two stereocentres in one step to 
form (S,S)-52 (Scheme 1.30). 
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Scheme 1.30 
From then, methyllithium-mediated deprotection would be followed by alkylation with 
allyl bromide to give azetidine (S,S)-53, then mesylation and ring expansion would be 
carried out to give pyrrolidine (R,R)-54. This reaction proceeds by initial mesylation of 
the alcohol, followed by an intramolecular nucleophilic substitution of the mesylate by 
the nitrogen lone pair, generating a transient aziridinium species.
69
 This would then be 
ring opened in another nucleophilic substitution reaction with a hydroxide anion to 
generate the product pyrrolidine (Scheme 1.31). Ring closing metathesis and fluoride 
deprotection should finally afford (+)-retronecine (+)-49 in eight linear steps. 
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Scheme 1.31 
In order to carry out an effective synthesis of (+)-retronecine, several mechanistic 
aspects of the asymmetric α-lithiation-trapping of N-thiopivaloyl azetidine 35 needed to 
be explored. Chapter 1.4 will explore racemic lithiation-trapping of N-thiopivaloyl 
azetidine and the unexpected reactivity of the lithiated intermediate. Chapter 1.5 will 
then explore the mechanism of asymmetric induction to determine whether 
enantioinduction occurs via an enantioselective deprotonation or a dynamic resolution.  
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1.4 Racemic Lithiation-Substitution Reactions 
To begin with, azetidine thiopivalamide 35 was prepared from azetidine hydrochloride 
according to the procedure reported by Hodgson.
20
 The two-step acylation-thiolation 
reaction sequence afforded N-thiopivaloyl azetidine 35 in an overall yield of 77% 
(Scheme 1.32). Both the intermediate amide 56 and the thioamide 35 could be purified 
by vacuum distillation and the reaction sequence worked reliably on a multi-gram scale.  
 
Scheme 1.32 
With our ultimate goal being a total synthesis of (+)-retronecine (+)-49, understanding 
the behaviour of the azetidine lithiation-trapping reaction was important, especially for 
acrolein-type electrophiles which had not been explored previously. Therefore, our first 
α-lithiation substitution reactions on thioamide 35 were carried out under racemic 
conditions using sBuLi and TMEDA as diamine and benzaldehyde as the electrophilic 
trapping partner. This was done to explore comparability with Hodgson's results and to 
gain familiarity with this chemistry. Thus lithiation-substitution with benzaldehyde as 
electrophile gave a 65:35 mixture of diastereomeric alcohols syn-38 and anti-57 by (
1
H 
NMR spectroscopy of the crude reaction mixture). They were readily separated by flash 
column chromatography to give syn-38 in 37% yield and anti-57 in 19% yield (Scheme 
1.33). 
Scheme 1.33 
The identity and relative stereochemistry of syn-38 and anti-57 were confirmed by X-
ray diffraction on a suitable single crystal of each diastereoisomer (Figure 1.6).  
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Figure 1.6 
Interestingly, Hodgson reported this reaction as being completely diastereoselective for 
the alcohol syn-38 (Scheme 1.34). 
 
Scheme 1.34 
However, in our hands, anti-58 was always observed, even after multiple repeats of the 
experiment. Upon closer inspection of the supporting information of Hodgson's paper, it 
is clear that anti-58 was present in the 
1
H NMR spectrum of syn-38. Yields of the 
reaction in our hands were also noticeably lower than that reported by Hodgson.  
Although the major diastereoisomer (syn-38) was the same, the presence of the minor 
diastereoisomer (anti-58), coupled with the lower than anticipated yields led to a need 
to develop more robust synthetic methodology before attempting reactions with 
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protected aldehyde 51 as needed for the total synthesis of (+)-retronecine (+)-49. 
Acrolein possesses both aldehyde and alkene functionality, but is commercially 
available and would serve as a reasonable model substrate in lieu of aldehyde 51. Thus 
azetidine thiopivalamide 35 was subjected to α-lithiation-substitution using acrolein as 
the electrophile (Scheme 1.35). 
Scheme 1.35 
Diastereomeric alcohols syn-58 and anti-59 were formed in a 60:40 diastereomeric ratio 
(by 
1
H NMR of the crude reaction mixture) in a disappointing 38% combined yield. The 
relative stereochemistry of each alcohol was determined by separately acylating each 
alcohol with para-nitrobenzoyl chloride to form the solid para-nitrobenzoate esters, 
then crystallising and subjecting each to X-ray diffraction (Scheme 1.36). The X-ray 
crystal structures are shown below in Figure 1.7. 
 
Scheme 1.36 
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Figure 1.7 
Given that neither benzaldehyde nor acrolein possess enolisable protons, it was 
envisaged that the cause of the low yields would not be due to the trapping step, but 
rather due to instability of the lithiated intermediate. Hence, we focused our attention on 
the lithiation step of the reaction and investigated whether or not lithiated azetidine 35 
was stable under the reaction conditions.  
Thus, azetidine 35 was lithiated at –78 °C in THF, allowed to stir for 1 h and then 
quenched with methanol (Scheme 1.37). Ideally, 35 should lithiate cleanly to give the 
lithiated azetidine. If the organolithium is stable, then starting material 35 should be 
recovered in quantitative yield upon addition of MeOH.  
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Scheme 1.37 
From this experiment, thioamide 35 was recovered in only 46% yield, along with a 
significant quantity of an unknown product 62. Based on a HRMS m/z value of 
258.1345 for the (M+H)
+
 peak for the unknown product, we calculated a 22% yield. It is 
also worth noting, that there is still 32% of material that was unaccounted for during 
this reaction, implying that there is an unknown deleterious reaction pathway.  
Unfortunately, we have not been able to definitively confirm the structure of the 
unknown product 62. It is useful however, to present the analytical data here and our 
speculations. The 
1
H NMR, 
13
C NMR and DEPT spectra and accompanying data are 
shown in Figures 1.8, 1.9 and 1.10.  
 
Figure 1.8 
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Figure 1.9 
 
Figure 1.10 
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Data for unknown product 62: 
1
H NMR (400 MHz, CDCl3) δ 5.01 (dd, J = 7.0, 3.5 Hz, 1H), 2.97 (ddd, J = 11.0, 10.0, 
5.0 Hz, 1H), 2.87–2.81 (m, 1H), 2.48–2.31 (m, 2H), 1.22 (s, 9H), 1.12 (s, 9H) 
13
C NMR (100.6 MHz, CDCl3) δ 179.2, 93.9, 86.0, 40.3, 39.8, 38.2, 31.9, 29.4, 27.5  
From the data, the presence of two t-butyl groups was clearly seen, each signal in the 
1
H 
NMR spectrum integrating for 9H. The presence of the azetidine ring hydrogens, 
integrating to a total of 5H, is also clearly observed. Initially, we believed this unknown 
product 62 to be self-addition product 63 (Figure 1.11), akin to what has also been 
independently observed by Luisi.
60
 
 
Figure 1.11 
We believed that this self-addition product would be formed by attack of lithiated 
azetidine 64 on unlithiated starting material, followed by collapse of the tetrahedral 
intermediate upon quenching, expelling a molecule of azetidine and forming self-
addition product 63 (Scheme 1.38).  
 
Scheme 1.38 
As previously stated, HRMS gave an m/z value of 258.1354, as expected for self-
addition product 63 and therefore appeared to confirm our initial assignment. However, 
the 
13
C NMR spectrum showed the absence of both C=S groups. Thioketones are 
known to have higher 
13
C chemical shifts when compared to ketones, typically in the 
region of 220-280 ppm.
70-72
 Thioamides also have higher chemical shifts relative to 
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amides,
70, 73
 the starting azetidine 35 has a 
13
C chemical shift of 210 ppm, by way of 
example. However, even when 62 was subjected to wide 
13
C NMR spectroscopy, 
scanning between 0-300 ppm, the thioketone and the thioamide peaks were not 
observed. Also worth noting, is that the methyl carbons in the tBu group responsible for 
the signal at 27.5 ppm in the 
13
C NMR spectrum is uncharacteristically broad. Single-
bond HMQC NMR experiments confirmed however that this broad peak was indeed 
caused by the methyl carbon atoms in the tBu group coupling to the methyl hydrogens 
at δ 1.12 ppm in the 1H NMR (Figure 1.12).  
 
Figure 1.12 
Thus, self-addition product 63 could not be the unknown product 62. This was also 
confirmed by the isolation of an authentic sample of 63 from other experiments which 
will be discussed later. By way of comparison, the analytical data for the authentic self-
addition product 63 is presented in Figures 1.13, 1.14 and 1.15: 
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Figure 1.13 
 
Figure 1.14 
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Figure 1.15 
Data for 63: 
1
H NMR (400 MHz, CDCl3) 6.09 (ddd, J = 9.5, 4.5, 1.5 Hz, 1H, CHN), 4.59–4.51 (m, 
1H, CHAHBN), 4.47 (ddd, J = 9.5, 9.5, 5.0 Hz, 1H, CHAHBN), 2.59–2.49 (m, 1H, 
CHAHB), 1.88–1.79 (m, 1H, CHAHB), 1.39 (s, 9H, CMe3), 1.35 (s, 9H, CMe3) 
13
C NMR (100.6 MHz, CDCl3) δ 259.2 (C=S), 209.2 (NC=S), 74.8 (CHN), 55.0 
(CH2N), 51.7 (CMe3), 43.1 (CMe3), 30.1 (CMe3), 29.8 (CMe3), 24.4 (CH2). 
Hitherto however, we have been unable to conclusively determine the identity of 
product 62.  Scheme 1.39 represents our best suggestion for the structure of unknown 
compound 62, as well as the mechanism for its formation. Initial attack of lithiated 
azetidine 64 on the sulfur atom of the thioamide 35 forms a second organolithium, 
partially stabilised by the electron withdrawing effect of the nitrogen atom and the α-
anion stabilising effect of the sulfur atom. Intramolecular attack of the organolithium on 
the thioamide group then forms the bicyclic intermediate, followed by expulsion of 
azetidine upon quenching with methanol. Finally, the sulfide attacks the thioxonium ion 
to generate the final product 62.  
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Scheme 1.39 
As we expected that solvent and temperature would affect the formation of the unknown 
product 62, we decided to repeat the reaction at –100 °C, reduce lithiation times and 
change the solvent from THF to Et2O. Thus, azetidine 35 was lithiated in Et2O at –100 
°C for 2 minutes. In order to determine whether complete lithiation occurs under these 
conditions, CD3OD was used as the electrophile rather than MeOH (Scheme 1.40). 
Under these conditions, starting deuterated azetidine 65 was recovered in 90% yield, 
with 100% deuteration occuring, as well as 14% of self-addition product rac-63. The 
greater than quantitative recovery of starting material was possibly due to a minor 
amount of contamination from long chain hydrocarbons that occurred during column 
chromatography.  
 
Scheme 1.40 
13
C NMR spectroscopy of 63 showed the expected thioketone and thioamide peaks at 
259 and 210 ppm respectively. 
1
H NMR spectroscopy showed 100% deuteration α to 
the nitrogen atom for 65 and no deuterium incorporation for self-addition product rac-
63. The percentage of deuterium incorporation can be calculated by taking the ratio of 
the integration value between the CH2 group and the adjacent CH2N/CHDN groups 
49 
 
(Figure 1.16). At 0% deuteration, each CH2N group, as well as the CH2 group, will 
integrate to 2H. At 100% deuteration, each CH2N/CHDN group will integrate to 1.5, 
whereas the CH2 group will remain unchanged at 2H. Thus, the observed ratio that can 
be seen from Figure 1.16 is 1.45:2, implying complete deuterium incorporation. 
13
C – D 
coupling  could also be clearly observed in the 
13
C NMR spectrum, with a coupling 
constant of 23 Hz (Figure 1.17).  
 
Figure 1.16 
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Figure 1.17 
These results allowed several conclusions to be drawn. First, azetidine 35 is very easily 
deprotonated, even at –100 °C. Second, that due to higher recovered yields of the 
starting material, the extent to which side reactions can compete is substantially 
lessened. Effectively all material was accounted for and the yield of recovered starting 
material was almost doubled. Third, the tetrahedral intermediate formed by reaction of 
35 with 64 is most likely to be stable under the reaction conditions until the addition of 
CD3OD. If the tetrahedral intermediate were to collapse under the reaction conditions, 
deprotonation of the acidic proton α to the thioketone would occur to generate a 
thioenolate (Scheme 1.41). Given that deuteration of thioenolate 66 to form deuterated  
self-addition product rac-67 is not observed, this reaction pathway does not occur. In 
terms of pKa values, it is also highly unlikely that a sulfur anion (pKa ~10.5) would 
expel a lithium amide (pKa ~35). 
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Scheme 1.41 
Given as we had identified suitable conditions for the lithiation-trapping of azetidine 35, 
the reactions with benzaldehyde and acrolein were carried out under the new lithiation 
conditions, the results of which are shown in scheme 1.42, along with a tentative 
explanation of the diastereoselectivity of the reaction: initial coordination of the oxygen 
atom to the lithium ion serves to tether the electrophile to the organolithium reagent. 
Trapping could then occur via a 2+2 cycloaddition-type mechanism. The lowest energy 
configuration shown in scheme 1.42 maximises the distance between the bulky R and 
tBu groups, thereby minimising steric hindrance and lowering the kinetic energy barrier 
to reaction via this configuration.  
 
Scheme 1.42 
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With benzaldehyde as electrophile, the total yield increased from 56% to 88% and, with 
acrolein, the total yield almost doubled from 38% to 65%. The diastereoselectivity for 
both reactions appeared to be relatively unchanged when compared to the results in 
THF at –78 °C. Of the two electrophiles, acrolein is most chemically similar to 
protected aldedyde 51, required for the total synthesis of (+)-retronecine. Yields for 
acrolein were acceptable and the major diastereoisomer is the same as that required for 
(+)-retronecine (+)-49, though the diastereoselectivity was lower than desired.  
Using our optimised procedure, the reaction was tested on a variety of electrophiles to 
check for generality and applicability. The electrophiles tested were CO2, Me2CO, 
Ph2CO (Scheme 1.43), Me3SiCl (Scheme 1.44) and MeOCOCl (Scheme 1.45). Yields 
for CO2, Ph2CO and Me2CO were much lower than the yields observed when 
benzaldehyde or acrolein were used as electrophiles. Benzophenone adduct rac-68 was 
insoluble in all but halogenated solvents and material was likely lost during flash 
column chromatography in its purification. Propanone contains enolisable protons, 
deprotonation of which by lithiated azetidine 64 could have contributed to the low 
yields observed in this instance.    
 
Scheme 1.43 
Lithiation-trapping of azetidine 35 with methyl chloroformate as electrophile gave 
methyl ester rac-70 in a disappointing 13% yield, with 62% yield of an additional 
unknown product. HRMS gave an m/z value of 363.1534 (M+Na)
+
, which would be 
consistent with the self-addition products meso/rac-71/72 shown in Scheme 1.44. The 
1
H NMR, 
13
C NMR and IR spectra gave results that were consistent with the proposed 
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structures for meso/rac-71/72, with the ketone being a key diagnostic peak in the IR 
spectrum (1703 cm
-1
) and the 
13
C NMR spectrum (δ 204 and 202 ppm). Whilst the 
relative stereochemistry of the major isomer could not be confirmed, the 
diastereoselectivity could be ascertained by taking the ratio of integrals for the CHN 
protons at δ 5.35 and 5.15 ppm in the 1H NMR spectrum of the crude reaction mixture. 
The 
1
H NMR and 
13
C NMR spectra of the purified 81:19 diastereomeric mixture of 
meso/rac-71/72 are shown below in Figures 1.18 and 1.19.  
 
Scheme 1.44 
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Figure 1.18  
 
Figure 1.19 
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Lithiation trapping of azetidine 35 with Me3SiCl gave the expected α-silyl azetidine 
rac-36 in 64% yield, as well as 14% of an unknown product with an m/z value of 
307.1785 (M+H)
+
, indicating the presence of two Me3Si substitutions. NMR data, as 
well as previous literature studies which will be discussed later, confirm that the 
unknown product is doubly substituted 1,1-disilyl azetidine 73. This reaction and the 
mechanism of its formation is shown below in Scheme 1.45. 
 
Scheme 1.45 
Theoretically, there are two additional isomers of disilane 73 that could form, cis-1,3-
disilane 74 and trans-1,3-disilane 75 (Scheme 1.46). Hodgson
58
 demonstrated in 2015 
that the half-life for interconversion of rotamers of azetidine 35 is 13.7 years at –78 °C! 
As previously discussed, the lone pair on the sulfur atom will direct lithiation to the 
same side of the azetidine ring. As the reaction temperature is –100 °C, rotameric 
interconversion followed by lithiation at the 3-position is highly unlikely. Not only that, 
but the initial silyl substitution serves to acidify the carbon atom it is bonded to via the 
α-anion effect, making deprotonation at the 3-position even less likely.  
Scheme 1.46 
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The 
1
H NMR spectrum also confirmed that substitution occured to give the 1,1-disilyl 
product 73 (Figure 1.20). Interconversion of rotamers in the product is likely to be slow 
on the NMR timescale. Therefore the CHN signals for both 1,3-disilyl azetidines cis-74 
and trans-75 would be non-equivalent and each would give its own signal. As can be 
seen from the 
1
H NMR spectrum of the obtained product (Figure 1.20), only 1 CH2N 
signal is observed, confirming its identity as 1,1-disilyl azetidine 73. The C(SiMe3)2 
atom in the 
13
C NMR spectrum also appears as a quarternary centre, further confirming 
the assignment of 73.  
 
 
Figure 1.20 
In summary, we have carefully studied the racemic lithiation-trapping of azetidine 35. 
In particular, new conditions for the lithiation of 35 (sBuLi, TMEDA, Et2O, –100 °C, 2 
min) were optimised. With some electrophiles and conditions, various side products 
were isolated and where possible, characterised.  
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1.5 Asymmetric α-Lithiation–Substitution Reactions of N-Thiopivaloyl Azetidine 
and Pyrrolidine 
1.5.1 Previous Results From Our Group 
During this time, results obtained within our group
74
 casted doubt on the viability of 
completing an asymmetric synthesis of (+)-retronecine via the α-lithiation-trapping 
methodology. The asymmetric α-lithiation-substitition reaction of azetidine 35 with 
benzaldehyde was investigated by another member of our group using three separate 
chiral diamines: (–)-sparteine (–)-1, Alexakis' diamine (S,S)-12 and the (+)-sparteine 
surrogate (+)-13 (Table 1.8). Whilst the yields for the major diastereoisomer were 
comparable, use of (S,S)-12 and (+)-13 gave effectively racemic product (Table 1.8, 
entries 2 and 3). The use of (–)-sparteine (–)-1 as the chiral diamine gave the highest 
enantioselectivities, though with the opposite configuration to that required for a 
synthesis of (+)-retronecine.  
 
Table 1.8: Role of Chiral Diamine in the Lithiation-Trapping of 35 with Benzaldehyde 
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Other recent results from within the group included the fact that lithiated azetidine 64 
was configurationally unstable at –78 °C. Enantioenriched stannane (S)-37 which had 
been prepared by an asymmetric lithiation-trapping with (–)-sparteine (–)-1 was 
subjected to tin-lithium exchange using nBuLi and TMEDA in Et2O at –78 °C, followed 
by trapping with benzaldehyde. The benzaldehyde adducts obtained were racemic 
(Scheme 1.47), thus demonstrating facile interconversion between the enantiomers of 
lithiated azetidine 64 at –78 °C as lithiated azetidine 64 was left for only 5 minutes 
before electrophilic trapping.  
Scheme 1.47 
This result is in stark contrast to N-Boc pyrrolidine 7, N-Boc piperidine 17 and borane-
aziridine complex 27, which lithiate to give configurationally stable intermediates at –
78 °C. The  lithiated species of the corresponding 5-membered analogue, N-thiopivaloyl 
pyrrolidine 76, was also found to be configurationally unstable at –78 °C. An analogous 
reaction was performed starting from enantioenriched stannane (S)-77, followed by tin-
lithium exchange and trapping with benzaldehyde (Scheme 1.48). Given that lithiated 
N-Boc pyrrolidine is configurationally stable at –78 °C, it can be concluded that the 
thiopivalamide directing group is responsible for the configurational instability in the 5- 
and 4-membered rings. 
Scheme 1.48 
The conclusion from the previous work in the group is that the asymmetric lithiation-
trapping of azetidine 35 carried out by Hodgson and us cannot be an enantioselective 
deprotonation, as this is not possible with configurationally unstable organolithium 
species. This explains why (–)-sparteine (–)-1 and the (+)-sparteine surrogate (+)-13 
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give such different results (Table 1.8). The mechanism that accounts for 
enantioinduction must therefore be either a dynamic thermodynamic resolution (Scheme 
1.59) or a dynamic kinetic resolution (Scheme 1.60).  
 
1.5.2 Electrophile Variation in the Asymmetric Lithiation-Substitution of N-
Thiopivaloyl Azetidine and Pyrrolidine 
With a lack of precedent for high enantioselectivities in the correct sense for the 
lithiation–trapping of azetidine 35, our attention turned away from the planned total 
synthesis of (+)-retronecine. Instead, research focused on varying the electrophile and 
diamine in the asymmetric lithiation-trapping reactions, with an ultimate aim to fully 
explore the scope and limitations of this chemistry. In addition, we wished to clarify the 
sense of induction with as many electrophiles as possible, as the group’s initial results 
indicated that different electrophiles were giving different absolute configurations under 
identical conditions for lithiation (Scheme 1.49). Hence, much time and effort was spent 
developing approaches to proving the absolute configuration of the major products.  
 
Scheme 1.49 
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As outlined above, lithiation-trapping of azetidine 35 with benzaldehyde and methyl 
iodide gave products with different absolute stereochemistry, but gave products with the 
same configuration were obtained for the corresponding pyrrolidine 76. Therefore, the 
reaction was repeated using other electrophiles.  
To begin with, azetidine 35 was subjected to an asymmetric lithiation-trapping with 
sBuLi/(–)-1 in Et2O at –78 °C for 30 minutes, then trapped with carbon dioxide to give 
the carboxylic acid (S)-69 in 96% yield and 75:25 er (Scheme 1.50). Interestingly, 
under these conditions, self-addition products 62 and 63 were not observed in the 
1
H 
NMR spectrum of the crude reaction mixture. As previously stated, (–)-sparteine (–)-1 
is known to be a much less activating diamine than TMEDA. Not only that, TMEDA is 
sterically much smaller than (–)-1. It is feasible to imagine that the additional steric bulk 
of (–)-1 prevents the reactive carbon centre of lithiated azetidine 64 from getting into 
close proximity to the C=S group to form the self-addition product. 
 
Scheme 1.50 
The enantioselectivities of the final product (S)-69 was determined by taking a small 
quantity (~ 2 mg) of the solid product (S)-69, forming the methyl ester by treatment 
with TMS-diazomethane in toluene/MeOH
75, 76
 and then subjecting the product ester to 
chiral stationary phase HPLC. It was noted that when the reaction was repeated under 
identical conditions, (S)-69 was found to have an er of 89:11. When the entirety of both 
samples were re-dissolved, an aliquot of both solutions taken then separately derivatized 
to the methyl ester, both samples showed an identical enantiomeric ratio of 75:25. This 
result led to the realisation that (S)-69 can enantioenrich via crystallisation. We 
wondered whether we could obtain a highly enantioenriched sample suitable for X-ray 
diffraction by recrystallisation. Indeed, a single recrystallisation of (S)-69 with an er of 
75:25 from hexane/EtOAc allowed isolation of (S)-69 in with an er of 97:3 from the 
filtrate (ie,. racemic crystals of 69 crystallised). From this material, single crystals 
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suitable for X-ray diffraction were grown and an X-ray structure was obtained, 
confirming the absolute stereochemistry of (S)-69 (Figure 1.21). 
 
Figure 1.21 
Given that the configuration of acid (S)-69 is opposite to the configuration α to nitrogen 
of benzaldehyde adducts (R,R)-38 and (R,S)-57 α to the nitrogen, we desired further 
proof of stereochemistry of acid (S)-69. Therefore, an independent synthesis from 
commercially available, enantiomerically pure (S)-azetidine carboxylic acid (S)-82 was 
developed.  Enantiomerically pure (S)-82 was esterified to the methyl ester using TMS-
diazomethane in toluene/MeOH, the Boc group removed via treatment with TFA and 
the nitrogen acylated with pivaloyl chloride to give enantiomerically pure (S)-83 in an 
overall yield of 41% over 3 steps (Scheme 1.51). Carboxylic acid (S)-69 with an er of 
75:25, prepared via sBuLi/(–)-1 lithiation-trapping of azetidine 35, was oxidised to the 
amide by treatment with oxone in a 1:1 mixture of water/MeOH, then the crude residues 
esterified to the methyl ester with TMS-diazomethane to give (S)-83 in a 47% yield 
over 2 steps and an er of 76:24. A racemic sample of rac-83 was also prepared via the 
same method from racemic carboxylic acid 69. Chiral stationary phase HPLC analysis 
was carried out on rac-83 to find appropriate conditions to separate the two enantiomers. 
Then, enantiomerically pure (S)-83 was subjected to chiral stationary phase HPLC to 
determine which of the two peaks in the HPLC trace corresponded to the (S)-enantiomer. 
Finally, (S)-83 of a 76:24 er was subjected to chiral stationary phase HPLC to confirm 
that the major isomer was the (S) enantiomer.  
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Scheme 1.51 
We wanted to investigate whether the corresponding pyrrolidine 76 would react with 
CO2 to give the corresponding carboxylic acid with the opposite configuration to the 
products obtained by reaction with benzaldehyde. Pyrrolidine 76 was lithiated using 
sBuLi/(–)-1 in Et2O at –78 °C for 1 h, then trapped with CO2 to give acid (S)-87 in 76% 
yield and an er of 80:20 (Scheme 1.52).  
 
Scheme 1.52 
Initial proof of stereochemistry followed the route of the previously established method 
for (S)-69. Carboxylic acid (S)-87 was enantioenriched via recrystallisation from 
hexane/EtOAc, with three successive recrystallisations improving the er from 80:20 to 
90:10, to 96:4 and finally to 98:2. Single crystals were then grown from this 
enantioenriched material and submitted for X-ray diffraction, confirming the 
stereochemical assignment of (S)-87 (Figure 1.22).  
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Figure 1.22 
As with the corresponding azetidine acid (S)-69, a two-step oxidation-esterification 
procedure was used to form (S)-88 in quantitative yield and 98:2 er. Enantiomerically 
pure (S)-proline was subjected to a Fischer esterification
77
 to form the methyl ester (S)-
90, then acylated with pivaloyl chloride to form enantiomerically pure (S)-88 in a 69% 
yield over two steps (Scheme 1.53). A racemic sample of rac-88 was also prepared 
using the same two step oxidation-esterification procedure using rac-87 as starting 
material. HPLC analysis of the racemate, the enantiomerically pure (S)-87 and (S)-87 of 
98:2 er confirmed the original X-ray assignment.  
 
Scheme 1.53 
With carbon dioxide as an electrophile having been fully explored, our attention turned 
to the use of methyl chloroformate as the electrophile. Lithiation of azetidine 35 with 
sBuLi/(–)-1 in Et2O at –78 °C for 30 minutes, followed by trapping with methyl 
chloroformate gave methyl ester (R)-70 in a 45% yield and 67:33 er, as well as 26% of 
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self-addition products 71/72 in an 80:20 diastereomeric ratio (Scheme 1.54). Proving 
the absolute stereochemistry of (R)-70 was trivial, as acid (S)-69 with known 
stereochemistry had to be derivatized to the corresponding methyl ester (S)-70 prior to 
HPLC analysis.  
 
Scheme 1.54 
For the corresponding reaction on pyrrolidine 76, lithiation with sBuLi/(–)-1 in Et2O 
at –78 °C for 1 hour, followed by trapping with methyl chloroformate gave (R)-91 in 
58% yield and a 76:24 er (Scheme 1.55). Curiously, the analogous self-addition 
products seen in the azetidine system was not observed in the pyrrolidine ring. Proving 
the absolute stereochemistry was straightforward due to the known stereochemistry of 
acid (S)-87.  
 
Scheme 1.55 
The use of methyl chloroformate as the electrophile gives products with the same 
configuration α to the nitrogen atom as to those obtained with benzaldehyde as the 
electrophile. Carbon dioxide, however, appears to react with lithiated azetidine 64 and 
pyrrolidine 78 with inversion of stereochemistry. 
Other electrophiles including benzophenone, acetone and Me3SiCl were also used in the 
sBuLi/(–)-1 lithiation-trapping of azetidine 35. However, enantioselectivities in all 
instances were poor and the absolute stereochemistry of the adducts were not 
determined (Scheme 1.56) 
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Scheme 1.56 
We also briefly investigated the use of (S,S)-Alexakis' diamine (S,S)-12 as a substitute 
chiral diamine for (–)-1. Azetidine 35 was lithiated using sBuLi/(S,S)-12 in Et2O at –78 
°C for 30 minutes, then trapped using Me3SiCl, carbon dioxide and methyl iodide (to 
check reproducibility with Hodgson's results) (Scheme 1.57). The highest 
enantioselectivities were achieved with the comparatively unreactive electrophile 
methyl iodide, with carbon dioxide and Me3SiCl giving almost racemic products.  
 
Scheme 1.57 
With enough results in hand, we then attempted to account for the mechanism of 
enantioinduction in the asymmetric lithiation-trapping of azetidine 35 and pyrrolidine 
76. An overview of the most important results is shown in Scheme 1.58. 
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Scheme 1.58 
The sense of induction in the final products is cleaerly dependent upon the electrophile 
used. Use of carbon dioxide gives a product of opposite configuration to methyl 
chloroformate and benzaldehyde. To the best of our knowledge, this is the first example 
of a non-benzylic C–Li stereocentre reacting with inversion of stereochemistry. Use of 
methyl iodide as electrophile also gives products of opposite configuration between the 
4- and 5- membered rings. Enantioselectivities appear to decrease as the reactivity of the 
electrophile decreases; benzaldehyde and carbon dioxide give near identical 
enantioselectivities, methyl chloroformate slightly lower and methyl iodide the lowest. 
One mechanistic scenario for fast trapping electrophiles such as benzaldehyde, carbon 
dioxide and methyl chloroformate is shown in Scheme 1.59. At –78 °C, a 
thermodynamic equilibrium consisting of a 75:25 mixture of diastereomeric lithiated 
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azetidines is established. With reactive electrophiles, the rate of reaction of each 
diastereomeric organolithium is faster than the rate of interconversion between the 
diastereomeric lithiated azetidines. Due to this, the enantiomeric ratio of the products is 
the same as, or close to, the ratio of diastereoisomers of lithiated azetidines. With less 
reactive electrophiles such as methyl iodide, the rate of reaction between each of the 
lithiated azetidines with the electrophile is slower than the rate of interconversion 
between the diastereoisomers of lithiated azetidine. Due to this, the enantioselectivities 
in the final product are dependent upon the different rates of reaction between each 
diastereomeric lithiated azetidine complex and the electrophile. The difference in the 
sense of induction between methylated products (R)-40 and (S)-81 could be due to the 
(R)-64 lithiated azetidine and (S)-78 lithiated pyrrolidine being the more reactive 
diastereomeric complexes. 
 
Scheme 1.59 
At –78°C, (–)-1 appears to favour the (S) enantiomer of lithiated azetidine 64 in a 75:25 
ratio and the (S) enantiomer of lithiated pyrrolidine 78 in a 80:20 ratio. This is too low 
to realistically be synthetically useful. 
In contrast to (–)-1, (S,S)-12 as the chiral diamine appears to give the opposite trend, 
whereby best enantioselectivities are achieved with methyl iodide, the least reactive 
electrophile. Carbon dioxide as the electrophile gives (S)-69 in a 57:43 er, implying that 
there is a 57:43 thermodynamic ratio between diastereoisomers of lithiated azetidines. 
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As methyl iodide gives a higher enantioselectivity than carbon dioxide, it would suggest 
that enantioinduction is due, in this case, to a dynamic kinetic resolution, whereby the 
rate of reaction between diastereomeric lithiated azetidines is slower than their rate of 
interconversion (Scheme 1.60).  
 
 
Scheme 1.60 
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1.6 Conclusions and Future Work 
Azetidine 35 has been shown to lithiate rapidly using sBuLi/TMEDA in Et2O, even at –
100 °C, to form a highly reactive TMEDA/lithiated azetidine complex, as demonstrated 
by deuteration incorporation experiments. Self-addition has been observed as a 
deletrious side reaction under these racemic conditions, with the isolation of 62 and 63 
being proof of this. An optimised procedure for the racemic lithiation-trapping of 
azetidine 35 has been developed, allowing yields as high as 88% when benzaldehyde is 
used as the electrophile. Diastereoselectivity for the two aldehyde products was shown 
to be modest, although the relative stereochemistry of the major diastereoisomer was 
shown to be correct for our planned synthesis of (+)-retronecine. The difference in the 
sense of induction of the final products when carbon dioxide and methyl chloroformate 
are used in the (–)-1 mediated lithiation-trapping of 35 and 76 is an unexpected result. 
(Scheme 1.61). 
 
Scheme 1.61 
Lithiated azetidine 64 and pyrrolidine 78 are configurationally unstable at –78 °C. The 
use of (–)-1 as a chiral diamine favours the formation of the (S) enantiomer of lithiated 
azetidine 64 and pyrrolidine 78 in a 75:25 and 80:20 ratio respectively. Reactive 
electrophiles are thus most likely to retain this ratio in the final products. (S,S)-12 
appears to induce enantioselectivity via a dynamic kinetic resolution, given that CO2 
gives a product with a lower enantiomeric ratio than with methyl iodide. Overall, the 
mechanism of enantioinduction is dependent upon both the ligand and the electrophile 
employed in the reaction. The poor enantioselectivities observed with the (+)-sparteine 
surrogate (+)-13 and (S,S)-Alexakis' diamine (S,S)-12 have meant that the asymmetric 
synthesis of (+)-retronecine was not feasible. Future work could include the use of the 
Botc group, recently reported by Hodgson,
57
 as well as a variety of other chiral 
diamines to find appropriate conditions to allow an asymmetric total synthesis of (+)-
retronecine to be attempted  (Scheme 1.62). 
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Scheme 1.62 
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Chapter Two: Studies Towards the Total Synthesis of Anthracimycin 
 
2.1 Introduction to Antibiotic Resistance 
One of the most revolutionary developments in human history has been the discovery of 
antibiotics; injuries that would have previously been considered a death sentence are 
now treated as a matter of routine. Nonetheless, as antibiotic use has become more 
frequent and widespread, so too have resistant strains of bacteria. The centre for disease 
control (CDC) lists 18 different antibiotic resistant bacteria of varying threat levels, 
including multi-drug resistant Neisseria gonorrhoeae, methicillin-resistant 
Staphylococcus aureus and alarmingly, vancomycin – an antibiotic of last resort – 
resistant enteroccoci and Staphylococcus aureus. Indeed, in 2014, the World Health 
Organisation stated that:
78
 
 "Antimicrobial resistance (AMR) within a wide range of infectious agents is a 
 growing public health threat of broad concern to countries and multiple sectors. 
 Increasingly, governments around the world are beginning to pay attention to a 
 problem so serious that it threatens the achievements of modern medicine. A 
 post-antibiotic era – in which common infections and minor injuries can kill – 
 far from being an apocalyptic fantasy, is instead a very real possibility for the 
 21
st
 century." 
The problem of antibiotic resistant bacteria is compounded by the fact that there have 
only been two classes of new synthetic antibiotics discovered within the past sixty 
years,
79
 the fluoroquinolones in 1961 and oxazolodinones in 1955, of which, only the 
former possess broad spectrum antibiotic activity. Similarly, for natural products with 
antibiotic activity, there have been only three that have been approved for medical use 
within the last forty years – daptomycin, quinupristin–dalfopristin and fidaxomicin – 
and each was deemed to be inappropriate for medical use when first discovered. Suffice 
to say, the need for new classes of antibiotics is urgent and difficult to overemphasise. 
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2.2 Introduction to Anthracimycin And Chlorotonil 
In 2013, Fenical isolated anthracimycin 92 from a strain of Streptomyces found in a sea 
sponge off the coast of California.
80, 81
 Anthracimycin was found to possess significant 
activity towards Bacillus anthracis, methicillin-resistant Staphylococcus aureus and 
vancomycin-resistant Enterococci,
82
 as well as a range of other gram positive bacteria. 
Interestingly, a similar product, chlorotonil 93, was found in an unrelated bacterium, 
Sorangium cellulosum and was recently discovered to possess potent antimalarial 
activity.
83, 84
 Chlorotonil 93 has an additional methyl group on the decalin ring and a 
gem-dichloro group. Perhaps most interesting, however, is that is has the opposite 
configuration to anthracimycin 92 at all remaining stereocentres. 
Figure 2.1 
Given the structural similarities between anthracimycin 92 and chlorotonil 93, 
anthracimycin was doubly chlorinated with N-chlorosuccinimide to give dichloro–
anthracimycin 94 and its biological activity tested and compared to anthracimycin. 
(Table 2.1).
80
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Table 2.1: Biological Activity Comparison Between 92 and 94 
Anthracimycin 92 showed potent antibiotic activity towards gram positive bacteria B. 
anthracis, S. aureus and E. faecalis, yet poor activity towards gram negative bacteria E. 
coli, H. influenzae, B. thailandensis and P. aeruginosa, whereas dichloro-anthracimycin 
94 is significantly more potent towards the gram negative bacteria with slightly 
decreased potency towards gram positive bacteria. It is speculated that dichlorination 
allows dichloro-anthracimycin 94 to cross the cell barrier more easily, although 
currently this remains unproven. 
Anthracimycin 92, unlike most other macrocyclic antibiobiotics, does not exert its 
biological effects by inhibiting protein synthesis by binding to the 50S ribosomal 
subunit. In contrast, it interferes with DNA replication, although the specific mechanism 
by which it does this has yet to be confirmed.
82
 Recently, the gene cluster responsible 
for the biosynthesis of anthracimycin 92 was identified and the enzyme-mediated 
biosynthetic pathway is shown in Scheme 2.1. Starting from malonyl coenzyme A 95, 
the biosynthetic pathway consists of multiple chain elongation reactions, with the key 
step being the intramolecular Diels-Alder reaction to form the decalin 96 and setting up 
the correct stereochemistry of four stereocentres.  
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Scheme 2.1 
The structurally related chlorotonil 93 on the other hand, is toxic towards all stages of 
Plasmodium falciparum, the organism responsible for causing malaria, with an IC50 of 
between 4-32 nm, depending on strain. The fact that chlorotonil 93 exhibits low toxicity 
towards mammalian cells makes it an attractive target for medicinal use.  
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Remarkably, a total synthesis of chlorotonil 93 was reported in 2008, the same year that 
the natural product was isolated by Kalesse (Schemes 2.2-2.6).
85
 Fragment 97 was 
synthesised from enantioenriched aldehyde 98 via a Still-Gennari
86
 reaction and 
reduction to give 99.
87
 Then, a three-step homologation
88
 gave aldehyde 100 which was 
followed by a Corey-Fuchs homologation
89
 to give 97 in six steps in an overall yield of 
41% (Scheme 2.2) . 
 
Scheme 2.2 
Next, a cross metathesis
90
 between PMB-protected alcohol 101 and vinyl boronic ester 
102 gave fragment 103 in 81% yield and as a single geometric isomer. Suzuki 
coupling
91, 92
 of 97 with boronic ester 103 gave brominated 104 in 76% yield which was 
then deprotected, oxidised and subjected to a stabilised Wittig reaction to give 105 in 
70% yield over three steps. Finally, a one-pot intramolecular Lewis acid-mediated 
Diels-Alder reaction, PMB deprotection and lactonisation gave the tricyclic core 106 in 
58% yield and a 13:1 diastereomeric ratio (Scheme 2.3).  
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Scheme 2.3 
Importantly, the presence of the vinylic bromine atom was necessary for the Diels-Alder 
step to proceed in high diastereoselectivity. When the same reaction conditions were 
applied to the debrominated derivative 107, diastereoisomers 108, 109 and 110 were 
isolated in 49% overall yield and a greatly reduced 1:1:3 diastereoselectivity (Scheme 
2.4).  
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Scheme 2.4 
Next, functionalised allyl phosphonate 111 was synthesised in another cross metathesis 
reaction in 39% overall yield from allyl bromide (Scheme 2.5). 
 
Scheme 2.5 
Brominated fragment 106 was then dehalogenated by treatment with sodium amalgam 
and the lactone opened with potassium hydroxide to give the intermittant carboxylic 
acid. Then, methylation with TMS-diazomethane,
93
 oxidation with DMP gave the 
aldehyde 112 in a 70% yield over three steps. Next, a second Still-Gennari reaction 
between 112 and allyl phosphonate 111 gave tetraene 113 in 55% yield and a 3:1 E/Z to 
E/E ratio, followed by a Claisen condensation to give 114. This was then immediately 
treated with BF3.OEt2 to deprotect the PMB ether and affect diastereoselective ring 
closure to give 115 in 47% yield over two steps. Finally, di-chlorination with NCS gave 
chlrotonil 93 in 65% yield. The complete synthesis proceeds in 18 linear steps and 1.5% 
overall yield.  
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Scheme 2.6 
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2.3 Project Outline 
Anthracimycin 92 has a very interesting antibiotic profile and has yet to be made 
synthetically. The development of a total synthesis would allow analogues to be 
prepared and evaluated for biological activity as antimicrobial agents. Also, given the 
structure-activity relationship between anthracimycin 92, di-chloroanthracimycin 94 and 
chlorotonil 93, our aim was to develop a racemic synthesis of anthracimycin to allow 
both enantiomers to be tested for biological activity. As such, all structures presented 
hereafter will be racemic unless stated otherwise. Our proposed synthesis of the 
macrocycle follows a similar route to that published by Kalesse for the synthesis of 
chlorotonil 93, but includes a new approach to the synthesis of the decalin core 116 and 
is shown below in Scheme 2.7. Most of our efforts focused on the early steps of this 
synthesis.  
Scheme 2.7 
From the starting enone 117, a stereoselective one-pot 1,4-addition of allyl cuprate, 
followed by trapping of the intermediate enolate with methallyl bromide is expected to 
give 118. Ring closing metathesis, for example, with Grubbs 2
nd
 generation catalyst 
would then form the desired trans-decalin 119. Next, regioselective formation of the 
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less substituted enolate with LDA, trapping with phenylselenium bromide and oxidative 
work-up was planned to then give enone 120. Stereoselective 1,2-reduction should then 
give alcohol 121 which would then be acylated with proprionyl chloride to give the 
propionyl ester 122. The resulting ester would be treated with LDA/DMPU to form the 
(E)-enolate,
94
 trapped with Me3SiCl and then warmed to allow a stereospecific Ireland-
Claisen
95
 rearrangement to give carboxylic acid 116.  
The relative stereochemistry of the five contiguous stereocentres in carboxylic acid 116 
will be controlled in the following ways. First, cyclohexenones such as 117 adopt a 
relatively flat orientation.
96
 The initial addition of allyl cuprate to 117 should therefore 
occur from the opposite face to the bulky CH2OTIPS substituent to minimize steric 
repulsion (Scheme 2.8).
97
 This will generate the intermediate enolate. As the allyl group 
is now closer to the nucleophilic centre, the approach of methallyl bromide to the 
enolate will occur opposite to it, thus creating diene 118 with all ring substituents 
adopting equatorial positions. 
 
Scheme 2.8 
Secondly, reduction of 120 using the sterically bulky LiAlH(OtBu)3 should proceed via 
equatorial attack of hydride to give alcohol 121 with the hydroxyl and CH2OTIPS 
groups on the same face (Scheme 2.9). 
 
Scheme 2.9 
Thirdly, proprionyl ester 122 will be treated with LDA/DMPU to selectively form the 
(E)-enolate,
94
 trapped with Me3SiCl to form the corresponding (Z)-silyl enol ether 123 
81 
 
and then warmed to allow a stereospecific Ireland-Claisen
95
 rearrangement to give 
carboxylic acid 116. The transition state of this reaction is shown in Scheme 2.10. The 
configuration of the exocyclic methyl group in carboxylic acid 116 will be dependent 
upon the enolate geometry. Should the Ireland-Claisen rearrangement proceed via a 
different transition state and give the methyl group with the opposite configuration, the 
corresponding (E)-silyl enol ether could be formed by deprotonation with LDA in the 
absence of DMPU.  
 
Scheme 2.10 
The proposed end-game synthesis to take carboxylic acid 116 to anthracimycin 92 is 
shown below in Scheme 2.11. LiAlH4 reduction of the carboxylic acid, DMP oxidation 
to the aldehyde and a (Z)-selective Still-Gennari olefination using the PMB-protected 
allyl phosphonate 124 should give the conjugated diene 125. Next, removal of the TIPS 
group with hydrogen fluoride in pyridine, Jones oxidation
98
 to the carboxylic acid 
followed by methylation with TMS-diazomethane would give the corresponding methyl 
ester 126. At this point, our synthesis follows that of Kalesse.
85
 A Claisen condensation 
of 126 with the dianion formed from ethylacetoacetate, PMB deprotection and 
diastereselective ring closure by treatment with BF3.OEt2 should allow access to 
anthracimycin 92. Anthracimycin 92 is a pseudo-enantiomer of chlorotonil 93, apart 
from the additional methyl group on chlorotonil 93, anthracimycin 92 possesses the 
opposite configuration at all remaining stereocentres. It would therefore be reasonable 
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to assume the ring closing step to form anthracimycin 92 from 127 will place the 
malonic methyl group in the opposite configuration to chlorotonil 93. 
 
Scheme 2.11 
In this chapter, our efforts exploring the early parts of this proposed route to 
anthracimycin 92 are described.  
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2.4 Synthetic Efforts Towards Anthracimycin 
 
2.4.1 Preparation of the Starting Enone 
As it is the beginning of a total synthesis, a reliable, scalable synthesis of enone 117 was 
required. Cyclohexanones with substitution at the 4-position such as 128, 129, 130 and 
131 are prohibitively expensive to be used as the starting material of a multi-step total 
synthesis, their per-gram prices from Sigma-Aldrich being shown below in Figure 2.2. 
Conveniently, the corresponding 1,4-disubstituted aromatic derivative 132, presents a 
much more economically viable starting material for the synthesis of TIPS protected 
enone 117. Thus, our proposed synthesis began with the hydrogenation of 4-
hydroxybenzyl alcohol 132 (Scheme 2.12). 
 
Figure 2.2 
With the chosen starting material in hand, our overall aim was to carry out ring 
hydrogenation, followed by TIPS protection of the primary alcohol. This would be 
followed by two successive oxidations to get to the desired TIPS protected enone 117 
(Scheme 2.12). 
 
Scheme 2.12 
Initially, small scale reactions were carried out to find appropriate conditions for the 
large scale synthesis of enone 117. Use of Pd/C as a heterogeneous catalyst led to 
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cleavage at the benzylic C–O position to give p-cresol as the major product. Changing 
the catalyst to PtO2, known for hydrogenation of aromatic rings,
99
 led to isolation of the 
desired saturated diols 133/134 as a 1:2 inseparable mixture of stereoisomers (by 
1
H 
NMR spectroscopy) in a combined yield of 58%. The reaction was very slow, requiring 
five days to reach completion. However, the catalyst loading was very low at 1 mol% 
and from a practical perspective, very straightforwards, requiring only occasional 
refreshing of the hydrogen source. The reaction also proved very amenable to scale up 
due to the robustness of the chemistry and the low cost of starting materials. The results 
of the multigram synthesis will be presented later.  
Heterogenous hydrogenations of alkenes typically proceed from the least hindered 
face.
100-105
 For the purposes of this discussion, the cis isomer is assumed to be the major 
isomer, although this was not definitively assigned due to the difficulty in assigning J 
values for 133/134, with the 
1
H NMR spectrum shown in Figure 2.3. The 
stereoselectivity for the reaction was taken by the ratio of the integrals from the signals 
at approximately δ 3.73 and 3.57 ppm, corresponding to the CH(OH) protons.  
 
 
Figure 2.3 
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Diols 133/134 were then selectively protected at the primary alcohol by treatment with 
TIPS-Cl in a total yield of 74% (Scheme 2.13). 
 
Scheme 2.13 
Initially, it was unclear whether or not one of stereoisomers trans-135 and cis-136 were 
in fact potential regioisomers 137 or 138 (Scheme 2.13). The identity of 135 and 136 
was confirmed by independently oxidising a pure sample of each isomer, each giving 
139 with identical analytical data (Scheme 2.14). 
 
Scheme 2.14 
TIPS protected ketone 139 also proved amenable to a multigram scale synthesis via the 
same route (Scheme 2.15). Yields for the hydrogenation of phenol 132 to give 133/134 
could be improved to 77% with longer reaction times (7 days) and reduced catalyst 
loadings (0.44 mol%) with no change in stereoisomeric ratio. Silylation of the primary 
alcohol also proceeded in a similar fashion upon scale up, with yields of 82% being 
observed with 2 g of diols 133/134 as starting material. Finally, ketone 139 could be 
formed in 72% via a Swern oxidation
106-108
 or an improved 82% via a Dess-Martin 
periodinane oxidation.
109, 110
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Scheme 2.15 
2.4.2 Oxidation of Ketone 139 
There are several known methods for the introduction of alkene functionality into 
ketones to generate the corresponding enones. Most commonly, methods for the 
oxidation of ketones into enones include α-bromination and elimination,111 
sulfoxide/selenoxide elimination,
112, 113
 catalytic oxidation of silyl enol ethers
114
 and the 
use of hypervalent iodine reagents.
115
 Not all these methods are equally suited for large 
scale synthesis. Selenium reagents are both toxic and expensive and the formation of the 
α-keto selenide intermediate requires large amounts of pyrophoric organolithium 
reagents. Sulfides are typically formed via the same methodology and although the 
sulfur reagents are usually less toxic, elimination of the sulfoxide requires elevated 
temperatures which often leads to deletrious side reactions occurring. The Saegusa 
oxidation, whereby silyl enol ethers are treated with palladium(II) acetate in the 
presence of a stoichometric oxidant, often requires catalyst loadings in excess of 50 
mol%, usually relegating it to late-stage synthesis. For these reasons, robust, scalable 
methodology for the introduction of the alkene bond into ketone 139 needed to be 
developed. In order not to waste ketone 139, commercially available 4-methyl 
cyclohexenone 140 was used initially in its place. 
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To begin with, cyclohexenone 140 was subjected to a two-step bromination-elimination 
reaction (Scheme 2.16). Bromination in CH2Cl2 proceeded rapidly at room temperature, 
but bromo-ketones 141/142 were found to be unstable and decomposed at room 
temperature, forming a dark, tarry material over several hours. Attempts to immediately 
eliminate the crude bromo-ketones 141/142 without prior purification, however, failed 
to give the desired enone 143. 
 
Scheme 2.16 
Also investigated was the use of a Rubottom oxidation of silyl enol ether 144, followed 
by mesylation and elimination of the α-hydroxy ketones 145/146 (Scheme 2.17). 
Cyclohexenone 140 was converted into the corresponding silyl enol ether 144 by 
treatment with Me3SiCl, sodium iodide and triethylamine in acetonitrile in 72% yield 
after distillation under reduced pressure. Then, reaction of 144 with buffered mCPBA, 
followed by acid-catalysed epoxide opening successfully gave a 57:43 diastereomeric 
mixture of α-hydroxy ketones 145/146 in 41% yield. Unfortunately, attempted 
mesylation-elimination of 145/146 gave rise to a complex mixture of products. 
 
Scheme 2.17 
The most promising method attempted was a Saegusa oxidation of silyl enol ether 144 
(Scheme 2.18). Although only 25 mg of crude product was obtained from 0.59 g of the 
starting silyl enol ether 144, 
1
H NMR spectroscopic data of the crude material showed 
complete conversion into enone 143.  
88 
 
 
Scheme 2.18 
The practical procedure for the isolation of enone 143 involved dilution of the reaction 
mixture, followed by extraction with hexane. It was envisioned that enone 143 is more 
soluble in water than in hexane. Due to the large hydrophobic group on ketone 139, the 
reaction was repeated on 139, hoping that the corresponding enone would be 
preferentially soluble in hexane.  
Silyl enol ether 147 was synthesised via the same procedure used to synthesise silyl 
enol ether 144, initially giving a 54% yield after reduced pressure distillation. Saegusa 
oxidation of 147 afforded enone 117 in 28% yield over two steps. It is worth noting the 
low catalyst loadings for the oxidation of 147 and this allowed efficient scale up of the 
reaction without being prohibitively expensive. On a multi-gram scale, yields of up to 
92% were observed for the formation of silyl enol ether 147 and 88% yield for the 
formation of enone 117, corresponding to a total yield over two steps of 81% (Scheme 
2.19).  
 
Scheme 2.19 
Concurrent to these investigations, we also looked into the use of hypervalent iodine 
reagents to carry out an efficient oxidation of ketone 139 into enone 117. In 2009, 
Ishihara
116
 first reported the use of the IBX-like analogue, IBS 148 as a catalytic oxidant 
for the formation of enones from alcohols. Some selected examples are shown in Table 
2.2. Unlike IBX, IBS 148 is formed in situ from pre-catalyst 149 upon reaction with the 
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stoichometric oxidant, oxone; the use of nitromethane as a solvent was necessary for 
adequate conversions.  
 
Table 2.2: IBS Mediated Oxidation of 4-Substituted Cyclohexanols 
We reasoned that the underlying mechanism was initial oxidation of the alcohol 
followed by a second oxidation of the ketone. Thus, pre-catalyst 149 was synthesised in 
a one-pot procedure from amino-sulfonic acid 150 in an overall yield of 25% (Scheme 
2.20) 
 
Scheme 2.20 
Unfortunately, no reaction was observed when ketone 139 was subjected to the same 
conditions reported by Ishihara (Scheme 2.21). In retrospect, the analogous reaction 
should have been attempted on alcohols 135/136, although this was not thought of at the 
time.  
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Scheme 2.21 
In summary, an efficient gram-scale protocol for the oxidation of ketone 139 into enone 
117 was developed, with the highest yields being achieved via a Saegusa oxidation of 
silyl enol ether 147. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
91 
 
2.5 Investigation of Cuprate Additions 
 
2.5.1 Literature Overview of Cuprate Additions to Enones 
In 1866, Rudolf Bӧettger reported the discovery of copper(I) acetylide117 which was 
prepared by passing acetylene gas through ammoniacal copper(I) chloride. Shock 
sensitive and explosive when dry, copper(I) acetylide was the first compound 
discovered to possess a carbon-copper bond. Since then, carbon-copper bond-containing 
compounds have proved to be of immense synthetic utility. In 1936, Gilman reported 
that organocopper reagents (RCu) can undergo cross-coupling reactions with 
organohalides.
118
 In 1941, Kharash demonstrated how catalytic quantities of a copper(I) 
salt could drastically influence the regioselectivity of Grignard reagent additions to 
enone 152.
119
 For example, the addition of 1 mol% of copper(I) chloride resulted in 1,4-
adduct 153 being the major product of the reaction, whilst in the absence of copper salts, 
1,2-adduct 154 was isolated in 43% yield (Scheme 2.22).  
 
Scheme 2.22 
Perhaps the most notable moment in organocuprate chemistry was the 1952 study by 
Gilman.
120
 Treatment of copper(I) iodide with one equivalent of methyllithium 
produced insoluble methyl copper. Upon treatment with a second equivalent of 
methyllithium, the solid precipitate redissolved to form the anionic lithium 
dimethylcuprate (Scheme 2.23). 
 
Scheme 2.23 
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The subsequent work by Corey, House and Whitesides
121-123
 firmly established the 
utility of organocuprates for a range of carbon-carbon forming reactions. In the context 
of our proposed synthesis, the ability of cuprates to carry out regioselective 1,4-addition 
to α,β-unsaturated carbonyl compounds, specifically enones, is of prime importance.  
Generally, when considering 1,4-additions of cuprates to enones, the mechanism is 
simplistically considered to be a classical conjugate addition of a nucleophile. This 
gives an enolate that is then protonated to give the final product (Scheme 2.24). 
 
Scheme 2.24 
In reality, cuprate chemistry is far more nuanced. The copper(I) salt, with general 
formula CuX, plays a large role in the identity of the cuprate species. Halides generally 
form weak bonds with copper, readily dissociating from copper upon treatment with one 
equivalent of organolithium/Grignard reagent to form the corresponding organocopper 
reagent (Scheme 2.25). The addition of a second equivalent of organolithium/Grignard 
reagent then forms the cuprate reagent, also known as "lower order" cuprates.
124
  
 
Scheme 2.25 
In 1981, Lipshutz
125
 suggested the use of a non-transferable ligand on copper, followed 
by the addition of two equivalents of organolithium reagent to achieve a "higher order" 
cyanocuprate (R2Cu(CN)Li2).  Although similar higher order cuprates have been 
characterised in dimethyl sulfide, namely [Li3(CuPh3)(CuPh2)(SMe2)4],
126, 127
 they have, 
to date, not been characterised in ethereal solvents and to the best of our knowledge, no 
cyanocuprate of general formula (R2Cu(CN)Li2) has ever been characterised. Indeed, 
NMR,
128-130
 EXAFS
131, 132
 and IR
133
 studies of these cyanocuprates demonstrated that 
whilst the cyanide ligand is bound to the copper following the addition of a single 
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equivalent of organolithium reagent, it is not upon addition of a second equivalent 
(Scheme 2.26). Indeed, 
15
NMR spectroscopic studies by Bertz
128
 demonstrated that the 
most likely structure of these cyanocuprate reagents was a dialkyl copper species, with 
bridging Li–CN–Li interactions. 
 
Scheme 2.26 
Cyanocuprates can have markedly different reactivities. In 1981, Lipshutz
125
 compared 
the efficiency of the Gilman vinyl cuprate with the higher order cyanocuprate equivalent 
in an SN2 reaction with 2-iodooctane 155. The higher order cyanocuprate gave greatly 
improved yields of the desired alkene 156 (Scheme 2.27). 
Scheme 2.27 
Nakamura
134
 offered an explanation for this difference in reactivity with a comparative 
computational study of the SN2 reaction of Me2CuLi/Me2CuLi.LiCN with MeBr. This 
study suggested that, firstly, an increased Lewis acidity of the [Li–CN–Li]+ moiety 
serves to better activate the MeBr to nucleophilic attack and, secondly, that there is a 
more energetically favourable structural change of the [Li–CN–Li]+ moiety. Indeed, 
Nakamura calculated the activation energy of reaction with cyanocuprate 157 to be 3.8 
kcal mol
-1
 lower than for the Gilman cuprate 158 (Scheme 2.28).  
 
Scheme 2.28 
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From in situ 
13
C NMR spectroscopic studies of the reaction between Me2CuLi and 
methyl and t-butyl cinammate 158 and 159, carried out by Ullenius,
135
 it was shown that 
the initial step of 1,4-addition involved the formation of an η2 Cu–π complex (Scheme 
2.29). Olefinic carbon atoms in both 158 and 159 experience roughly an 80 and 70 ppm 
upfield shift upon addition of Me2CuLi (Scheme 2.29). The small downfield shift of the 
carbonyl carbon atoms was also postulated to be due to co-ordination to the lithium ion, 
although the precise aggregation state in which it exists is not known and will likely 
differ depending on cuprate identity, solvent and stoichometry. 
 
Scheme 2.29 
For many years, the existence of a transient Cu(III) species had been speculated to 
exist.
136, 137
 Recently, low temperature, rapid injection 
13
C NMR spectroscopy provided 
the first experimental evidence to confirm this idea.
138, 139
 The σ-bonded cuprate 160 
was observed following the addition of Me2CuLi to cyclohexenone and Me3SiCN 
(Scheme 2.30).  
 
Scheme 2.30 
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In 2012, Bertz later discovered a key role of the silyl reagent, often used to trap the 
enolate.
139
 Use of Me3SiCN directly gave the σ-bonded, square planar enolate 161 
(Scheme 2.31) whereas addition of (CD3)2PhSiCl in fact gave the η
3
 allyl π-complex 
162. In both cases, thermal decomposition leads to the formation of the desired 1,4-
adduct. The steric bulk of the silyl reagent determines the temperature at which η3 π-
allyl complex 162 undergoes decomposition. The η3 allyl π-complex derived from the 
use of Et3SiCl instead of (CD3)2PhSiCl, rapidly decomposed at –100 °C, whereas 162 
was indefinitely stable at the same temperature. In the absence of a silyl reagent, the η2 
π-allyl complex requires higher temperatures to undergo oxidative addition/reductive 
elimination. The overall mechanism for cuprate additions to enones, therefore, is the 
initial formation of a copper η2 π-complex, followed by an oxidative addition process to 
form the transient Cu(III) species, then a rate determining reductive elimination type 
process
140
 to form an enolate which can then be quenched (Scheme 2.31). 
 
Scheme 2.31 
Although there are many examples of 1,4-additions of alkyl and aryl cuprates to enones, 
there are few successful examples of successful 1,4-addition of allylic cuprates to 
enones. To the best of our knowledge, there are no reported reactions of successful 1,4-
addition of an allylic cuprate to an enone, followed by alkylation of the resulting enolate. 
In 1989, Lipshutz
141
 demonstrated that allylic cuprates exist as the η1, σ-bonded 
tautomer, instead of the corresponding π-allyl species (Figure 2.4). Curiously, it was 
noted that allyl Gilman cuprate (allyl)2CuLi had to be prepared at –105 °C and 
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underwent extensive decomposition at –90 °C. The corresponding cyanocuprate, 
however, was stable at –70 °C.  
 
Figure 2.4 
2.5.2 Exploration of Addition of Cuprates to Cyclohexenones 
The next stage of our proposed total synthesis of anthracimycin 92 requires the 1,4-
addition of allyl cuprate to TIPS-protected enone 117 (Scheme 2.32), with our ultimate 
aim being to trap the enolate that is formed with methallyl bromide. Our initial studies 
however, focused on developing effective conditions to allow the 1,4-addition. 
 
Scheme 2.32 
Lipshutz generated allyl cyanocuprate (allyl)2CuCNLi via a transmetallation reaction of 
tetraallyltin and nBuLi, followed by addition of the CuCN.LiCl. Reductive lithiation of 
allyl halides is not typically considered a viable method of accessing allyllithium, due to 
the propensity of the intermediate allyl radical to homocouple.
142
 Nonetheless, due to 
the toxicity and persistence of stannanes, it was decided to make allyllithium via the 
method reported by Eisch,
142
 whereby allyl phenyl ether 163 is treated with lithium 
metal to generate lithium phenoxide and allyllithium (Scheme 2.32).  
 
Scheme 2.32 
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However, this reaction proved difficult to reproduce in our hands. Due to being a 
hetereogeneous reaction, yields were highly dependent on the surface area and the 
degree of oxidation of the lithium metal. For this reason, allylic cuprates derived from 
the corresponding Grignard reagent were used in our studies 
Our initial experiments began with small scale (20 mg) trial reactions on enone 117. 
Thus, enone 117 was treated with 4 equivalents of allylmagnesium chloride and 0.5 
equivalents of copper(I) iodide. We expected to see 1,4-adducts 164 and 165. However, 
instead, 1,2-adducts 166 and 167 were isolated in quantitative yield and a 3:1 
diastereomeric ratio (by 
1
H NMR spectroscopy of the crude product). The absence of 
the expected ketone was clearly observed in the IR and 
13
C NMR spectra, and there was 
a hydroxyl peak in the IR spectrum. Not only that, an additional two signals in the 
alkene region were observed in the 
13
C NMR spectra (Figures 2.5 and 2.6), as well as an 
additional two protons in the alkene region of the 
1
H NMR spectra (Figures 2.7 and 2.8). 
The relative stereochemistry of alcohols 166 and 167 was not definitively assigned, 
although we assume equatorial attack at the carbonyl to predominate, giving rise to cis-
166 as the major product (Scheme 2.33). 
Scheme 2.33  
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Figure 2.5 
 
Figure 2.6 
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Figure 2.7 
 
Figure 2.8 
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In order to find appropriate conditions to affect successful 1,4-addition to enone 117, we 
repeated the reaction and investigated the equivalents of allylmagnesium chloride, the 
identity and equivalents of the copper(I) salt, the solvent and the role of Me3SiCl as an 
additive. As mentioned earlier, silyl reagents in 1,4-additions of cuprates to enones 
serve as Lewis acids, increasing the rate of addition of the cuprate to the enone. 
Ultimately, however, all reaction conditions effectively gave the same result, namely, 
direct 1,2-addition to the carbonyl group (Table 2.3). 
 
Table 2.3: Failed 1,4-Additions of Allyl Cuprate to 117 
For all but reaction entries 2 and 4, there were significant issues with copper salt 
solubility. From a practical perspective, small scale reactions involving copper salts had 
to use a stock solution of the relevant copper salt, transfer a small aliquot of the solution 
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into the flask and then evaporate the solvent. The copper salt, upon removal of the 
solvent, coated itself around the reaction flask and did not re-dissolve upon addition of 
the Grignard reagent. This likely explained the identical results between reactions, 
namely, that the uncatalysed reaction between enone 117 and allylmagnesium chloride 
was taking place. 
With these results in hand, our next iteration of experiments varied only the equivalents 
and identity of the copper salt. Particular attention was paid to ensuring complete 
dissolution of the copper salt prior to the addition of Grignard reagent. The THF soluble 
CuCN.2LiCl adduct was used in lieu of CuCN, whilst CuI was used in a THF/SMe2 co-
solvent mixture. Under these new reaction conditions, the use of stoichometric amounts 
of CuI allowed access to 1,4-adducts 164/165 in a 63% yield and a 65:35 mixture of 
inseparable diastereoisomers (Table 2.4, entry 2), as well as approximately 5% of 1,2-
adducts 166/167 and 35% of unreacted starting material (by 
1
H NMR of the crude 
reaction mixture). The relative stereochemistry was not confirmed. Similar work by 
Lipshutz
143
 on other 4-substituted cyclohexenones would suggest that the trans-isomer 
164 is favoured (Figure 2.9). The diasteroeomeric ratio was determined by the ratio of 
the integrals for the CH2OTIPS protons in the 
1
H NMR spectrum, as well as the ratio of 
the integrals for the HC=CH2 signals in the 
13
C NMR (Figures 2.10 and 2.11). 
 
Figure 2.9 
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Figure 2.10 
 
Figure 2.11 
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Entries 1 and 3 give exclusive access to 1,2-adducts 166/167. This result is not 
unexpected; copper(I) salts cannot sequester 8 equivalents of Grignard reagent, 
therefore it could easily be argued that the Grignard reagent itself adds to the carbonyl 
group much more rapidly than the cuprate can add to the C=C double bond. Nonetheless, 
entry 4 is worth noting; CuCN is known to be capable of sequestering 2 equivalents of 
Grignard reagent to form the cyanocuprate, the fact that the 1,2-adduct is exclusively 
observed demonstrates the atypical reactivity of these allylic cuprate species.  
 
Table 2.4: Optimisation of Conditions for 1,4-Addition of Allyl Cuprate to 117 
With these new conditions from entry 2 in hand, our attention moved onto attempting to 
trap the resulting enolate with methallyl bromide. Enone 117 was treated with 4 
equivalents of allylmagnesium chloride, 2 equivalents of copper(I) iodide in a 
THF/SMe2 (88:12) co-solvent mixture at –78 °C for 4 h to allow complete conjugate 
addition to occur. Then, methallyl bromide was added to trap the enolate (Scheme 2.34). 
Unfortunately, no alkylation was observed in the 
1
H NMR spectrum of the crude 
reaction mixture. As 12% of the reaction solvent was SMe2, itself nucleophilic, we 
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envisioned that it was feasible that alkylation of SMe2 was out-competing alkylation of 
the formed enolate.  
 
Scheme 2.34 
The inclusion of SMe2 as a co-solvent was done to solubilise the CuI prior to the 
addition of the Grignard reagent. In order to ensure complete dissolution of CuI in the 
absence of SMe2, the THF soluble CuI.2LiCl adduct was used instead. Unfortunately, 
the absence of SMe2 led to a reversal of reactivity, with the 1,2-adducts 166/167 being 
the major products in the 
1
H NMR spectrum of the crude reaction mixture (Scheme 
2.35). 
 
Scheme 2.35 
Using a similar method reported by Lipshutz,
143
 whereby allylcopper was added to 
various 4-substituted cyclohexenones, we attempted to utilise Lipshutz's conditions and 
trap the copper enolate as the silyl enol ether, with the idea the we would then alkylate 
in a separate step. Thus, allylcopper was generated by the addition of 2 equivalents of 
allylmagnesium chloride to 2.2 equivalents of CuBr.2LiCl in THF, followed by the 
addition of enone 117 and excess Me3SiCl (Scheme 2.36). Indeed, the use of 
allylcopper did give successful 1,4-addition, but despite strictly anhydrous conditions 
being used for the reaction and the accompanying workup, the intermediate silyl enol 
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ether could not be isolated. Instead, only 1,4-adducts 164/165 were observed in the 
1
H 
NMR spectrum of the crude reaction mixture.  
 
Scheme 2.36 
Due to the difficulty of alkylating the intermediate copper enolate or trapping as the 
silyl enol ether, we briefly investigated whether we could acylate the copper enolate 
using methyl cyanoformate as the electrophilic quench. The overall strategy would then 
be to deprotonate 170 to form the malonate, alkylate with methallyl bromide to form the 
tetra-substituted cyclohexanone 171, then carry out a Krapcho decarboxylation
144
 to 
gain access to 118 (Scheme 2.37). Given that the Krapcho decarboxylation takes place 
at elevated temperatures, allowing reversibility of the final enolate quench, we 
envisioned that the thermodynamic product 118, with all substitutents adopting an 
equatorial position, would be preferentially formed. 
 
Scheme 2.37 
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Thus, with this new proposed synthesis, the model substrate cyclohexenone was treated 
with 4 equivalents of allylmagnesium chloride and 2 equivalents of CuI in THF/SMe2 
(88:12) to affect 1,4-addition, followed by the addition of excess methyl cyanoformate 
(Scheme 2.38). The reaction, however, gave two products which did not fit with the 
expected structure and hitherto, have not been positively identified. 
 
Scheme 2.38 
Unfortunately, despite our best efforts, we could not realise our intention of cuprate-
mediated double addition and, as a result, other methods were explored. 
One of the first methods that was briefly investigated is shown in Scheme 2.39. Initially, 
we planned to carry out a Kumada coupling of iodo-alcohol 173, obtained from the 
successful 1,2-addition reactions described previously with methallyl magnesium 
bromide. This would be followed by an oxy-Cope rearrangement to give the desired tri-
substituted ketone 118. Depending on the conditions for the oxy-Cope reaction, an 
isomerisation step to give the trans-isomer 118 may not be necessary (Scheme 2.39) 
 
Scheme 2.39 
In order to obtain access to iodo-alcohol 173, enone 117 was first subjected to a Baylis-
Hilman type iodination. Using the method reported by Taber,
145
 TIPS protected enone 
was treated with iodine and catalytic DMAP in a 1:1 THF/H2O mixture, using K2CO3 as 
the stoichometric base.  These conditions, however, only gave access to iodo-enone 175 
in a disappointing 27% yield. Instead, carrying out the reaction in a 1:1 mixture of 
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CHCl3 and pyridine, the method reported by Felpin,
146
 gave iodo-enone 175 in a much 
improved 86% yield (Table 2.5).  
 
Table 2.5: Optimisation of Conditions for the Iodination of 117 
Iodo-enone 175 was then converted into the corresponding tertiary alcohols 173/176 by 
treatment with allyl magnesium chloride, in an overall yield of 90% (Scheme 2.40). The 
products were formed in a 2:1 diastereomeric ratio, determined by the ratio of the 
integrals of the IC=CH protons in 
1
H NMR spectrum of the crude reaction mixture at 
approximately δ 6.60 and 6.50 ppm (Figure 2.12). The relative stereochemistry of the 
major isomer was not determined.  
 
Scheme 2.40 
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Figure 2.12 
A Kumada coupling using NiCl2.dppp as catalyst on the diastereomeric mixture of 
173/176 was then attempted using a modified procedure reported by Taber (Scheme 
2.41).
145
 Due to the difficulty of forming the methallyl Grignard reagent, commercially 
available allyl magnesium bromide was used in lieu for a trial reaction. To our surprise, 
no reaction was observed, even with 10 times the catalyst loading of the original paper 
and extended reaction times (Scheme 2.41). 
 
Scheme 2.41 
We attempted to repeat Taber's coupling conditions using iodo-alcohol 175 with methyl 
magnesium bromide and allyl magnesium chloride, to check for reproducibility 
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(Scheme 2.42). Cyclohexenone was iodinated to give iodo-enone 177, then treated with 
allyl magnesium chloride to give tertiary alcohol 178 in an overall yield of 62% over 2 
steps (Scheme 2.42) 
 
Scheme 2.42 
However, as with iodo-alcohols 173/176, neither treatment with methyl magnesium 
bromide nor allyl magnesium chloride, even with 10 times the reported catalyst loadings 
and several days reaction time gave the desired alkylated products (Scheme 2.43). As a 
result, this approach was not investigated further.  
 
Scheme 2.43 
In summary, we were able to develop a novel method for the addition of allyl cuprate to 
TIPS protected enone 117 in 63% yield. To the best of our knowledge, this is the first 
reported example of a successful 1,4-addition of an allylic cuprate reagent, of general 
formula R2CuMgX2, to an enone. Unfortunately, we were unable, despite our best 
efforts, to trap the resultant enolate with any of the electrophiles we tested.  
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2.6 Synthesis of the Decalin Framework of Anthracimycin 
 
2.6.1 TiCl4-Mediated Addition of Allyltrimethylsilane to Cyclohexenone.  
As aforementioned, there is relatively little literature precedent for the addition of allylic 
cuprates to enones. For the nucleophilic addition of the allylic moiety to enones, the 
Sakurai reaction is more commonly employed.
147
 In this reaction, an enone is treated 
with allyltrimethylsilane in the presence of TiCl4 to give the 1,4-adduct. For example, it 
was reported that TiCl4 mediated addition of allyltrimethylsilane to cyclohexenone gave 
the 1,4-adduct 179 in 82% yield (Scheme 2.44).
148
  
 
Scheme 2.44 
Typically, the titanium enolate is quenched to get access to the 1,4-adduct. We 
wondered, however, whether titanium enolate 180 could be alkylated with methallyl 
bromide to gain access to doubly substituted 181 (Scheme 2.45). If this idea could be 
realised, it would provide a novel alternative to our previously unsuccessful allylic 
cuprate chemistry.  
 
Scheme 2.45 
To begin with, cyclohexenone was subjected to treatment with allyltrimethylsilane in 
the presence of TiCl4. Quenching gave to give access to 1,4–adduct 179 in a 66% yield 
(Scheme 2.46).  
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Scheme 2.46 
The reaction was then repeated under the same conditions to form the titanium enolate 
but methallyl bromide was added. Unfortunately no alkylation was observed in the 
1
H 
NMR spectrum of the crude product, with only the 1,4-adduct 179 being identified 
(Scheme 2.47).  
 
Scheme 2.47 
Literature precedent for a similar reaction does, however, exist. In 2002, Hayashi
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reported the rhodium-catalysed enantioselective addition of a phenyl moiety to 
cyclohexenone to form the enantioenriched titanium enolate (S)-182. This was followed 
by the addition of lithium isopropoxide to form the titanium "ate" complex (S)-183 
which was then trapped with allyl bromide to form doubly substituted (S,R)-184 in 
99.5% ee and 82% yield (Scheme 2.48). The diastereoselectivity was not explicity 
reported, although it is likely that the reaction only gives a single diastereoisomer. The 
addition of lithium isopropoxide leads to the formation of a more nucleophilic enolate 
which is sufficiently reactive to undergo allylation.  
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Scheme 2.48 
Given that titanium enolate 180 was insufficiently nucleophilic to attack methallyl 
bromide, we wondered whether titanium enolate 180 could be converted into the 
corresponding "ate" complex 185 by treatment with 4 equivalents of LiOiPr and then 
alkylated with methallyl bromide (Scheme 2.49). Alternatively, use of Ti(OiPr)4 as the 
Lewis acid for the initial 1,4-addition would require only 1 equivalent of LiOiPr being 
required for the formation of the "ate" complex 185. Our plan is set out in Scheme 2.49. 
 
Scheme 2.49 
Unfortunately, both avenues did not allow access to doubly alkylated 181. Ti(OiPr)4 
was not sufficiently Lewis acidic to allow 1,4-addition, even when the reaction was 
carried out at 0 °C, whilst attempted trapping of the "ate" complex 185 via TiCl4 
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mediated addition only gave the 1,4-adduct 179 and no doubly alkylated 181. With such 
limited success attempting to directly alkylate these titanium enolates, alternative 
electrophiles were investigated.  
In 2000, Lalic
150
 reported the alkylation of several titanium enolates with ethylene oxide 
to give access to primary alcohols. Selected examples are shown in Table 2.6.  
 
Table 2.6: Alkylation of Titanium Enolates with Ethylene Oxide 
Whilst the reaction of ethylene oxide with titanium enolate 180 is of little use towards 
the synthesis of anthracimycin, we considered that the use of isobutylene oxide could 
give tertiary alcohol 186 which could then be dehydrated to give doubly alkylated 181 
(Scheme 2.50).  
114 
 
 
Scheme 2.50 
Cyclohexenone, as our model substrate, underwent TiCl4 mediated addition with 
allyltrimethylsilane to form the intermediate titanium enolate. Then, isobutylene oxide 
was added as the electrophile. Additional TiCl4 was added to affect the second addition 
to the epoxide. Expecting to see tertiary alcohol 186, the reaction instead gave multiple 
products, one of which was enone 187 and was isolated in 10% yield (Scheme 2.51). 
The key diagnostic peaks of enone 187 was confirmed by the enone proton at 
approximately δ 6.20 ppm, as well as the alkene peaks in the 13C NMR spectrum at 
approximately δ 145 and 139 ppm. The geometry about the enone double bond was not 
determined.  
 
Scheme 2.51 
We were initially buoyed by this result. Although enone 187 was not the desired 
product, it is possible that it could have formed via dehydration and isomerisation of 
tertiary alcohol 186 (Scheme 2.52).  
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Scheme 2.52 
In order to prevent this dehydration-isomerisation sequence, the reaction was repeated 
but the temperature maintained at –78 °C. To our initial surprise, inseparable 
diastereomeric alcohols 188/189 were isolated in a 41% yield and a 78:22 
diastereomeric ratio. After careful chromatography, chlorinated adducts 190, 191 and 
192 were isolated in 4.6, 8.8 and 0.8% yield, respectively (Scheme 2.53). The relative 
stereochemistry of each was assigned by X-ray crystallography (Figures 2.13, 2.14 and 
2.15). These types of products have been observed before in related Prins chemistry.
151
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Scheme 2.53 
 
Figure 2.13 
 
Figure 2.14 
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Figure 2.15 
Aldol products 188/189 appear to have formed via a TiCl4 mediated ring opening of 
isobutylene oxide to form the corresponding tertiary carbocation, followed by an 
internal hydride shift to form isobutyraldehyde in situ, which then acts as the 
electrophile to trap the titanium enolate 180 (Scheme 2.54). The relative 
stereochemistry of 188/189 was not definitively assigned, although it is likely that the 
ring substituents are trans to one another, with the hydroxyl group carbon atom being 
the variable stereocentre.  
 
Scheme 2.54 
Chlorinated diols 190, 191 and 192 arise from an intramolecular Prins
152
 reaction to 
form the bicyclic core, followed by trapping of the resultant carbocation with chloride 
from the least hindered face, itself sourced from TiCl4 (Scheme 2.55).  
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Scheme 2.55 
Regioisomer 192 may be formed by a small amount of the intermediate carbocation 
undergoing a hydride shift before reaction with chloride (Scheme 2.56) 
 
Scheme 2.56 
Notably, isomer 190 has a cis relationship between the two ring substituents, implying 
that ketones 188/189 must equilibrate to some extent before the Prins cyclisation 
(Scheme 2.57).  
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Scheme 2.57 
The rearrangement of isobutylene oxide to isobutyraldehyde as shown in Scheme 2.54 
is catalysed by TiCl4. In order to avoid this re-arrangement, the reaction was repeated 
without a second addition of TiCl4 (Table 2.7, entry 1). Unfortunately, this omission of 
additional TiCl4 did not seem to prevent the rearrangement occuring. Tertiary alcohol 
186 was not isolated nor observed in the 
1
H NMR spectrum of the crude product, 
instead, keto-alcohols 188/189 were isolated in 80% yield and 88:12 dr. 
Next, the reaction was repeated at –116 °C, again in an attempt to prevent the 
rearrangement of the epoxide (Table 2.7, entry 2). Surprisingly, even at such a low 
temperature, tertiary alcohol 186 was not isolated nor observed in the 
1
H NMR 
spectrum of the crude reaction mixture, with keto-alcohols 188/189 being isolated in 
50% yield and 87:13 dr. Notably, in both experiments, chlorinated diols 190, 191 or 192 
were not observed in the 
1
H NMR spectrum of the crude product. This would appear to 
indicate that the Prins cyclisation is dependent upon the second addition of TiCl4.  
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Table 2.7: Reactions of 180 With Isobutylene Oxide 
Unfortunately, we were unable to realise our intention of alkylating titanium enolate 
180. The titanium enolate 180 was insufficiently nucleophilic to react with methallyl 
bromide, whilst attempted alkylation with isobutylene oxide proved impossible due to 
the extremely facile rearrangement of isobutylene oxide. For this reason, we turned our 
attention to the use of alternative electrophilic traps for the titanium enolate 180. 
 
2.6.2 Aldol and Ring Closing Metathesis Route to Decalins 
Given how readily isobutylene oxide rearranges to isubutyraldehyde, it appeared 
extremely unlikely that tertiary alcohol 186 could be accessed via this method. 
Nonetheless, were titanium enolate 180 to be trapped with methacrolein instead of 
isubutylene oxide, it would allow the desired ring closing metathesis step to deliver the 
hydroxylated decalins 193/194. Whilst this extra hydroxyl group would need to be 
removed to gain access to anthracimycin 92, the functional handle it provides would be 
useful for late-state functionalisation and the synthesis of structurally related analogues. 
Our modified synthetic proposal is shown in Scheme 2.58.  
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Scheme 2.58 
Thus, titanium enolate 180 was formed by treatment of cyclohexenone with TiCl4 and 
allyltrimethylsilane at –78°C. Trapping with methacrolein (Scheme 2.59) gave aldol 
products 197 and 198 in a 2:3 diastereomeric ratio respectively. After purification, we 
isolated 197 and 198 with yields of 18% and 10% respectively, as well as 49% of a 1:3 
diastereomeric mix of 197 and 198 that co-eluted during chromatography. The 
diastereomeric ratio was determined by taking the ratio of the integrals of the signals for 
the CHOH protons in the crude 
1
H NMR spectrum at approximately δ 4.50 and 4.35 
ppm (Figure 2.16). 
 
Scheme 2.59 
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Figure 2.16 
As anticipated, the ring substituents on both 197 and 198 are trans to one another, with 
the hydroxyl group being the variable stereocentre. Our work on proving the relative 
stereochemistry of aldol products 197 and 198 will be presented later.  
Ring closing metathesis of both 197 and 198 proceeded smoothly with just 5 mol% of 
Grubbs 2
nd
 generation catalyst giving the corresponding decalinones 194 and 193 in 
67% and 95% yield respectively (Scheme 2.60). The corresponding work up and 
purification was straighforwards, requiring only evaporation of the solvent and flash 
chromatography of the residues.  
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Scheme 2.60 
With decalinones 193 and 194 in hand, our attention turned to regioselective oxidation 
of the ketone to form the less substituted enone (Scheme 2.61). Given our previous 
success with a Saeugsa oxidation of TIPS protected ketone 139 to enone 117, we 
attempted to subject the corresponding silyl enol ethers to the same conditions, hoping 
for a similar result.  
 
Scheme 2.61 
Prior to the formation of the silyl enol ether, the hydroxyl group of decalinones 193 and 
194 had to be protected. Thus, 193 and 194 were protected with chloromethyl methyl 
ether to give the corresponding MOM-protected decalinones 199 and 200 in 86% and 
28% yield respectively (Scheme 2.62).  
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Scheme 2.62 
Formation of silyl enol ethers from the corresponding ketones are usually obtained by a 
kinetic deprotonation with a strong base, typically a lithium amide, followed by addition 
of the silyl reagent to give the less substituted silyl enol ether. Conversely, if the more 
substituted silyl enol ether is required, treatment of the ketone with the silyl reagent in 
the presence of a tertiary amine is commonly employed (Scheme 2.63).
153, 154
 
 
Scheme 2.63 
Given the plethora of compounds containing a nitrogen-palladium bond, it is vital that 
the Saegusa oxidation be performed in the absence of any remaining nitrogen 
compounds from the formation of the silyl enol ether, as these could diminish the 
catalytic activity of the palladium(II) acetate. For this reason, initial attempts at forming 
the silyl enol ether used TIPS-OTf instead of TMS-Cl. The extra steric bulk of the TIPS 
group serves to increase the stability of the silyl enol ether and should allow 
chromatographic purification prior to treatment with palladium(II) acetate.  
Thus, major decalinone 199 was treated with TIPS-OTf in pyridine to give a 5:2 
mixture of regioisomers 201/202 (Scheme 2.64). The regioselectivity was confirmed by 
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the integrals of the C=CH protons at approximately δ 5.61 and 5.66 ppm in the 1H NMR 
of the crude reaction mixture (Figure 2.17).   
Scheme 2.64 
 
Figure 2.17 
The identity of the major regioisomer was not definitively confirmed, although if the 
signal at approximately δ 5.51 ppm in Figure 2.17 is due to the TIPSOC=CH proton, 
then it would mean that the less substituted regioisomer 201 is favoured.  
In an attempt to exclusively form the less substituted silyl enol ether 201, ketone 199 
was treated with LiHMDS at –78 °C in THF for 1 hour, followed by the addition of 
TIPS-OTf. To our surprise, regioisomers 201 and 202 were again observed to form in a 
5:2 mixture (from the 
1
H NMR spectrum of the crude reaction mixture) (Scheme 2.65).  
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This unexpected result may be due to deprotonation not occurring at –78 °C prior to the 
addition of TIPS-OTf and that deprotonation occurs as the reaction mixture begins to 
warm. The increased temperature at which the deprotonation occurs may therefore 
account for the decreased regioselectivity of the reaction.  
Scheme 2.65 
In order to ensure complete deprotonation prior to warming the reaction mixture, the  
LDA was used as a base instead of LiHMDS. Due to the increased basicity of LDA, 
complete, regioselective deprotonation should occur at –78 °C. Ketone 199 was 
therefore treated with LDA at –78 °C  for 1 hour in THF, followed by the addition of 
TIPS-OTF or TIPS-Cl. In both instances, only starting material was observed in the 
1
H 
NMR spectrum of the crude reaction mixture (Scheme 2.66). We are not currently able 
to explain this result.  
 
Scheme 2.66 
With our limited success at forming the TIPS-silyl enol ether 201, we investigated 
whether or not the use of Me3SiCl would allow complete regioselective formation of the 
corresponding silyl enol ether. Treatment of 199 with LDA in THF at –78 °C for 1 hour, 
followed by trapping with excess Me3SiCl gave an unknown product (Scheme 2.67).  
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Scheme 2.67 
Initially, we believed this to be the desired silyl enol ether 203. As can be seen from the 
1
H NMR spectrum of the crude reaction mixture (Figure 2.18), the signal at 
approximately δ 5.61 ppm was believed to be the C=CH proton, the signal at δ 5.05 
ppm was believed to be due to the TIPSOC=CH proton and the two signals at δ 5.08 
and 4.88 ppm were believed to be the OCH2OMe protons. The presence of only one set 
of signals for each of these protons initially led us to believe that 203 had been formed 
as a single regioisomer.  
 
Figure 2.18 
Nonetheless, 
13
C NMR and DEPT NMR experiments cast doubt on our initial sstructure 
assignment. The signals at δ 172, 167, 153 and 137 ppm all correspond to quarternary 
carbons (Figure 2.19). As such, its identity remains unknown.  
128 
 
 
Figure 2.19 
During subsequent repeats of the reaction, it was observed that the reaction mixture 
would rapidly darken upon concentration. This prevented complete removal of the 
solvent, excess Me3SiCl and diisopropylamine. It was thought that Lewis acid-promoted 
polymerisation of the silyl enol ether could be an explanation (Scheme 2.68) for this 
observation. 
 
Scheme 2.68 
If polymerization akin to that shown in Scheme 2.67 was occurring, we speculated that 
a rapid wash with aqueous NaHCO3 would be sufficient to neutralize or remove all of 
the acidic compounds present. Thus, the reaction was repeated, partially concentrated, 
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diluted into hexane and rapidly washed with saturated aqueous NaHCO3 (Scheme 2.69). 
Unfortunately, this led to decomposition of the silyl enol ether and only starting 
material 199 was observed in the 
1
H NMR spectrum of the crude reaction mixture. 
 
Scheme 2.69 
Given our lack of success at oxidising ketone 199 via a Saegusa oxidation, we 
attempted to instead synthesise the corresponding selenide, with the intent to then carry 
out an oxidation-elimination reaction to gain access to enones 204/205 as shown in 
Scheme 2.70.  
 
Scheme 2.70 
Thus, decalinone 200 was deprotonated with LDA in THF at –78 °C for 1 hour and the 
enolate trapped with PhSeBr to give selenides 206/207 in an 65:35 diastereomeric ratio, 
as determined by the ratio of the integrals of the C=CH protons in the 
1
H NMR 
spectrum of the crude reaction mixture. After flash chromatography, selenides 206/207 
were isolated as an 85:15 diastereomeric mixture and a disappointing 10% yield, along 
with 20% of di-selenide 208, the identity of which was confirmed by HRMS giving an 
m/z value of 559.0279, as well as a total integration value of 10H for the protons in the 
aromatic region between δ 7.80–7.30 (Figure 2.20) Presumably formed by a second 
deprotonation-trapping event on selenides 206/207 (Scheme 2.71). 
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Scheme 2.71 
 
Figure 2.20 
As shown earlier in Scheme 2.68, it was speculated that Lewis-acid catalysed 
polymerisation was occurring with methoxymethyl protected silyl enol ether 203. 
Wishing to test this hypothesis, we looked to protect the hydroxyl group of decalinone 
194 as a more chemically stable methyl ether.  Decalinone 194 was therefore treated 
with iodomethane and silver oxide in acetonitrile to methylate the hydroxyl group 
(Scheme 2.72). However, even with vast excesses of reagents and extended reaction 
times, decalinone methylated decalinone 209 was only formed in 21% yield, with 53% 
of starting material being recovered. 
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Scheme 2.72 
Whilst we were able to develop methodology for the formation of model decalinones 
199 and 200, oxidation to the corresponding enones via a Saegusa oxidation proved 
much more difficult than anticipated and silyl enol ether 203 could not be isolated. 
Attempted selenation-oxidation of 200 did not proceed cleanly, giving substantial 
quantities of di-selenide 208, as well as low yields of the desired mono-selenides 
206/207.   
 
2.6.3 Proof of Relative Stereochemistry of Aldol Products 188 and 189 
Attempts to discern the relative stereochemistry of aldol products 188 and 189 directly 
were problematic, due to the difficulty in assigning J values to key diagnostic signals. 
We therefore looked to derivatise 188 and 189, both being oils, to a crystalline analogue 
that could then be subjected to X-ray diffraction after growing suitable single crystals. 
Thus, aldol products 188 and 189 were acylated with 4-nitrobenzoyl chloride in 
pyridine with catalytic DMAP to give acylated 210 and 211 in 87% and 75% yield 
respectively (Scheme 2.73). Both 210 and 211 however, ironically, remained as oils.   
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Scheme 2.73 
Whilst aldol products 188 and 189 were oils, the major decalinone 193 was a waxy 
solid and eventually, conditions that allowed the growth of a single crystal of adequate 
quality for X-ray diffraction was grown. The X-ray crystal structure for 193 was thus 
determined and its relative stereochemistry was proven (Figure 2.21).  
 
Figure 2.21 
Although the relative stereochemistry for the major decalinone 193 had been proven and 
the trans relationship between the ring substituents established, the relative 
stereochemistry of the minor decalinone was still unknown. Thus, reduction of 194 with 
NaBH4 in MeOH gave a 63:37 mixture of diasteromeric diols 212/213 (by 
1
H NMR 
spectroscopy of the crude reaction mixture) in a 63% and 37% isolated yield (Scheme 
2.74). 
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Scheme 2.74 
Whilst the major diol 212 remained as an oil, the minor diol 213 was a well-defined 
crystalline solid. A suitable single crystal was grown for X-ray diffraction and the 
relative stereochemistry for 213 was thus proven (Figure 2.22). With the relative 
stereochemistry of 213 now known and by extension, the relative stereochemistry of the 
minor decalinone 194 now known, it proved that the variable stereocentre between aldol 
products 188 and 189 was the hydroxyl group and that the two ring substituents adopt a 
trans relationship between one another.  
 
Figure 2.22 
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2.7 Conclusions and Future Work 
Significant progress has been made at developing methodology suitable for the 
synthesis of the core of anthracimycin 92 and potential analogues thereof. A robust and 
scalable route has been developed for the synthesis of the starting enone 117, as well as 
for the synthesis of decalinones 193 and 194 via titanium enolate chemistry.  
The addition of allyl cuprate to TIPS enone 117 was thoroughly investigated. Although 
conditions for the initial 1,4-addition were discovered, we were unable to trap the 
enolate with any of the electrophiles that were tested.  
Oxidation of decalinone 199 via a Saegusa oxidation proved to be more difficult than 
anticipated, possibly due to the acid-labile nature of the methoxymethyl protecting 
group. Formation of the α-seleno-ketones 206/207 also gave rise to unwanted side 
product formation including di-selenide 208. 
It was noted in an earlier experiment to TIPS protect the hydroxyl group of aldol 
product 188, that the TIPS protected silyl enol ether was formed in 42% yield instead 
(Scheme 2.74). A Saegusa oxidation at this stage may prove to be a viable alternative to 
a Saegusa oxidation after the ring closing metathesis step.  
 
Scheme 2.74 
Another avenue of research may be to change the protecting group for decalinones 199 
and 200 to an acid-stable protecting group in order to prevent polymerisation of the sort 
speculated in Scheme 2.67 from occurring.  
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Chapter Three: Experimental Procedures 
3.1 General Methods 
Water is distilled water. Brine refers to a saturated aqueous solution of NaCl. All non-
aqueous reactions were carried out under oxygen-free Ar using flame-dried glassware.  
Alkyllithiums were titrated against N-benzylbenzamide before use.
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 Grignard reagents 
and allyllithium were titrated against salicylaldehyde phenylhydrazone before use.
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All diamines and electrophiles were distilled over CaH2 before use. Et2O and THF were 
freshly distilled from sodium and benzophenone ketyl.  Petrol refers to the fraction of 
petroleum ether boiling in the range 40-60 C.  
 
Flash column chromatography was carried out using Fluka Chemie GmbH silica (220-
440 mesh). Thin layer chromatography was carried out using Merck F254 aluminium-
backed silica plates. 
1
H (400 MHz) and 
13
C (100.6 MHz) NMR spectra were recorded 
on a Jeol ECX-400 instrument with an internal deuterium lock. Chemical shifts are 
quoted as parts per million and referenced to CHCl3 (H 7.27), CDCl3 (C 77.0, central 
line of triplet), PhH (δH 7.16), benzene-d6 (δC 128.4, central line of triplet), MeOH (δH 
3.34, central line of quintet) or MeOH-d4 (δC 49.2, central line of septet). 
13
C NMR 
spectra were recorded with broadband proton decoupling. 
13
C NMR spectra were 
assigned using DEPT experiments. Coupling constants (J) are quoted in Hertz. IR 
spectra were recorded on a Perkin-Elmer Spectrum Two infrared spectrophotometer. 
Melting points were measured on a Stuart Equipment SMP3 melting point apparatus. 
Electrospray high and low resolution mass spectra were recorded on a Bruker Daltronics 
microOTOF spectrometer.  Chiral stationary phase HPLC was performed on an Agilent 
1200 series instrument and a multiple wavelength, UV/Vis diode array detector.   
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General Procedure A: Racemic sBuLi/diamine-mediated lithiation-electrophilic 
trapping of N-thiopivaloyl azetidine 35 and N-thiopivaloyl pyrrolidine 76  
sBuLi (1.3 eq of a 1.3 M solution in hexanes) was added rapidly to a stirred solution of 
N-thiopivaloyl azetidine 35 or N-thiopivaloyl pyrrolidine 76 (1.0 eq) and TMEDA (2.6 
eq.) in Et2O at −100 °C under N2.  The resulting solution was stirred at −100 °C for 2 
min.  Then, the electrophile (2.0 eq.) was added and the solution was stirred at −100 °C 
for 10 min and allowed to warm to rt over the course of 1 h. 2 M HCl(aq) (3 mL) was 
added and the two layers were separated. The aqueous layer was extracted with CH2Cl2 
(3 × 10 mL). The combined organic layers were dried (MgSO4) and the solvent 
evaporated under reduced pressure to give the crude product.  
 
General Procedure B: Asymmetric sBuLi/(–)-sparteine mediated lithiation-
electrophilic trapping of N-thiopivaloyl azetidine 35 and N-thiopivaloyl pyrrolidine 
76 
sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 1.2 eq.) was added rapidly 
to a stirred solution of N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.50 mmol, 1.0 eq) or 
N-thiopivaloyl pyrrolidine 76 (80 μL, 86 mg, 0.5 mmol, 1.0 eq)  and (–)-sparteine  (–)-1 
(0.14 mL, 141 mg, 0.6 mmol, 1.2 eq) or (S,S)-Alexakis' diamine (S,S)-12 (186 mg, 0.6 
mmol, 1.2 eq) in Et2O (5 mL) at –78 °C under N2. The resulting solution was stirred 
at  –78 °C for 30 min. Then, the electrophile (2.0 eq) was added and the solution was 
stirred at –78 °C for 30 min. Then, MeOH (2 mL) was added at –78 °C and the resulting 
solution was allowed to warm to rt over the course of 1 h. 2 M HCl(aq) (10 mL) was 
added and the layers were seperated. The aqueous layer was extracted with CH2Cl2 (3 x 
10 mL). The combined organic layers were dried (MgSO4) and the solvent evaporated 
under reduced pressure to give the crude product.   
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3.2 Experimental Procedures For Chapter One 
 
N-Thiopivaloyl azetidine 35 
 
To a stirred solution of P2S5 (1.89 g, 8.50 mmol, 1.2 eq) in pyridine (60 mL) was added 
amide 56 (1.0 g, 7.08 mmol, 1.0 eq). The resulting solution was heated to 85 °C for 16 h. 
Then, the reaction mixture was cooled to 0 °C and diluted with water (100 mL) and the 
pH adjusted to 2-3 with HCl(aq) (12 M) and stirred at room temperature for 3 h. The 
reaction was diluted with CH2Cl2 (100 mL), the layers separated and the aqueous layer 
washed with CH2Cl2 (3 x 50 mL). The combined organic layers were dried (MgSO4) 
and the solvent evaporated under reduced pressure to give the crude product. 
Purification by Kugelrohr distillation (approx. 106 °C bp at 0.5 mbar) gave thioamide 
35 (0.51 g, 3.26 mmol, 46%) as a bright yellow oil, RF (8:2 hexane – EtOAc) 0.25; IR 
(ATR) 2963, 1462, 1434, 1363, 1259, 1142, 1080, 1010, 864, 789, 701, 661, 480 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ  4.51 (dddd, J = 8.0, 8.0, 1.0, 1.0 Hz, 2H, CH2N), 4.28 
(dddd, J = 7.5, 7.5, 1.0, 1.0 Hz, 2H, CH2N), 2.33–2.24 (m, 2H, CH2), 1.35 (s, 9H, 
CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 209.6 (C=S), 57.1 (CH2N), 56.2 (CH2N), 43.2 
(CMe3), 29.8 (CMe3), 14.9 (CH2); MS (ESI) m/z 158 [(M+H
+
), 100], 180 [(M+Na)
+
, 20]; 
HRMS m/z cacld for C8H15NS (M + Na)
+
 180.0817, found 180.0811 (+3.4 ppm error).  
Lab Book Reference: JCS-5-57 
 
To a stirred solution of P2S5 (4.57 g, 20.6 mmol, 1.05 eq) in pyridine (60 mL) was 
added amide 56 (2.76 g, 19.6 mmol, 1.0 eq). The resulting solution was heated to 75 °C 
for 16 h. Then, the reaction mixture was cooled to 0 °C and diluted with water (100 mL) 
and the pH adjusted to 2-3 with H2SO4 (95% w/w) and stirred at room temperature for 3 
h. The reaction was diluted with CH2Cl2 (30 mL), the layers separated and the aqueous 
layer washed with CH2Cl2 (5 x 30 mL). The combined organic layers were dried 
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(MgSO4) and the solvent evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 8:2 petroleum ether – 
EtOAc as eluent gave thioamide 35 (2.83 g, 18.0 mmol, 92%) as a bright yellow oil. 
Lab Book Reference: JCS-2-3 
 
Rac-2,2-dimethyl-1-(2-(trimethylsilyl)azetidin-1-yl)propane-1-thione rac-36 and 1-
(2,2-bis(trimethylsilyl)azetidin-1-yl)-2,2-dimethylpropane-1-thione 73 
 
Using general method A, thioamide 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq), sBuLi (0.5 
mL, 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq), TMEDA (0.18 mL, 1.2 mmol, 2.6 
eq) and Me3SiCl (0.130 mL, 0.109 mg, 1.0 mmol, 2.0 eq) as electrophile in Et2O (5 mL) 
yielded crude product. Purification by flash column chromatography on silica with 8:2 
petroleum ether – EtOAc as eluent gave rac-36 (73 mg, 0.32 mmol, 64%), mp 49–52 °C; 
RF (8:2 petroleum ether – EtOAc) 0.44; IR (ATR) 2950, 1474, 1441, 1361, 1244, 1134, 
1016, 1110, 1003, 945, 833, 752, 687, 645, 496 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
4.61 (ddd, J = 11.0, 6.5, 2.0 Hz, 1H, CHN), 4.52–4.39 (m, 2H, CH2N), 2.47–2.35 (m, 
1H, CHAHB), 2.10–2.00 (m, 1H, CHAHB), 1.33 (s, 9H, CMe3), 0.18 (s, 9H, SiMe3); 
13
C 
NMR (100.6 MHz, CDCl3) δ 206.1 (C=S), 62.2 (CHN), 57.1 (CH2N), 42.9 (CMe3), 
30.0 (CMe3), 17.1 (CH2), –1.30 (SiMe3); MS (ESI) m/z 230 [(M + H)
+
, 100]; HRMS m/z 
calcd for C11H24NSSi (M+H)
+
 230.1393, -found 230.1388 (+2.3 ppm error), and di-
substituted 73 (21.2 mg, 0.070 mmol, 14%) as a white solid, mp 100.5–102.0 °C; RF 
(8:2 petroleum ether – EtOAc) 0.59; IR (ATR) 2950, 1473, 1441, 1391, 1361, 1244, 
1193, 1134, 1110, 1017, 1002, 945, 833, 752, 687, 597, 496 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 4.41–4.36 (m, 2H, CH2N), 2.26–2.19 (m, 2H, CH2), 1.30 (s, 9H, CMe3), 0.21 
(s, 18H, SiMe3); 
13
C NMR (100.6 MHz, CDCl3) 203.1 (C=S), 66.9 (NC(SiMe3)2), 56.0 
(CH2N), 42.4 (CMe3), 29.9 (CMe3), 20.2 (CH2), 0.29 (SiMe3); MS (ESI) 302 [(M+H)
+
, 
100], 324 [(M+Na)
+
, 50]; HRMS m/z calcd for C14H31NSSi2 (M+H)
+
 302.1789, found 
302.1785 (+0.7 ppm error). 
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Lab book reference: JCS-7-86  
 
2,2-Dimethyl-1-(2-(trimethylsilyl)azetidin-1-yl)propane-1-thione-36  
 
Using general procedure B, sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 
1.2 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and (–)-1 (0.14 
mL, 141 mg, 0.6 mmol, 1.2 eq) in Et2O (5 mL) and Me3SiCl (95 μL, 81 mg, 0.75 mmol, 
1.5 eq) gave the crude product. Purification by flash column chromatography on silica 
with 9:1 hexane-EtOAc as eluent gave silane 36 (64 mg, 0.28 mmol, 56%, 54:46 er by 
CSP-HPLC) as a white solid; [α]D +15.6 (c 0.52 in EtOAc); CSP-HPLC: Chiralcel OD-
H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) 4.7 min (major), 5.9 min (minor). 
Spectroscopic data consistent with literature values.
20
 
Lab Book Reference: JCS-2-11 
 
Using general procedure B, sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 
1.2 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and diamine 
(S,S)-12 (186 mg, 0.6 mmol, 1.2 eq) in Et2O (5 mL) and  Me3SiCl (95 μL, 81 mg, 0.75 
mmol, 1.5 eq) gave the crude product. Purification by flash column chromatography on 
silica with 9:1 hexane-EtOAc gave silane 36 (51 mg, 0.22 mmol, 45%, 54:46 er by 
CSP-HPLC) as a white solid, mp 46–49 °C; [α]D +19.2 (c 1.145 in EtOAc); CSP-HPLC: 
Chiralcel OD-H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) 5.2 min (major), 6.9 min (minor). 
Lab Book Reference: JCS-2-12 
 
Rac-1-(2-(hydroxy(phenyl)methyl)azetidin-1-yl)-2,2-dimethylpropane-1-thione rac-
38 and  rac-39 
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sBuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq) was added to a stirred 
solution of  thioamide 35  (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and TMEDA (0.20 mL, 
0.151 g 1.3 mmol, 2.6 eq) in THF (5 mL) at –78 °C under N2. After 30 min,  
benzaldehyde (0.1 mL, 1.0 mmol, 2.0 eq) was added and the resultant solution was 
allowed to warm to room temperature over 30 m. HCl(aq) (2 M, 3 mL) was added and 
the reaction mixture was diluted with EtOAc (20 mL). The layers were seperated and 
the aqueous layer was extracted with CH2Cl2 (3 x 5 mL). The combined organic extracts 
were dried (MgSO4) and the solvent evaporated under reduced pressure to give the 
crude product which ontained a a 65:35 mixture (by 
1
H NMR of the crude mixture) of 
diasteromeric alcohols 38 and 57. Purification by column chromatography through 
silica with 95:5 – 8:2 petroleum ether – EtOAc as eluent gave rac-57 (25 mg, 0.095 
mmol, 19%) as a white solid, mp 130.5–132.2 °C; RF (8:2 petroleum ether – EtOAc) 0.5; 
IR (ATR) 3351 (O–H), 2998, 2973, 2931, 2897, 2868, 1481, 1455, 1468, 1432, 1394, 
1359, 1276, 1242, 1220, 1206, 1136, 1112, 1065, 1052, 1030, 992, 977, 929, 828, 778, 
753, 703, 668, 657, 607, 560, 514, 472 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.45-7.41 
(m, 2H, PhH), 7.38-7.33 (m, 2H, PhH), 7.32-7.27 (m, 1H, p-PhH), 5.46 (d, J = 1.5 Hz, 
1H, CHOH), 5.25 (dddd, J = 9.0, 5.0, 1.5, 1.5 Hz, 1H, CHN), 4.20 (ddd, J = 10.0, 10.0, 
5.0 Hz, 1H, CHAHBN), 3.87 (dddd, J = 7.5, 7.5, 7.5, 2.0 Hz, 1H, CHAHBN), 2.30 (m, 1H, 
CHAHB), 2.11 (m, 1H, CHAHB), 1.29 (s, 9H, CMe3); 
13
C NMR (100 MHz, CDCl3) δ 
211.1 (C=S), 139.6 (i-Ph), 128.2 (Ph), 127.7 (Ph), 126.7 (Ph), 73.7 (CHOH), 73.5 
(CHN), 56.1 (CH2N), 43.4 (CMe3), 29.5 (CMe3), 17.2 (CH2); MS (ESI) m/z 264 
[(M+H)
+
, 60], 286 [(M+Na)
+
, 100]; HRMS m/z calcd for C15H21NOS (M+H)
+
 264.1417, 
found 264.1423 (-3.2 ppm error); CDCC No. 1417066, and rac-38 (49 mg, 0.19 mmol, 
37%) as a white solid, mp 132.5–133.2 °C; RF (8:2 petroleum ether – EtOAc) 0.4; IR 
(ATR) 3213 (O-H), 2969, 1463, 1367, 1292, 1253, 1219, 1135, 1118, 1078, 1060, 987, 
926, 854, 762, 704, 634, 597, 543, 502, 483 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.44-
7.40 (m, 2H, PhH), 7.38-7.28 (m, 3H, PhH), 5.31 (d, J = 7.5 Hz, 1H, CHOH), 5.21 (m, 
1H, CHN), 4.29 (ddd, J = 10.0, 10.0, 5.5 Hz, 1H, CHAHBN), 4.15 (m, 1H, CHAHBN), 
2.19 (m, 1H, CHAHB), 1.85 (m, 1H, CHAHB) 1.34 (s, 9H, CMe3); 
13
C NMR (100 MHz, 
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CDCl3) δ 212.3 (C=S), 140.0 (i-Ph), 128.4 (Ph), 128.2 (p-Ph), 127.4 (Ph), 76.1 (CHOH), 
73.9 (CHN), 56.1 (CH2N), 43.7 (CMe3), 29.7 (CMe3), 18.4 (CH2); MS (ESI) m/z 264 
[(M+H)
+
, 10], 286 [(M+Na)
+
, 100]; HRMS m/z calcd for C15H21NOS (M+Na)
+
 
286.1236, found 286.1234 (+0.4 ppm error), CDCC No. 1417067. 
 
Procedure for growing crystals of rac-38 and rac-57 
Alcohol rac-57 (Approx 5 mg) was dissolved in the minimum amount of EtOAc. The 
solution was placed into a small glass vial and placed upright in a sealed vessel 
containing pentane (~ 20 mL). After several days, suitable crystals had precipitated in 
the glass vial. These were collected and subjected to X-ray analysis. The same method 
was used to grow appropriate crystals of diasteromeric alcohol rac-38. 
Lab Book Reference: JCS-1-19, JCS-7-71 
 
Using general method A, thioamide 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq), sBuLi (0.50 
mL, 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq), TMEDA (0.20 mL, 0.151 g 1.3 
mmol, 2.6 eq) and benzaldehyde (0.1 mL, 0.104 g, 1.0 mmol, 2.0 eq) as electrophile in 
Et2O (5 mL) yielded crude product containing alcohols rac-57 and rac-38 in a 27:73 
ratio respectively. Purification by flash column chromatography with 8:2 petroleum 
ether – EtOAc gave a mixture of alcohols 57 and 38 (116 mg, 0.44 mmol, 88% 
combined yield). 
Lab book reference: JCS-1-97 
 
Rac-1-(2-(2-hydroxypropan-2-yl)azetidin-1-yl)-2,2-dimethylpropane-1-thione 39 
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Using general procedure A, sBuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and TMEDA 
(0.20 mL, 155 mg,  1.3 mmol, 2.6 eq) in Et2O (7 mL) and freshly distilled, dry acetone 
(73 μL, 58 mg, 1.0 mmol, 2.0 eq) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 – 7:3 hexane – EtOAc as eluent gave alcohol rac-39 
(40 mg, 0.187 mmol, 37%) as a brown solid, mp 74–77 °C; IR (ATR) 3264 (O–H), 
2967, 2924, 1464, 1433, 1402, 1362, 1300, 1255, 1173, 1136, 986, 948, 541, 474 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 6.00 (br s, 1H, OH), 4.96 (dd, J = 10.0, 6.0 Hz, 1H, 
CHN), 4.46-4.40 (m, 2H, CH2N), 2.52–2.41 (m, 1H, CHAHB), 1.97-1.87 (m, 1H, 
CHAHB), 1.36 (s, 9H, CMe3), 1.30 (s, 3H, MeA), 1.15 (s, 3H, MeB); 
13
C NMR (100.6 
MHz, CDCl3) δ 212.5 (C=S), 79.1 (CHN), 73.3 (C(Me)2OH), 56.3 (CH2N), 43.8 
(CMe3), 29.8 (CMe3), 25.7 (Me), 23.2 (Me), 19.5 (CH2); MS (ESI) m/z 238 [(M+Na)
+
, 
85], 216 [(M+H]
+
, 100]; HRMS m/z calcd for C11H22NOS (M+Na)
+ 
238.1236, found 
238.1229 (+3.0 ppm error).  
Spectroscopic data consistent with literature values.
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Lab Book Reference: JCS-2-6 
 
1-(2-(2-Hydroxypropan-2-yl)azetidin-1-yl)-2,2-dimethylpropane-1-thione 39 
 
Using general procedure B, sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 
1.2 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and (–)-1  (0.14 
mL, 141 mg,  0.6 mmol, 1.2 eq) in Et2O (5 mL) and freshly distilled, dry acetone (60 μL, 
48 mg, 0.75 mmol, 1.5 eq) gave the crude product. Purification by flash column 
chromatography on silica with 8:2-7:3 hexane-EtOAc as eluent gave 39 (23 mg, 0.107 
mmol, 22%, 60:40 er by CSP-HPLC) as a brown solid, mp 70–75 °C; [α]D –7.5 (c 0.95 
in EtOAc); CSP-HPLC: Chiralcel OD-H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) 13.0 min 
(minor), 14.1 min (major).  
143 
 
Lab Book Reference: JCS-2-7 
 
(S)-2,2-Dimethyl-1-(2-methylazetidin-1-yl)propane-1-thione (S)-40  
 
Using general procedure B, sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 
1.2 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and diamine 
(S,S)-12 (186 mg, 0.6 mmol, 1.2 eq) in Et2O (5 mL) and methyl iodide (50 μL, 106 mg, 
0.75 mmol, 1.5 eq) gave the crude product. Purification by flash column 
chromatography on silica with 9:1 hexane-EtOAc gave adduct (S)-40 (41 mg, 0.24 
mmol, 48%, er 71:29 by CSP-HPLC) as a yellow oil, RF (8:2 petroleum ether – EtOAc) 
0.35; IR (ATR) 2962, 2924, 1456, 1425, 1363, 1255, 1139, 1049, 993, 493 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) (83:17 mixture of rotamers) δ 4.91–4.78 (m, 0.83H, CHN), 
4.91–4.78 (m, 0.13H, CHN), 4.61–4.51 (m, 0.83H, CHAHBN), 4.61–4.51 (m, 0.13H, 
CHAHBN), 4.45–4.38 (m, 0.83H, CHAHBN), 4.45–4.38 (m, 0.13H, CHAHBN), 2.59–2.47 
(m, 0.83H, CHAHB), 2.59–2.47 (m, 0.13H, CHAHB), 1.88–1.79 (m, 0.83H, CHAHB), 
1.88–1.79 (m, 0.13H, CHAHB), 1.65 (d, J = 6.5 Hz, 0.39H, CH3), 1.60 (d, J = 6.5 Hz, 
2.49H, CH3), 1.40 (s, 1.17H, CMe3), 1.33 (s, 7.47H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 210.5 (C=S), 65.9 (CHN), 55.8 (CH2N), 43.6 (CMe3), 29.8 (CMe3), 23.2 
(CH2), 18.7 (CH3); [α]D +4.3 (c 0.725 in EtOAc); CSP-HPLC: Chiralcel OD-H 
(99.9:0.1 Hexane-iPrOH, 1.0 mL min
-1
) (R)-40 15.1 min, (S)-40 16.8 min. 
Spectroscopic data consistent with literature values.
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Lab Book Reference: JCS-2-13 
 
N-Pivaloyl Azetidine 56 
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tBuCOCl (3.16 mL, 3.10 g, 25.7 mmol, 1.2 eq) was added dropwise to a stirred 
suspension of azetidine HCl (21.4 mmol, 2.00 g, 1.0 eq), Et3N (14.9 mL, 10.8 g, 0.11 
mol, 5.0 eq), and DMAP (0.52 g, 4.28 mmol, 0.2 eq) in CH2Cl2 (50 mL) at 0 °C under 
N2 atmosphere over 5 minutes. The resulting solution was then allowed to warm to rt 
over 16 h. Then, HCl(aq) (2 M, 100 mL) was added, followed by the addition of 50 mL 
of CH2Cl2. The layers were separated and the organic layer was washed with HCl(aq) (2 
M, 2 x 20 mL), dried (MgSO4) and the solvent evaporated under reduced pressure to 
give the crude product. Purification by Kugelrohr distillation (approx. 80 °C bp at 0.5 
mbar) gave 56 (2.54 g, 18.0 mmol, 84%) as a colourless oil; IR (ATR) 2962, 2883, 
1809, 1730, 1625 (C=O), 1589 (C=O), 1481, 1413, 1364, 1165, 1043, 1004, 941, 862, 
748, 629, 564, 527 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 4.35 (br s, 2H, CH2N), 4.00 (br 
s, 2H, CH2N), 2.22 (dddd, J = 7.5, 7.5, 7.5, 7.5 Hz, 2H, CH2), 1.17 (s, 9H, CMe3); 
13
C 
NMR (100.6 MHz, CDCl3) δ 183.7 (C=O), 177.9 (C=O), 53.4 (CH2N), 49.2 (CH2N), 
38.6 (CMe3), 38.5 (CMe3), 27.2 (CMe3), 27.1 (CMe3), 16.0 (CH2); MS (ESI) m/z 142 
[(M+H)
+
, 100], 164 [(M+Na)
+
, 50]; HRMS m/z calcd for C8H15NO (M+Na)
+
 164.1046, 
found 164.1051 (-3.5 ppm error). 
Lab Book Reference: JCS-5-55 
 
Rac-1-(2-(1-hydroxyallyl)azetidin-1-yl)-2,2-dimethylpropane-1-thione rac-58 and 
rac-59 
 
Using general procedure A, sBuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 
1.3 eq), N-thiopivaloyl azetidine 35 (0.154 mL, 0.151 g, 1.0 mmol, 1.0 eq) and TMEDA 
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(0.39 mL, 0.302 g,  2.6 mmol, 2.6 eq) in Et2O (7 mL) and acrolein (0.134 mL, 0.112 g, 
2.0 mmol, 2.0 eq) gave the crude product which contained a 65:35 mixture of 
diastereomeric alcohols rac-58 and rac-59 (by 
1
H NMR of the crude reaction mixture). 
Purification by flash column chromatography on silica with 9:1 hexane – EtOAc as 
eluent gave alcohol rac-59 (48 mg, 0.23 mmol, 23%) as a pale yellow oil, RF (8:2 
petroleum ether - EtOAc) 0.18; IR (ATR) 3400 (O–H), 2967, 2925, 1464, 1431, 1395, 
1363, 1301, 1248, 1219, 1143, 1078, 988, 925, 872, 790, 695, 662, 560, 493 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 5.87 (ddd, J = 17.0, 10.5, 6.0 Hz, 1H, HC=CH
1
H
2
), 5.42 
(ddd, J = 17.0, 1.5, 1.5 Hz, 1H, HC=CH
1
H
2
), 5.27 (ddd, J = 10.5, 1.5, 1.5 Hz, 1H, 
HC=CH
1
H
2
), 5.04–4.98 (m, 1H, CHN), 4.70 (br d, J = 4.5 Hz, 1H, CHOH), 4.37–4.31 
(m, 2H, CH2N), 4.27 (br s, 1H, CHOH), 2.43–2.31 (m, 1H, CHAHB), 2.10–2.00 (m, 1H, 
CHAHB), 1.34 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 211.2 (C=S), 135.1 
(HC=CH2), 117.3 (HC=CH2), 73.1 (CHOH), 72.9 (CHN), 56.2 (CH2N), 43.5 (CMe3), 
29.7 (CMe3), 17.7 (CH2); MS (ESI) m/z 214 [(M+H)
+
, 50], 236 [(M+Na)
+
, 100]; HRMS 
m/z calcd for C11H19NOS (M+Na)
+
 236.1080, found 236.1084 (-2.1 ppm error), and 
rac-58 (89 mg, 0.42 mmol, 42%) as a pale yellow oil, RF (8:2 petroleum ether - EtOAc) 
0.14; IR (ATR) 3392 (O–H), 3270, 2968, 2927, 1460, 1429, 1395, 1363, 1290, 1248, 
1142, 1118, 1055, 992, 926, 872, 811, 701, 662, 511 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 
δ 5.82 (m, 1H, HC=CH1H2), 5.43 (ddd, J = 17.0, 1.0, 1.0 Hz, 1H, HC=CH1H2), 5.29 
(ddd, J = 10.5, 0.5 Hz, 1H, HC=CH
1
H
2
), 4.99–4.91 (m, 1H, CHN), 4.81 (br s, 1H, 
CHOH), 4.73 (dd, J = 7.0, 7.0 Hz, CHOH), 4.47–4.33 (m, 2H, CH2N), 2.42–2.30 (m, 
1H, CHAHB), 2.03–1.93 (m, 1H, CHAHB), 1.35 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 212.4 (C=S), 135.7 (HC=CH2), 118.4 (HC=CH2), 75.2 (CHOH), 72.7 (CHN), 
56.3 (CH2N), 43.6 (CMe3), 29.7 (CMe3), 18.3 (CH2); MS (ESI) m/z 214 [(M+H)
+
, 40], 
236 [(M+Na)
+
, 100]; HRMS m/z calcd for C11H19NOS (M+Na)
+
 236.1080, found 
236.1080 (-0.3 ppm error). 
Lab book reference: JCS-7-72 
 
sBuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.0 eq) was added dropwise 
over 2 m to a stirred solution of TMEDA (0.39 mL, 0.302 g, 2.6 mmol, 2.6 eq) and N-
thiopivaloyl azetidine 35 (0.154 mL, 0.151 g, 1.0 mmol, 1.0 eq) in THF (7 mL) at –78 
°C under N2. After 30 minutes, acrolein (0.134 mL, 0.112 g, 2.00 mmol, 2.0 eq) was 
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added rapidly and the solution was stirred for a further 30 mins at the same temperature. 
AcOH(l) (2 mL) was added and the solution was allowed to warm to room temperature. 
NaHCO3(aq) (sat. 10 mL) was added and the layers were separated. The aqueous layer 
was washed with CH2Cl2 (3 x 5 mL) and the combined organic layers were washed with 
brine (1 x 10 mL), dried (MgSO4) and the solvent evaporated under reduced pressure to 
give crude product which contained a 60:40 mixture of diastereomeric alcohols rac-58 
and rac-59. Purification by flash column chromatography on silica with 9:1 petroleum 
ether - EtOAc as eluent gave rac-59 (27 mg, 0.124 mmol, 12%) as a pale yellow oil and 
rac-58 (55 mg, 0.257 mmol, 26%) as a pale yellow oil.  
Lab Book Reference: JCS-1-71 
 
Rac-(S)-1-((S)-1-(2,2-dimethylpropanethioyl)azetidin-2-yl)allyl 4-nitrobenzoate 
rac-60 
 
4-nitrobenzoylchloride (348 mg, 1.87 mmol, 20 eq) was added in one portion to a 
stirred solution of alcohol rac-58 (20 mg, 0.094 mmol, 1.0 eq) and DMAP (2.3 mg, 
0.019 mmol, 0.2 eq) in pyridine (2 mL) at rt. The resulting solution was stirred at the 
same temperature for 16 h. Then, the reaction mixture was diluted with EtOAc (50 mL) 
and washed with HCl(aq) (2 M, 1 x 20 mL), water (1 x 20 mL), K2CO3(aq) (5% w/w, 1 x 
50 mL), dried (MgSO4) and the solvent evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 7:3 hexane – 
EtOAc as eluent gave rac-60 (22 mg, 0.061 mmol, 65%) as a pale yellow solid, mp 
103.5–105.5 °C; RF (7:3 hexane – EtOAc) 0.31; IR (ATR) 3111, 2958, 2926, 2854, 
1720 (C=O), 1606, 1525 (N–O), 1462, 1432 (N–O), 1364, 1339, 1316, 1292, 1271, 
1173, 1147, 1117, 1106, 1006, 983, 967, 928, 880, 865, 841, 814, 786, 720, 505 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 8.31–8.27 (m, 2H, H
1
), 8.22–8.17 (m, 2H, H2), 6.72 (dd, 
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J = 5.5, 5.5 Hz, CHOCOOAr), 6.01 (ddd, J = 17.0, 10.5, 5.5 Hz, H=CH2), 5.50 (br d, J 
= 17.0 Hz, 1H, H
3
), 5.45 (d, J = 10.5 Hz, 1H, H
4
), 5.18 (ddd, J = 9.5, 5.5, 5.5 Hz, 1H, 
CHN), 4.48–4.35 (m, 2H, CH2N), 2.54–2.42 (m, 1H, CHAHB), 2.38–2.27 (m, 1H, 
CHAHB), 1.32 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 212.1 (C=S), 163.3 
(COOAr), 150.7 (i-ArNO2), 135.5 (p-ArNO2), 130.9 (m-ArNO2), 130.6 (HC=CH2), 
123.7 (o-ArNO2), 120.0 (HC=CH2), 71.5 (CHOCOOAr), 67.3 (CHN), 56.6 (CH2N), 
43.5 (CMe3), 29.7 (CMe3), 16.6 (CH2); MS (ESI) m/z 363 [(M+H)
+
, 60], 385 [(M+Na)
+
, 
100]; HRMS m/z calcd for C18H22N2O4S (M+H)
+
 363.1373, found 363.1369 (+0.9 ppm 
error).   
 
Method For Growing Crystals of rac-60 
 
A solid sample of rac-60 (approx. 1 mg) was placed in a small glass vial and dissolved 
in the minimum quantity of EtOAc (approx. 0.05 mL) and placed upright in a sealed 
vessel containing pentane (approx. 5 mL). After 24 h, crystals suitable for X-Ray 
analysis had formed on the inner vial. 
Lab Book Reference: JCS-7-77 
 
Rac-(R)-1-((S)-1-(2,2-Dimethylpropanethioyl)azetidin-2-yl)allyl 4-nitrobenzoate 
rac-61 
 
4-nitrobenzoylchloride (348 mg, 1.87 mmol, 20 eq) was added in one portion to a 
stirred solution of alcohol rac-59 (20 mg, 0.094 mmol, 1.0 eq) and DMAP (2.3 mg, 
0.019 mmol, 0.2 eq) in pyridine (2 mL) at rt. The resulting solution was stirred at the 
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same temperature for 16 h. Then, the reaction mixture was diluted with EtOAc (50 mL) 
and washed with HCl(aq) (2 M, 1 x 20 mL), water (1 x 20 mL), K2CO3(aq) (5% w/w, 1 x 
50 mL), dried (MgSO4) and the solvent evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 7:3 hexane – 
EtOAc as eluent gave rac-61 (21 mg, 0.058 mmol, 62%) as a pale yellow solid, mp 
140.9–143.5 °C; RF (7:3 hexane – EtOAc) 0.29; IR (ATR) 2971, 2924, 2854, 1723 
(C=O), 1608, 1528 (N–O), 1455, 1433 (N–O), 1345, 1319, 1265, 1244, 1205,  1147, 
1117, 1102, 1076, 1010, 977, 936, 912, 867, 848, 829, 783, 716, 666, 506 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.35–8.30 (m, 2H, H
1
), 8.27–8.22 (m, 2H, H2), 6.89 (dd, J = 
5.0, 1.5 Hz, 1H, CHORCOOAr), 5.86 (ddd, J = 16.5, 11.0, 5.0 Hz, 1H, HC=CH2), 5.44 
(br d, J = 16.5 Hz, 1H, H
3
), 5.36 (br d, J = 11.0 Hz, 1H, H
4
), 5.11–5.05 (m, 1H, CHN), 
4.46–4.39 (m, 2H, CH2N), 2.55–2.44 (m, 2H, CH2), 1.21 (s, 9H, CMe3); 
13
C NMR 
(100.6 MHz, CDCl3) δ 212.0 (C=S), 163.1 (C=O), 150.8 (C–NO2), 135.6 (p-ArNO2), 
131.1 (HC=CH2), 130.7 (o-ArNO2), 123.9 (m-ArNO2), 118.9 (HC=CH2), 71.8 
(CHOCOOAr), 68.7 (CHN), 56.6 (CH2N), 43.7 (CMe3), 29.6 (CMe3), 17.0 (CH2); MS 
(ESI) m/z 363 [(M+H)
+
, 60], 385 [(M+Na)
+
, 100]; HRMS m/z calcd for C18H22N2O4S 
(M+H)
+
 363.1373, found 363.1369 (+0.9 ppm error).  
 
Method For Growing Crystals of rac-61 
 
A solid sample of rac-61 (approx. 1 mg) was placed in a small glass vial and dissolved 
in the minimum quantity of EtOAc (approx. 0.05 mL) and placed upright in a sealed 
vessel containing pentane (approx. 5 mL). After 24 h, crystals suitable for X-Ray 
analysis had formed on the inner vial. 
Lab Book Reference: JCS-7-76 
 
Rac-(2S,4R,6R)-2,4-di-tert-butyl-3,5-dithia-1-azatricyclo[4.2.0.02,4]octane rac-62 
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sBuLi (1 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq) was added dropwise 
over 3 m to a stirred solution of TMEDA (0.39 mL, 0.302 g, 2.6 mmol, 2.6 eq) and N-
thiopivaloyl azetidine 35 (0.151 mL, 0.157 g, 1.0 mmol, 1.0 eq) held at –78 oC under N2. 
The solution was stirred at the same temperature for 1 hour before being quenched by 
the addition of MeOH (2 mL). The resulting solution was allowed to warm to room 
temperature and HCl(aq) (2 M, 10 mL) was added. The reaction  mixture was diluted 
with EtOAc (100 mL) and the layers were separated. The organic layer was dried 
(MgSO4) and the solvent evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica gave rac-62 (28 mg, 0.108 mmol, 
22%) as a pale yellow oil, IR (ATR) 2960, 2928, 2867, 1618, 1476, 1460, 1393, 1364, 
1263, 1221, 1171, 1127, 1051, 998, 967, 943, 889, 853, 817, 792, 681, 666, 575 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.01 (dd, J = 7.0, 3.5 Hz, 1H, CHN), 2.97 (ddd, J = 11.0, 
10.0, 5.0 Hz, 1H, CHAHBN), 2.87–2.81 (m, 1H, CHAHBN), 2.48–2.31 (m, 2H, CH2), 
1.22 (s, 9H, (CMe3)A), 1.12 (s, 9H, (CMe3)B); 
13
C NMR (100.6 MHz, CDCl3) δ 179.2, 
93.9, 86.0 (CHN), 40.3 (CH2), 39.8 (CMe3), 38.2 (CMe3), 31.9 (CH2N), 29.4 ((CMe3)A), 
27.5 ((CMe3)B); MS (ESI) m/z 258 [(M+H)
+
, 100]; HRMS m/z calcd for C13H23NS2 
(M+H)
+
 258.1345, found 258.1353 (-2.6 ppm error), and RSM (73 mg, 0.46 mmol, 
46%). This is a tentatively proposed structure for rac-62. 
Lab book reference: JCS-7-73 
 
Rac-d
1
-N-thiopivaloyl azetidine rac-65 and rac-1,1'-(azetidine-1,2-diyl)bis(2,2-
dimethylpropane-1-thione) rac-63 
 
150 
 
sBuLi (0.5 mL, 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq) was rapidly added to a 
stirred solution of TMEDA (0.2 mL, 0.151 g, 1.3 mmol, 2.6 eq) and N-thiopivaloyl 
azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) in Et2O (5 mL) at –100 
o
C under N2. 
After 2 min at the same temperature, CD3OD (36 mg, 40 μL, 1.0 mmol, 2.0 eq) was 
added rapidly and the solution was allowed to warm to room temperature over 10 m. 
The solvent was evaporated under reduced pressure to yield the crude product. 
Purification by flash column chromatography on silica with 7:3 petroleum ether – 
EtOAc as eluent gave rac-65 (71 mg,  0.45 mmol,  90%, 100% deuteration) as a yellow 
oil; IR (ATR) 2966, 1464, 1435, 1393, 1362, 1313, 1291, 1255, 1235, 1145, 1093, 1010, 
988, 924, 853, 791, 690, 556. 477 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 4.42–4.34 (m, 
1.5H, CH2N/CHDN), 4.19–4.11 (m, 1.5H, CH2N/CHDN), 2.16 (dddd, J = 8.0, 8.0, 8.0, 
8.0 Hz, 2H, CH2), 1.23 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (Rotameric mix) 
δ 209.6 (C=S), 57.1 (CH2N), 56.8 (t, J = 23.0 Hz, CHDN), 56.1 (CH2N), 55.8 (t, J = 
23.0 Hz, CHDN), 43.2 (CMe3), 29.8 (CMe3), 14.7 (CH2); MS (ESI) m/z 159 [(M+H)
+
, 
100], 181 [(M+Na)
+
, 50]; HRMS m/z calcd for C8H14DNS (M+Na)
+
 181.0880, found 
181.0877 (-0.6 ppm error), and self-addition product rac-63 (9.1 mg, 35μmol, 14%) as a 
pink solid, RF (7:3 hexane – EtOAc) 0.38; mp 104.6–105.3 °C; IR (ATR) 2964, 1465, 
1429, 1393, 1363, 1330, 1230, 1192, 1153, 1053, 1032, 1005, 968, 916, 856, 644, 598, 
544, 517, 503, 491, 462, 475 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 6.09 (ddd, J = 9.5, 4.5, 
1.5 Hz, 1H, CHN), 4.59–4.51 (m, 1H, CHAHBN), 4.47 (ddd, J = 9.5, 9.5, 5.0 Hz, 1H, 
CHAHBN), 2.59–2.49 (m, 1H, CHAHB), 1.88–1.79 (m, 1H, CHAHB), 1.39 (s, 9H, CMe3), 
1.35 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 259.2 (C=S), 209.2 (NC=S), 74.8 
(CHN), 55.0 (CH2N), 51.7 (CMe3), 43.1 (CMe3), 30.1 (CMe3), 29.8 (CMe3), 24.4 (CH2); 
MS (ESI) m/z 258 [(M+H)
+
, 100], 280 [(M+Na)
+
, 10]; HRMS m/z calcd for C13H23NS2 
(M+H)
+
 258.1345, found 258.1351 (-3.3 ppm error). 
Lab book reference: JCS-7-85 
 
Rac-1-(2-(Hydroxydiphenylmethyl)azetidin-1-yl)-2,2-dimethylpropane-1-thione 
rac-68 
151 
 
 
Using general procedure A, sBuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and TMEDA 
(0.20 mL, 155 mg, 1.3 mmol, 2.6 eq) in Et2O (7 mL) and a solution of benzophenone 
(182 mg, 1.0 mmol, 2.0 eq) in Et2O (0.5 mL) gave the crude product. Purification by 
flash column chromatography on silica with 95:5-8:2 hexane-EtOAc as eluent gave 
alcohol rac-68 (55 mg, 0.16 mmol, 32%) as a white solid, mp 191–193 °C; RF (8:2 
petroleum ether – EtOAc) 0.4; IR (ATR) 3163 (O–H), 2961, 2929, 1467, 1395, 1366, 
1316, 1287, 1247, 1214, 1060, 1013, 767, 704, 587 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
7.49–7.45 (m, 2H, Ph), 7.38–7.30 (m, 6H, Ph), 7.27–7.24 (m, 2H, Ph), 5.93 (ddd, J = 
9.5, 5.0, 1.5 Hz, 1H, CHN), 4.16 (ddd, J = 10.0, 10.0, 4.5 Hz, 1H, CHAHBN), 3.41–3.32 
(m, 1H, CHAHBN), 2.72–2.61 (m, 1H, CHAHB), 2.11–2.02 (m, 1H, CHAHB), 1.18 (s, 9H, 
CMe3); 
13
C NMR (100.6 MHz, CDCl3)  δ 212.6 (C=S), 144.6 (ipso-Ph), 142.6 (ipso-Ph), 
128.5 (m-Ph), 128.1 (m-Ph), 127.8 (p-Ph), 127.7 (p-Ph), 127.5 (o-Ph), 127.3 (o-Ph), 
82.8 (C(Ph)2OH), 77.3 (CHN), 56.7 (CH2N), 43.7 (CMe3), 29.7 (CMe3), 21.0 (CH2); 
MS (ESI) m/z 340 [(M + H)
+
, 100]; HRMS m/z calcd for C21H26NOS (M+H)
+
 340.1730, 
found 340.1723 (+2.0 ppm error). 
Lab Book Reference: JCS-2-2 
 
1-(2-(Hydroxydiphenylmethyl)azetidin-1-yl)-2,2-dimethylpropane-1-thione 68 
 
Using general procedure B, sBuLi (0.5 mL of a 1.3 M solution in hexanes, 0.65 mmol, 
1.3 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and (–)-1 (0.14 
mL, 141 mg, 0.6 mmol, 1.2 eq) in Et2O (7 mL) and a solution of benzophenone (182 mg, 
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1.0 mmol, 2.0 eq) in Et2O (0.5 mL) gave the crude product. Purification by flash 
column chromatography on silica eluting with 95:5-8:2 hexane-EtOAc as eluent gave 
alcohol 68 (61 mg, 0.18 mmol, 36%, 60:40 er by CSP-HPLC) as a white solid, mp 179–
183 °C; [α]D +23.6 (c 0.85 in CHCl3). CSP-HPLC: Chiralcel OD-H (98:2 Hexane-
iPrOH, 1.0 mL min
-1
) 7.7 min (minor), 12.8 min (major). 
Lab Book Reference: JCS-2-10 
 
Rac-1-(2,2-Dimethylpropanethioyl)azetidine-2-carboxylic acid rac-69 
 
sBuLi (0.50 mL of a 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq) was added rapidly 
to a stirred solution of N-thiopivaloyl azetidine 35 (77 μL, 79 mg,  0.5 mmol, 1.0 eq) 
and TMEDA (0.2 mL 0.151 g, 1.3 mmol, 2.6 eq) in Et2O (7 mL) at –100 °C under N2. 
The resulting solution was stirred at –100 °C for 2 min. Then, dry CO2 (generated from 
solid CO2 flushed through CaCl2 and added into the reaction via cannula) was bubbled 
through the reaction mixture for 10 min at –100 °C and then allowed to warm to rt over 
1 h. The reaction mixture was diluted with Et2O (10 mL) and extracted with water (6 x 
5 mL). The aqueous layer was acidified to pH < 2 with 2 M HCl(aq) and extracted with 
CH2Cl2 (6 x 5 mL). The combined organic extracts were dried (MgSO4) and evaporated 
under reduced pressure to give acid rac-69 (47 mg, 0.23 mmol, 46%) as an off white 
solid, IR (ATR) 2968, 2924, 2867, 2638 (CO2H), 2554 (CO2H), 1705 (C=O), 1455, 
1421, 1397, 1365, 1339, 1294, 1254, 1223, 1198, 1164, 1045, 1031, 1005, 931, 825, 
780, 721, 680, 655, 563, 537, 528 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.07 (dd, J = 9.0, 
5.0 Hz, 1H, CHN), 4.62 (ddd, J = 9.5, 9.5, 9.5 Hz, 1H, CHAHBN), 4.49 (ddd, J = 9.5, 9.5, 
5.5 Hz, 1H, CHAHBN), 2.64-2.53 (m, 1H, CHAHB), 2.46-2.35 (m, 1H, CHAHB), 1.34 (s, 
9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 212.0 (C=S), 173.8 (CO2H), 66.5 (CHN), 
56.5 (CH2N), 43.3 (CMe3), 29.6 (CMe3), 19.0 (CH2); MS (ESI) material degraded 
during analysis. 
Lab Book Reference: JCS-2-5 
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(S)-1-(2,2-Dimethylpropanethioyl)azetidine-2-carboxylic acid (S)–36 
 
sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq) was added to a stirred 
solution of N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and (–)-1 (0.14 
mL, 141 mg, 0.6 mmol, 1.2 eq) in Et2O (5 mL) at –78 °C under N2. The resulting 
solution was stirred at –78 °C for 30 min. Then, dry CO2 (generated from solid CO2 
flushed through CaCl2 and added into the reaction via cannula) was bubbled through the 
reaction mixture for 10 min at –78 °C and then allowed to warm to rt over 1 h. The 
reaction mixture was diluted with Et2O (10 mL) and extracted with water (6 x 5 mL). 
The aqueous layer was acidified to pH < 2 with 2 M HCl(aq) and extracted with CH2Cl2 
(6 x 5 mL). The combined organic extracts were dried (MgSO4) and evaporated under 
reduced pressure to give acid (S)-69 (97 mg, 0.48 mmol, 96%, 75:25 er by CSP-HPLC 
of the methyl ester) as an off white solid, mp 126–139 °C; [α]D –62.2 (c 0.93 in EtOAc); 
CSP-HPLC of the methyl ester: Chiralcel OD-H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) 
(S)-69 14.3 min, (R)-69 18.2 min.  
Lab Book Reference: JCS-2-15 
 
 
sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq) was added to a 
solution of N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and (S,S)-12  
(178 mg, 0.6 mmol, 1.2 eq) in Et2O (5 mL) at –78 °C under N2. The resulting solution 
was stirred at –78 °C for 30 min. Then, dry CO2 (generated from solid CO2 flushed 
through CaCl2 and added into the reaction via cannula) was bubbled through the 
reaction mixture for 10 min at –78 °C and then allowed to warm to rt over 1 h. The 
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reaction mixture was diluted with Et2O (10 mL) and extracted with water (6 x 5 mL). 
The aqueous layer was acidified to pH < 2 with 2 M HCl(aq) and extracted with CH2Cl2 
(6 x 5 mL). The combined organic extracts were dried (MgSO4) and evaporated under 
reduced pressure to give acid (S)-69 (71 mg, 0.36 mmol, 71%, 57:43 er by CSP-HPLC 
of the methyl ester) as an off white solid. CSP-HPLC of the methyl ester: Chiralcel OD-
H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) (S)-69 14.5 min, (R)-69 18.3 min. 
Lab Book Reference: JCS-3-69 
 
Determination of er of acid (S)-69: 
The entirety of solid (S)-69 was dissolved in CH2Cl2 (~ 10 mL) and a small aliquot (~ 
0.2 mL) of this solution was evaporated under reduced pressure. The residue was 
dissolved in MeOH/toluene (4:6 v/v, 2 mL) and, to this stirred solution, was added 
Me3SiCHN2 (2.0 M solution in Et2O) dropwise until the yellow colour persisted. Glacial 
AcOH (5 mL) was then added to destroy excess Me3SiCHN2 and the solvent was 
evaporated under reduced pressure. The residue was dissolved in HPLC grade hexane 
(~ 2 mL) and subjected to HPLC analysis. 
 
Enantioenrichment of (S)-69 
A stirred solution of acid (S)-69 (60 mg, 75:25 er) in hexane (approx. 2 mL) was gently 
heated until boiling. Then, boiling EtOAc was added until the solids just dissolved and 
the solution was allowed to slowly cool to rt. Then, the solution was cooled to 0 °C for 
30 min. The formed crystals were collected by filtration through a piece of cotton wool 
in a pipette to give acid (S)-69 (29 mg, 50.1:49.9 er by CSP-HPLC). The filtrate was 
evaporated under reduced pressure to give acid (S)-69 (30 mg, 97:3 er) as a white solid, 
CSP-HPLC of the methyl ester: Chiralcel OD-H (98:2 Hexane-iPrOH, 1 mL min
-1
) (S)-
69 13.5 min, (R)-69 17.4 min. 
 
Method for growing crystals of acid (S)-69 
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Acid (S)-69 (30 mg, 97:3 er) was dissolved in the minimum amount of EtOAc. The 
solution was placed into a small glass vial and placed upright in a sealed vessel 
containing pentane (~ 20 mL). After several days, suitable crystals had precipitated in 
the glass vial. These were collected and subjected to X-ray analysis. 
CCDC No: 1417069 
 
Rac-methyl 1-(2,2-dimethylpropanethioyl)azetidine-2-carboxylate rac-70 and rac-
bis(1-(2,2-dimethylpropanethioyl)azetidin-2-yl)methanone rac-71/72 
 
Using general method A, thioamide 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq), sBuLi (0.5 
mL, 1.3 M solution in hexanes, 0.65 mmol, 1.3 eq), TMEDA (0.18 mL, 1.2 mmol, 2.6 
eq) and methyl chloroformate (80 μL, 95 mg, 1.0 mmol, 2.0 eq) as electrophile in Et2O 
(5 mL) yielded the crude product containing alcohols 71 and 72 in a 26:74 ratio. 
Purification by flash column chromatography with 95:5 petroleum ether - EtOAc gave 
rac-70 (13.6 mg, 0.063 mmol, 13%); RF (8:2 petroleum ether - EtOAc) 0.14; 
1
H NMR 
(400 MHz, CDCl3) δ 5.02–4.96 (m, 1H, CHN), 4.68–4.59 (m, 1H, CHAHBN), 4.52–4.43 
(m, 1H, CHAHBN), 3.75–3.73 (m, 3H, CO2Me), 2.59–2.48 (m, 1H, CHAHB), 2.24–2.14 
(m, 1H, CHAHB), 1.35–1.33 (m, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 211.6 
(C=S), 170.0 (CO2Me), 65.9 (CHN), 56.1 (CH2N), 52.4 (CO2CH3), 43.1 (CMe3), 29.6 
(CMe3), 19.1 (CH2). and ketones 70/71 as a 19:81 inseperable mixture of diastereomers 
(53 mg, 0.156 mmol, 62%); RF (8:2 hexane – EtOAc) 0.33; IR (ATR) 2959, 1703 
(C=O), 1464, 1430, 1393, 1360, 1337, 1299, 1252, 1230, 1144, 1090, 1004, 984, 830, 
724, 665, 551, 511, 477 cm
-1
; 
1
H NMR (400 MHz, CDCl3) (Major) δ 5.38–5.32 (m, 1H, 
CHN), 4.56–4.47 (m, 1H, CHAHBN), 4.43–4.34 (m, 1H, CHAHBN), 2.53–2.34 (m, 2H, 
CH2), 1.32 (s, 9H, CMe3); (Minor) δ 5.18–5.12 (m, 1H, CHN), 4.73–4.64 (m, 1H, 
CHAHBN), 4.45–4.37 (Assumed, m, 1H, CHAHBN), 2.52–2.33 (Assumed, m, 2H, CH2), 
1.37 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) (Major) δ 208.5 (C=S), 202.2 
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(C=O), 71.2 (CHN), 55.9 (CH2N), 42.5 (CMe3), 29.7 (CMe3), 20.9 (CH2); (Minor) δ 
210.6 (C=S), 204.1 (C=O), 69.1 (CHN), 56.1 (CH2N), 43.2 (CMe3), 29.8 (CMe3), 21.0 
(CH2); MS (ESI) m/z 341 [(M+H)
+
, 60], 363 [(M+Na)
+
, 100]; HRMS m/z calcd for 
C17H28N2OS2 (M+Na)
+
 363.1535, found 363.1534 (0.0 ppm error). 
Spectroscopic data consistent with literature values.
20
 
Lab book reference: JCS-1-102  
 
(R)-Methyl 1-(2,2-dimethylpropanethioyl)azetidine-2-carboxylate (R)-70 and ((R)-
1-(2,2-dimethylpropanethioyl)azetidin-2-yl)(1-(2,2-
dimethylpropanethioyl)azetidin-2-yl)methanone (R)-71/72 
 
Using general procedure B, sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 
1.2 eq), N-thiopivaloyl azetidine 35 (77 μL, 79 mg, 0.5 mmol, 1.0 eq) and (–)-1 (0.14 
mL, 141 mg,  0.6 mmol, 1.2 eq) in Et2O (5 mL) and methyl chloroformate (60 μL, 71 
mg, 0.75 mmol, 1.5 eq) gave the crude product which contained an 80:20 mixture of 
diastereomeric ketones (R)-71/72. Purification by flash column chromatography on 
silica with 8:2 to 7:3 hexane-EtOAc as eluent gave (R)-70 (48 mg, 0.225 mmol, 45%, 
67:33 er by CSP-HPLC) as a pale yellow oil, [α]D +45.5 (c 0.52 in EtOAc); CSP-HPLC: 
Chiralcel OD-H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) (S)-70 12.7 min, (R)-70 13.8 min 
and double addition products (R)-71/72 (22 mg, 64.6 μmol, 26%) as an inseperable 
81:19 mixture (by 
1
H NMR) of diastereoisomers, mp 145–157 °C (with decomposition); 
[α]D +295.5 (c 0.49 in EtOAc). 
Lab Book Reference: JCS-5-58 
 
N-thiopivaloyl pyrrolidine 76 
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Amide 216 (10.6 g, 68.5 mmol, 1.0 eq) in pyridine (10 mL) was added dropwise over 5 
min to a stirred solution of P2S5 (16.0 g, 71.9 mmol, 1.05 eq) in pyridine (180 mL) at rt. 
The resulting solution was then stirred at 75°C for 16 hours. Then, the reaction mixture 
was cooled to RT and water (200 mL) was added. The solution was adjusted to pH = 2-
3 with H2SO4 (95% w/w) and the resulting solution was allowed to stir at room 
temperature for 2 hours. The reaction mixture was extracted with CH2Cl2 (6 x 30 mL), 
dried (MgSO4) and the solvent evaporated under reduced pressure to give the crude 
product. Purification by Kugelrohr distillation (approx. 105°C bp at 0.35 mbar) gave 76 
(11.0 g, 64.3 mmol, 94%) as a bright yellow oil, RF (95:5 petroleum ether – EtOAc) 0.3; 
IR (ATR) 2956, 2876, 1468, 1441, 1412, 1393, 1359, 1323, 1257, 1211, 1169, 1149, 
1092, 1046, 1015, 967, 926, 873, 845, 798, 697,  666, 475 cm
-1
;  
1
H NMR (400 MHz, 
CDCl3) δ 3.95 (dd, J = 7.0, 7.0 Hz, 2H, CH2N), 3.82 (dd, J = 6.5, 6.5 Hz, 2H, CH2N), 
2.03 (dddd, J = 6.5, 6.5, 6.5, 6.5 Hz, 2H, CH2), 1.90 (dddd, J = 7.0, 7.0, 7.0, 7.0 Hz, 2H, 
CH2), 1.42 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) 209.0 (C=S), 58.0 (CH2N), 
53.1 (CH2N), 43.9 (CMe3), 30.6 (CMe3), 27.6 (CH2), 23.3 (CH2); MS (ESI) m/z 172 
[(M+H)
+
, 100], 194 [(M+Na)
+
, 85]; HRMS m/z calcd for C9H17NS (M+Na)
+
 194.0974, 
found 194.0973 (+0.3 ppm error).  
Lab Book Reference: JCS-1-40, JCS-5-56 
 
(S)-Methyl 1-pivaloylazetidine-2-carboxylate (S)-83 
 
Me3SiCHN2 (0.15 mL of a 2.0 M solution in Et2O, 0.30 mmol, 1.2 eq) was added 
dropwise to a stirred solution of acid (S)-82 (50 mg, 0.248 mmol, 1.0 eq) in 
MeOH/toluene (4:6, 3 mL) at rt. After 5 min, glacial AcOH (4 mL) was added and the 
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solvent was evaporated under reduced pressure to give the crude ester (57 mg) as a 
colourless oil, 
1
H NMR (400 MHz, CDCl3) δ 4.60 (dd, J = 9.0, 5.5 Hz, 1H, CHN), 4.01 
(ddd, J = 8.5, 8.5, 6.0 Hz, 1H, CHAHBN), 3.87 (ddd, J = 8.5, 8.5, 5.5 Hz, 1H, CHAHBN), 
3.76 (s, 3H, CO2Me), 2.54-2.43 (m, 1H, CHAHB), 2.16 (dddd, J = 11.0, 8.5, 5.5, 5.5 Hz, 
1H, CHAHB), 1.40 (s, 9H, CMe3). Freshly distilled TFA (0.57 mL, 0.855 g, 7.50 mmol, 
30 eq) was added to a stirred solution of the crude methyl ester (57 mg) in CH2Cl2 (5 
mL) at rt. The resulting solution was stirred at rt for 48 hours. Then, the solvent was 
evaporated under reduced pressure to give the crude TFA salt (88 mg) as a yellow oil, 
1
H NMR (400 MHz, CDCl3) δ 5.11 (dd, J = 9.0, 9.0 Hz, 1H, CHN), 4.24 (ddd, J = 10.0, 
10.0, 10.0 Hz, 1H, CHAHBN), 4.10 (ddd, J = 10.0, 10.0, 6.5 Hz, 1H, CHAHBN), 3.84 (s, 
3H, CO2Me), 2.97-2.86 (m, 1H, CHAHB), 2.75-2.63 (m, 1H, CHAHB). Pivaloyl chloride 
(0.15 mL, 150 mg, 1.24 mmol, 5 eq) was added to a stirred solution of the crude TFA 
salt (88 mg), Et3N (0.35 mL, 251 mg, 2.48 mmol, 10 eq) and DMAP (6.1 mg, 0.05 
mmol, 0.2 eq) in CH2Cl2 (5 mL) at rt under N2. The resulting solution was stirred at rt 
for 48 hours. Then, 2 M HCl(aq) (10 mL) was added and the layers were separated. The 
aqueous layer was extracted with CH2Cl2 (3 x 10 mL) and the combined organic layers 
were dried (MgSO4) and evaporated under reduced pressure. The residue was absorbed 
onto a plug of silica and eluted with 80 mL of EtOAc-pentane (1:1) to give the crude 
product. Purification by dry column flash chromatography through 13 cm of silica in a 2 
cm diameter flash column, eluting with 50 mL aliquots of 5% increasing polarity of 
EtOAc-pentane (95:5 to 70:30) as eluent gave amido-ester (S)-83 (6.8 mg, 34.1 μmol, 
13.7% over 3 steps from (S)-82, >99:1 er by CSP-HPLC) in the sixth fraction as a pale 
yellow oil, IR (ATR) 2959, 1744 (C=O), 1631 (C=O), 1573, 1435, 1407, 1381, 1362, 
1281, 1242, 1199, 1179, 1159, 1135, 1065, 1025, 980, 933, 881, 756, 632 cm
–1
; 
1
H 
NMR (400 MHz, CDCl3) δ 4.70 (br s, 1H, CHN), 4.48 (br s, 1H, CHAHBN), 4.30 (br s, 
1H, CHAHBN), 3.76 (s, 3H, CO2Me), 2.61-2.48 (m, 1H, CHAHB), 2.22-2.13 (m, 1H, 
CHAHB), 1.20 (s, 9H, CMe3); 
13
C NMR (400 MHz, CDCl3) δ 172.0 (C=O, CO2Me), 
123.6 (NC=O), 60.1 (CHN), 52.4 (CO2Me), 29.8 (CH2N), 27.1 (CMe3), 20.4 (CH2), 
14.3 (CMe3); MS (ESI) m/z 200 [(M + H)
+
, 100 ], 222 [(M + Na)
+
, 65]; HRMS m/z 
calcd for C10H18NO3 (M + Na)
+
 222.1101, found 222.1097 (+1.7 ppm error); [α]D –78.5 
(c 0.34 in EtOAc); CSP-HPLC: Chiralcel OD-H (98:2 Hexane – iPrOH, 1.0 mL min-1) 
(S)-83 26.2 min. A second portion of (S)-83 (13.3 mg, 66.8 μmol, 26.9% over 3 steps of 
lesser purity) was isolated from the fifth fraction. 
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Lab Book Reference: JCS-4-84, JCS-4-80, JCS-4-81 
 
 
Oxone (142 mg, 0.46 mmol, 5.1 eq) was added to a stirred solution of acid (S)-69 (18.6 
mg, 0.092 mmol, 75:25 er, 1.0 eq) in MeOH/water (1:1, 5 mL) at rt. The resulting 
solution was stirred at rt for 72 hours. Then, the reaction mixture was diluted with 
EtOAc (50 mL) and washed with water (2 x 5 mL), dried (MgSO4) and the solvent 
evaporated under reduced pressure to give the crude product (15.9 mg), 
1
H NMR (400 
MHz, CDCl3) δ 5.04 (dd, J = 8.5, 7.0 Hz, 1H, CHN), 4.45–4.29 (m, 2H, CH2N), 2.55–
2.45 (m, 1H, CHAHB), 2.22–2.13 (m, 1H, CHAHB), 1.23 (s, 9H, CMe3). The residues 
were dissolved in MeOH/toluene (4:6 v/v, 3 mL) and to this stirred solution was added 
Me3SiCHN2 (2.0 M in Et2O) dropwise at rt until the yellow colour persisted (~0.05 mL). 
The resulting solution was stirred at rt for 5 min. Then, glacial AcOH (5 mL) was added 
to destroy excess Me3SiCHN2 and the solvent was evaporated under reduced pressure to 
give (S)-83 (6.9 mg, 0.044 mmol, 47% over 2 steps, 76:24 er) as a pale yellow oil that 
did not require further purification, [α]D –79.0 (c 0.35 in EtOAc); CSP-HPLC: Chiralcel 
OD-H (98:2 Hexane – iPrOH, 1.0 mL min-1) (S)-83 25.6 min, (R)-83 47.4 min. 
Lab Book Reference: JCS-5-20, JCS-5-21 
 
Rac-1-pivaloylazetidine-2-carboxylic acid rac-84 
 
Oxone (154 mg, 0.50 mmol, 5 eq) was added to a stirred solution of acid rac-84 (20 mg, 
0.1 mmol, 1.0 eq) in MeOH/water (1:1, 2 mL) at rt. The resulting solution was stirred at 
rt for 72 hours. Then, the reaction mixture was diluted with EtOAc (50 mL) and washed 
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with water (2 x 5 mL), dried (MgSO4) and the solvent evaporated under reduced 
pressure to give the crude product (22 mg). A sample of this solid was then derivatized 
to the methyl ester using the same procedure as for the enantioenriched material.  
Lab Book Reference: JCS-5-32 
 
Rac-1-(2,2-dimethylpropanethioyl)pyrrolidine-2-carboxylic acid rac-87 
 
sBuLi (1.0 mL of a 1.3 M solution in hexanes, 1.3 mmol, 1.3 eq) was added to a 
solution of N-thiopivaloyl pyrrolidine 76 (0.16 mL, 171 mg, 1.0 mmol, 1.0 eq) and 
TMEDA (0.2 mL, 155 mg, 1.3 mmol, 1.3 eq) in Et2O (10 mL) at –78 °C under N2. The 
resulting solution was stirred at –78 °C for 30 min. Then, dry CO2 (generated from solid 
CO2 flushed through CaCl2 and added into the reaction via cannula) was bubbled 
through the reaction mixture for 10 min at –78 °C and then allowed to warm to rt over 1 
h. The reaction mixture was diluted with Et2O (10 mL) and extracted with water (6 x 5 
mL). The aqueous layer was acidified to pH < 2 with 2 M HCl(aq) and extracted with 
CH2Cl2 (6 x 5 mL). The combined organic extracts were dried (MgSO4) and evaporated 
under reduced pressure to give acid rac-87 (184 mg, 0.86 mmol, 86%) as an off white 
solid, mp 153.0–154.5 °C (with decomposition); IR (ATR) 2978, 2869 (CO2H), 2646 
(CO2H), 2553 (CO2H), 1703 (C=O), 1474, 1416, 1368, 1336, 1297, 1272, 1225, 1173, 
1152, 1090, 1058, 1021, 929, 915, 871, 804, 692, 61, 597, 502 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 5.25-5.13 (m, 1H, CHN), 4.06-3.98 (m, 1H, CHAHBN), 3.96-3.88 (m, 
1H, CHAHBN), 2.31-1.99 (m, 4H, CH2CH2), 1.43 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, 
CDCl3) 211.8 (C=S), 175.2 (CO2H), 66.6 (CHN), 53.3 (CH2N), 43.9 (CMe3), 30.5 
(CMe3), 27.9 (CH2), 26.1 (CH2); MS (ESI) m/z 216 [(M + H)
+
, 55], 238 [(M + Na)
+
, 
100]; HRMS m/z calcd for C10H17NO2S (M+Na)
+
 238.0872, found 238.0878 (-2.2 ppm 
error). 
Lab Book Reference: JCS-2-29 
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(S)-1-(2,2-Dimethylpropanethioyl)pyrrolidine-2-carboxylic acid (S)-87 
 
sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.6 mmol, 1.2 eq) was added to a 
solution of N-thiopivaloyl pyrrolidine 76 (80 μL, 86 mg, 0.5 mmol, 1.0 eq) and (–)-
sparteine (0.14 mL, 141 mg, 0.6 mmol, 1.2 eq) in Et2O (5 mL) at –78 °C under N2. The 
resulting solution was stirred at –78 °C for 30 min. Then, dry CO2 (generated from solid 
CO2 flushed through CaCl2 and added into the reaction via cannula) was bubbled 
through the reaction mixture for 10 min at –78 °C and then allowed to warm to rt over 1 
h. The reaction mixture was diluted with Et2O (10 mL) and extracted with water (6 x 5 
mL). The aqueous layer was acidified to pH < 2 with 2 M HCl(aq) and extracted with 
CH2Cl2 (6 x 5 mL). The combined organic extracts were dried (MgSO4) and evaporated 
under reduced pressure to give acid (S)-87 (79 mg, 0.37 mmol, 74%, 80:20 er by CSP-
HPLC of the methyl ester) as an off white solid. CSP-HPLC of the methyl ester: 
Chiralcel OD-H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) (S)-87 11.6 min, (R)-87 12.9 min. 
X-ray crystallography analysis of enantioenriched (S)-87, 98:2 er proved the absolute 
stereochemistry to be (S). [α]D of 98:2 material -23.9 (c 0.095 in EtOAc). 
 
Determination of er of acid (S)-87: 
The entirety of solid (S)-87 was dissolved in CH2Cl2  (~ 10 mL) and a small aliquot (~ 
0.2 mL) of this solution was evaporated under reduced pressure. The residue was 
dissolved in MeOH/toluene (4:6 v/v, 2 mL) and, to this stirred solution, was added 
Me3SiCHN2 (2.0 M solution in Et2O) dropwise until the yellow colour persisted. Glacial 
AcOH (5 mL) was then added to destroy excess Me3SiCHN2 and the solvent was 
evaporated under reduced pressure. The residue was dissolved in HPLC grade hexane 
(~ 2 mL) and subjected to HPLC analysis. 
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Enantioenrichment of (S)-87 
A stirred solution of acid (S)-87 (80 mg, 80:20 er) in hexane (~ 2 mL) was gently heated 
until boiling. Then, boiling EtOAc was added until the solids just dissolved and the 
solution was allowed to slowly cool to rt. Then, the solution was cooled to 0 °C for 30 
min. The formed crystals were collected by filtration through a piece of cotton wool in a 
pipette to give rac-acid 87 (21 mg). The filtrate was evaporated under reduced pressure 
to give acid (S)-87 (59 mg, 90:10 er) as a white solid. The solid was then recrystallized 
again using the same procedure to give rac-acid 87 (9.9 mg) and (S)-87 (49.5 mg, 96:4 
er), then a third time to give rac-acid 87 (4.4 mg) and (S)-87 (44.1 mg, 98:2 er) as a 
white solid. CSP-HPLC of the methyl ester: Chiralcel OD-H (98:2 Hexane-iPrOH, 1 
mL min
-1
) (S)-87 11.6 min, (R)-87 12.9 min. 
 
Method for growing crystals of acid (S)-87 
Acid (S)-87 (44.1 mg, 98:2 er) was dissolved in the minimum amount of EtOAc. The 
solution was placed into a small glass vial and placed upright in a sealed vessel 
containing pentane (~ 20 mL). After several days, suitable crystals had precipitated in 
the glass vial. These were collected and subjected to X-ray analysis. 
CCDC No: 1417068 
Lab Book Reference: JCS-2-28, JCS-3-72, JCS-2-29 
 
(S)-Methyl 1-pivaloylpyrrolidine-2-carboxylate (S)-88 
 
Oxone (18 mg, 0.059 mmol, 5 eq) was added  to a stirred solution of acid (S)-87 (5 mg, 
11.9 μmol, 1.0 eq, 98:2 er) in MeOH/water (1:1 v/v, 1 mL) at rt. The resulting solution 
was stirred at rt for 72 h. Then, the reaction was diluted with EtOAc (50 mL) and 
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washed with water (2 x 5 mL), dried (MgSO4) and the solvent evaporated under reduced 
pressure to give the crude product (7.2 mg), 
1
H NMR (400 MHz, CDCl3) 4.68–4.61 (br 
m, 1H, CHN), 3.74–3.69 (m, 2H, CH2N), 2.15–1.87 (m, 4H, CH2CH2), 1.29 (s, 9H, 
CMe3). The residues were redissolved in MeOH/toluene (4:6 v/v, 2 mL) and 
Me3SiCHN2 (2.0 M soln in Et2O) was added dropwise at rt until the yellow colour 
persisted (~0.03 mL). The resulting solution was stirred at rt for 5 min. Then, glacial 
AcOH (5 mL) was added to destroy excess Me3SiCHN2 and the solvent was evaporated 
under reduced pressure to give the crude product. Purification on silica with 80 mL of 
1:1 EtOAc – pentane gave (S)-88 (2.6 mg, 0.012 mmol, 102% over 2 steps, 98:2 er), 1H 
NMR (400 MHz, CDCl3) 4.52–4.45 (br m, 1H, CHN), 3.82–3.66 (m, 2H, CH2N), 3.72 
(s, 3H, CO2Me), 2.17–2.01 (m, 2H, CH2), 2.00–1.81 (m, 2H, CH2), 1.23 (s, 9H, CMe3); 
13
C NMR (100.6 MHz, CDCl3) δ 176.9 (C=O), 173.5 (C=O), 60.9 (CHN), 52.1 (CH2N), 
48.2 (CO2Me), 38.8 (CMe3), 27.9 (CH2), 27.3 (CMe3), 26.1 (CH2); [α] -14.5 (c 0.13 in 
EtOAc). Chiralcel OD-H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) (S)-88 13.1 min, (R)-88 
17.8 min. 
Spectroscopic data consistent with literature values.
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To a stirred solution of (S)-proline (2 g, 17.4 mmol, 1.0 eq) in MeOH (30 mL) was 
added thionyl chloride (2.53 mL, 4.13 g, 34.8 mmol, 2.0 eq) dropwise at 0 °C. The 
resulting solution was stirred at 0 °C for 2 h. Then, the solvent was evaporated under 
reduced pressure to give the crude product (2.97 g). The crude product (0.59 g) was 
suspended in CH2Cl2 (10 mL). To this was added DMAP (74 mg, 0.60 mmol), Et3N 
(2.10 mL, 1.53 g, 15.1 mmol) and pivaloyl chloride (0.58 mL, 546 mg, 4.53 mmol) at 0 
°C under N2. The resulting solution was allowed to warm to rt over 4 h. Then, the 
reaction was diluted with EtOAc (50 mL) and washed with 2 M HCl (2 x 20 mL), 
K2CO3 (10% w/w, 1 x 30 mL), dried (MgSO4) and the solvent evaporated under 
reduced pressure to give the crude product. Purification on a plug of silica with 200 mL 
of 8:2 hexane – EtOAc gave (S)-88 (509 mg, 2.39 mmol, 69% over 2 steps) as a pale 
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red oil, [α] -47.2 (c 1.025 in EtOAc); CSP-HPLC: Chiralcel OD-H (96:4 Hexane-iPrOH, 
1.0 mL min
-1
) (S)-88 13.3 mins.  
Lab Book Reference: JCS-5-4, JCS-4-90, JCS-5-28, JCS-5-10, JCS-6-38, JCS-6-39 
 
Rac-1-pivaloylpyrrolidine-2-carboxylic acid rac-89 
 
Oxone (178 mg, 0.58 mmol, 5 eq) was added to a stirred solution of acid rac-89 (25 mg, 
0.116 mmol, 1.0 eq) in MeOH/water (1:1, 2 mL) at rt. The resulting solution was stirred 
at rt for 48 hours. Then, the reaction mixture was diluted with EtOAc (50 mL) and 
washed with water (2 x 5 mL), dried (MgSO4) and the solvent evaporated under reduced 
pressure to give the crude product (21 mg). A sample of this solid was then derivatized 
to the methyl ester using the same procedure as for the enantioenriched material.  
Lab Book Reference: JCS-5-30 
 
(R)-Methyl 1-(2,2-dimethylpropanethioyl)pyrrolidine-2-carboxylate (R)-91 
 
Using general procedure B, sBuLi (0.46 mL of a 1.3 M solution in hexanes, 0.60 mmol, 
1.2 eq), N-thiopivaloyl pyrrolidine 76 (0.084 mL, 86 mg, 0.5 mmol, 1.0 eq) and (–)-1  
(0.14 mL, 141 mg,  0.6 mmol, 1.2 eq) in Et2O (5 mL) and methyl chloroformate (60 μL, 
71 mg, 0.75 mmol, 1.5 eq) gave the crude product. Purification by flash column 
chromatography on silica with 8:2 hexane-EtOAc as eluent gave (R)-91 (67 mg, 0.29 
mmol, 58%, 76:24 er by CSP-HPLC) as a waxy solid, 
1
H NMR (400 MHz, CDCl3) δ 
5.11 (dd, J = 8.5, 5.0 Hz, CHN), 4.04–3.90 (m, 2H, CH2N), 3.71 (s, 3H, CO2Me), 2.30–
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2.10 (m, 2H, CH2), 2.07–1.90 (m, 2H, CH2), 1.42 (s, 9H, CMe3); 
13
C NMR δ 211.6 
(C=S), 171.5 (CO2Me), 68.6 (CHN), 53.4 (CH2N), 52.3 (CO2Me), 43.8 (CMe3), 30.4 
(CMe3), 28.0 (CH2), 26.1 (CH2); [α]D +25.3 (c 1.075 in EtOAc). CSP-HPLC: Chiralcel 
OD-H (98:2 Hexane-iPrOH, 1.0 mL min
-1
) (S)-10.6 min, (R)-11.8 min.  
Lab Book Reference: JCS-5-59 
 
N-pivaloyl pyrrolidine 216 
 
Trimethylacetyl chloride (1.10 mL, 9.13 mmol, 1.0 eq) was added dropwise over 10 m 
to a stirred solution of pyrrolidinium hydrochloride (1.0 g, 9.13 mmol, 1.0 eq), Et3N 
(6.41 mL, 46 mmol, 5.0 eq) and DMAP (0.22 g, 1.83 mmol, 0.2 eq) in CH2Cl2 (20 mL) 
at 0°C under N2. The resulting solution was allowed to warm to rt over 16 hours. Then,  
HCl(aq) (2M, 30 mL) was added and the layers were seperated. The aqueous layer was 
extracted with CH2Cl2 (3 x 5 mL) and the combined organic layers were dried (MgSO4) 
and the solvent evaporated under reduced presure to give the crude product. Purification 
by filtration through a small plug of silica with 7:3 petroleum ether – EtOAc as eluent 
gave 216 (1.10 g, 7.12 mmol, 78%) as a colourless oil that crystallised upon standing, 
RF (7:3 petroleum ether – EtOAc) 0.4; IR (ATR) 2969, 2874, 1718, 1599 (C=O), 1479, 
1408, 1383, 1363, 1341, 1257, 1214, 1113, 1043, 1028, 981, 950, 919, 876, 862, 755, 
744, 731, 604, 581, 556, 524, 475, 453 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.53 (br s, 
4H, CH2N), 1.84 (br s, 4H, CH2), 1.24 (s, 9H, CMe3); 
13
C (100.6 MHz, CDCl3) δ 176.6 
(C=O), 48.0 (CH2N), 39.1 (CMe3), 27.6 (CMe3), 27.2 (CH2); MS (ESI) m/z 156 
[(M+H)
+
, 60], 178 [(M+Na)
+
, 100]; HRMS m/z calcd for C9H17NO (M+Na)
+
 178.1202, 
found 178.1204 (-0.6 ppm error). 
Lab Book Reference: JCS-1-8 
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Trimethylacetyl chloride (9.1 mL, 73.9 mmol, 1.05 eq) was added dropwise over 5 m to 
a stirred solution of pyrrolidine (5.8 mL, 70.4 mmol, 1.0 eq), Et3N (49 mL, 0.35 mol, 
5.0 eq) and DMAP (1.72 g, 14.1 mmol, 0.2 eq) in CH2Cl2 (200 mL) at 0°C under N2. 
The resulting solution was allowed to slowly warm to rt over 16 hours. Then, HCl(aq) 
(2M, 250 mL) was added and the layers were separated. The aqueous layer was 
extracted with CH2Cl2 (3 x 30 mL) and the combined organic layers were dried (MgSO4) 
and the solvent evaporated under reduced pressure to give the crude product. 
Purification by filtration through a small plug of silica with 7:3 petroleum ether – 
EtOAc as eluent gave 216 (10.6 g, 68.5 mmol, 97%) as a colourless oil that crystallised 
upon standing. 
Lab Book Reference: JCS-1-38 
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3.3 Experimental Procedures For Chapter Two 
All compounds listed hereafter were synthesised racemically unless otherwise stated. 
 
4-(((Triisopropylsilyl)oxy)methyl)cyclohex-2-enone 117 
 
Ketone 139 (100 mg, 0.35 mmol, 1.0 eq) in MeCN (1.5 mL) was added dropwise over 5 
min to a stirred solution of NaI (105 mg, 0.70 mmol, 2.0 eq), Et3N (178 mg, 0.24 mL, 
1.76 mmol, 5.0 eq) and Me3SiCl (152 mg, 0.18 mL, 1.40 mmol, 4.0 eq) in MeCN (1.5 
mL) at rt under N2. The resulting solution was then heated to 45 °C and stirred for 16 h 
before the solvent and excess reagents were evaporated under reduced pressure. The 
residues were triturated with dry hexane (3 x 20 mL), filtered through celite and the 
solvent evaporated under reduced pressure to give the crude silyl enol ether. Distillation 
under reduced pressure gave the intermediate racemic silyl enol ether (68 mg, 0.19 
mmol, 54%) as a colourless oil which was used immediately. 
1
H NMR (400 MHz, 
CDCl3) δ 4.86-4.82 (m, 1H, HC=CH2), 3.62-3.51 (m, 2H, CH2C=O), 2.15-1.94 (m, 3H, 
CH2 and CH), 1.87-1.66 (m, 3H, CH2 and CH), 1.42-1.30 (m, 1H, CH), 1.09-1.03 (m, 
21H, Si(iPr)3), 0.176 (s, 9H, SiMe3). Pd(OAc)2 (4.2 mg, 18.1 μmol, 0.1 eq) was added 
to a stirred solution of silyl enol ether (65 mg, 0.181 mmol, 1.0 eq) in dry DMSO (5 mL) 
at rt. The reaction vessel was then evacuated and backfilled with dry O2 at 1 atm and 
stirred at rt for 16 h. Then, the reaction was diluted with water (100 mL), extracted with 
hexane (4 x 20 mL), dried (MgSO4) and the solvent evaporated under reduced pressure 
to give the crude product. Purification by flash column chromatography on silica eluting 
with 9:1 hexane – EtOAc as eluent gave 117 (28 mg, 98.0 μmol, 28% over 2 steps) as a 
colourless oil, RF (9:1 petroleum ether – EtOAc) 0.28; IR (ATR) 2942, 2891, 2856, 
1681 (C=O), 1463, 1418, 1390, 1252, 1209, 1184, 1110, 1068, 995, 918, 881, 865, 842, 
784, 766, 749, 681, 659, 514 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 6.99 (ddd, J = 10.0 
2.5, 1.5 Hz, 1H, HC=CHCO), 6.04 (dd, J = 10.0, 2.5 Hz, 1H, HC=CHCO), 3.71 (m, 2H, 
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CH2OSi(iPr)3), 2.66-2.57 (m, 1H, CHAHBCO), 2.53 (ddd, J = 16.5, 4.5, 4.5 Hz, 1H, 
CHAHBCO), 2.42-2.33 (m, 1H, CHAHB ), 2.13-2.03 (m, 1H, CHAHB), 1.78 (dddd, J = 
13.0, 13.0, 10.0, 4.5 Hz, 1H, CH), 1.10-1.03 (m, 21H, Si(iPr)3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 200.1 (C=O), 152.3 (HC=CHCO), 130.1 (HC=CHCO), 66.1 (CH2), 39.6 (CH), 
36.9 (CH2), 25.6 (CH2), 18.1 (CH3), 12.0 (CH(CH3)2); MS (ESI) m/z 283[(M+H)
+
, 5], 
305 [(M+Na)
+
, 100]; HRMS m/z calcd for C16H30O2Si (M+Na)
+
 305.1907, found 
305.1900 (+2.3 ppm error). 
Lab Book Reference: JCS-5-43, JCS-5-44 
 
Me3SiCl (2.90 g, 3.34 mL, 26.3 mmol, 4.0 eq) was added to a stirred solution of ketone 
139 (1.87 g, 6.58 mmol, 1.0 eq), Et3N (3.33 g, 4.59 mL, 32.9 mmol, 5.0 eq) and NaI 
(1.97 g, 13.2 mmol, 2.0 eq) in MeCN (56 mL) at rt under N2. The resulting solution was 
then heated to 45 °C and stirred for 16 h before the solvent and excess reagents were 
evaporated under reduced pressure. The residues were triturated with dry hexane (3 x 50 
mL), filtered through celite and the solvent evaporated under reduced pressure to give 
the crude silyl enol ether. Distillation under reduced pressure gave the intermediate 
racemic silyl enol ether (2.16 g, 6.06 mmol, 92%) as a colourless oil which was used 
immediately. Pd(OAc)2 (137 mg, 0.61 mmol, 0.1 eq) was added to a stirred solution of 
silyl enol ether (2.16 g, 6.06 mmol, 1.0 eq) in dry DMSO (50 mL) at rt. The reaction 
vessel was then evacuated and backfilled with dry O2 at 1 atm and stirred at rt for 16 h. 
Then, the reaction was diluted with water (450 mL) and extracted with hexane (6 x 50 
mL). TLC analysis of the water/DMSO layer indicated that product enone had remained 
in solution. The aqueous layer was then saturated with NaCl and re-extracted with 
hexane (3 x 50 mL). The combined organic layers were then dried (MgSO4) and the 
solvent evaporated under reduced pressure to give the crude product. Purification by 
distillation under reduced pressure gave enone 117 (1.51 g, 5.35 mmol, 81% over 2 
steps) as a colourless oil. 
Lab Book Reference: JCS-5-46 and JCS-5-48 
 
4-(hydroxymethyl)cyclohexanol 133/134 and 4-(hydroxymethyl)cyclohexanone 129 
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A solution of 4-hydroxybenzylalcohol (2.0 g, 16.1 mmol, 1.0 eq) and PtO2 (37 mg, 0.16 
mmol, 1 mol%) in MeOH (20 mL) was evacuated and backfilled with N2 twice, then 
evacuated and backfilled with H2 gas at 1 atm. The resulting solution was stirred for 7 
days at room temperature before being filtered through celite and the solvent evaporated 
under reduced pressure. Purification by flash column chromatography through silica 
with 1:1 – 9:1 EtOAc – Hexane as eluent gave a 56:44 inseperable mix of 134 and 133 
(393 mg, 3.02 mmol, 19%) as a white, waxy solid, RF (1:1 hexane – EtOAc) 0.05; IR 
(ATR) 3284 (O–H), 2923, 2859, 1448, 1362, 1296, 1200, 1126, 1097, 1048, 1023, 976, 
932, 898, 820, 690, 597, 506 cm
-1
; 
1
H NMR (400 MHz, MeOH-d4) δ 3.86 (dddd, J = 
2.5, 2.5, 2.5, 2.5 Hz, 0.44H, CHOH), 3.43 (dddd, J = 11.0, 11.0, 4.5, 4.5 Hz, 0.56 H, 
CHOH), 3.36 (d, J = 6.0 Hz, 0.88H, CH2OH), 3.31 (d, J = 6.5 Hz, 1.12H, CH2OH), 
1.96–1.87 (m, 1H, 0.5 x CH2), 1.82–1.73 (m, 1H, 0.5 x CH2), 1.71–1.61 (m, 1H, CH), 
1.56–1.30 (m, 4H, 2 x CH2), 1.26–1.14 (m, 1H, 0.5 x CH2), 1.01–0.88 (m, 1H, 0.5 x 
CH2); 
13
C NMR (100.6 MHz, MeOH-d4) (Major) δ 71.7 (CHOH), 68.2 (CH2OH), 40.9 
(CH), 35.8 (CH2), 28.9 (CH2); (Minor) δ 67.8 (CHOH), 67.7 (CH2OH), 40.3 (CH), 32.7 
(CH2), 24.7 (CH2); MS (ESI) 153 [(M+Na)
+
, 100]; HRMS m/z calcd for C7H14O2 
(M+Na)
+
 153.0886, found 153.0882 (+2.8 ppm error), and keto-alcohol 129 (36 mg, 
0.28 mmol, 1.7%) as a colourless oil, RF (1:1 hexane – EtOAc) 0.11; IR (ATR) 3386 
(O–H), 2927, 2866, 1704 (C=O), 1615, 1517, 1448, 1421, 1331, 1240, 1167, 1085, 
1034, 1006, 972, 938, 917, 820, 597, 496, 458 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 3.55 
(d, J = 6.5 Hz, CH2OH), 2.44–2.27 (m, 4H, 2 x CH2), 2.21–2.06 (m, 3H, 2 x CHAHB and 
OH), 2.00–1.88 (m, 1H, CH), 1.42 (dddd, J = 13.0, 13.0, 13.0, 5.0 Hz, 2H, 2 x CHAHB); 
13
C NMR (100.6 MHz, CDCl3) δ 212.5 (C=O), 66.8 (CH2OH), 40.5 (CH2), 38.7 (CH), 
29.2 (CH2); MS (ESI) m/z 151 [(M+Na), 100]; HRMS m/z calcd for C7H12O2 (M+Na)
+
 
151.0730, found 151.0729 (0.0 ppm error). 
Lab Book Reference: JCS-7-79 
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A solution of 4-hydroxybenzylalcohol (1.01 g, 8.14 mmol, 1.0 eq) and PtO2 (20 mg. 
0.081 mmol, 1 mol%) in MeOH (40 mL) was evacuated and backfilled with N2 twice, 
then evacuated and backfilled with H2 gas at 1 atm. The resulting solution was stirred 
for 5 days at room temperature, then filtered through celite and the solvent evaporated 
under reduced pressure. Purification by flash column chromatography through silica 
with 7:3 – 9:1 EtOAc – hexane as eluent gave a 2:1 inseperable mix of 134/133 (0.62 g, 
4.73 mmol, 58%) as a white, waxy solid.  
Lab Book Reference: JCS-3-56 
 
A solution of 4-hydroxybenzylalcohol (5.0 g, 40.3 mmol, 1.0 eq) and PtO2 (40 mg. 
0.176 mmol, 0.44 mol%) in MeOH (50 mL) was evacuated and backfilled with N2 twice, 
then evacuated and backfilled with H2 gas at 1 atm. The resulting solution was stirred 
for 7 days at room temperature, then filtered through celite and the solvent evaporated 
under reduced pressure. Purification by flash column chromatography through silica 
with 7:3 – 9:1 EtOAc – hexane as eluent gave a 2:1 inseperable mix of 134/133 (4.17 g, 
31.2 mmol, 77%) as a white, waxy solid.  
Lab Book Reference: JCS-3-66 
 
4-(((Triisopropylsilyl)oxy)methyl)cyclohexanol 135/136 
 
Triisopropylsilyl chloride (214 mg, 1.11 mmol, 0.24 mL, 1.0 eq) was added dropwise to 
a stirred solution of a 2:1 diastereomeric mixture of alcohols 134/133 (170 mg, 1.11 
mmol, 1.0 eq) and imidazole (114 mg, 1.67 mmol, 1.5 eq) in DMF (5 mL) at rt. The 
resulting solution was stirred for 16 h. Then, additional triisopropylsilyl chloride (2 mL 
of a 0.11 M soln in DMF, 0.22 mmol, 0.2 eq) and imidazole (114 mg, 1.67 mmol, 1.5 eq) 
was added and the resulting solution was stirred for a further 2 h at rt. The reaction 
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mixture was diluted with EtOAc (100 mL) and washed with HCl (2 M, 2 x 10 mL), 
water (3 x 10 mL), dried (MgSO4) and the solvent was evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography with 
19:1 to 4:1 hexane – EtOAc gradient elution gave 135 (91 mg, 0.32 mmol, 29%) as a 
colourless oil, RF (1:1 hexane – EtOAc) 0.8; IR (ATR) 3345 (O–H), 2923, 2890, 2864, 
1463, 1383, 1254, 1137, 1111, 1090, 1064, 1031, 1013, 995, 979, 959, 950, 937, 813, 
679, 658, 640 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 4.03–3.97 (m, 1H, CHOH), 3.52 (d, 
J = 6.0 Hz, CH2OSi(iPr)3), 1.77–1.68 (m, 2H, CH2) 1.61–1.50 (m, 4H, 2 x CH2), 1.46–
1.32 (m, 3H, CH2 and CH), 1.13–1.00 (m, 21H, OSi(iPr)3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 68.1 (CHOH), 67.2 (CH2OSi(iPr)3), 39.6 (CH), 32.2 (CH2), 23.6 (CH2), 18.2 
(CH(CH3)2), 12.1 (CH(CH3)2); MS (ESI) m/z 309 [(M+Na)
+
, 100]; HRMS m/z calcd for 
C16H34O2Si (M+Na)
+
 309.2220, found 309.2213 (+2.2 ppm error), and 136 (141 mg, 
0.49 mmol, 45%) as a colourless oil; RF (1:1 hexane – EtOAc) 0.7; IR (ATR) 3331 (O–
H), 2928, 2864, 1462, 1383, 1361, 1249, 1204, 1114, 1083, 1066, 1012, 995, 949, 918, 
881, 802, 787, 775, 680, 658, 513, 465 cm
-1 
; 
1
H NMR (400 MHz, CDCl3) δ 3.55 (dddd, 
J = 11.0, 11.0, 4.5, 4.5 Hz, 1H, CHOH), 3.48 (d, J = 6.0 Hz, CH2OSi(iPr)3), 2.03–1.94  
(m, 2H, CH2) 1.86–1.77 (m, 2H, CH2), 1.51–1.38 (m, 2H, CH2), 1.31–1.18 (m, 3H, CH2 
and CH) 1.11–0.95 (m, 21H, OSi(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) δ 71.4 (CHOH), 
68.5 (CH2OR), 39.9 (CH), 35.3 (CH2), 27.9 (CH2), 18.2 (CH(CH3)2), 12.1 (CH(CH3)2); 
MS (ESI) m/z 309 [(M+Na)
+
, 100]; HRMS m/z calcd for C16H34O2Si (M+Na)
+
 309.2220, 
found 309.2214 (+2.0 ppm error). 
Lab Book Reference: JCS-3-76 
 
Triisopropylsilyl chloride (2.97 g, 15.4 mmol, 3.29 mL, 1.0 eq) was added dropwise to a 
stirred solution of a 2:1 diastereomeric mixture of alcohols 134/135 (2.0 g, 15.4 mmol, 
1.0 eq) and imidazole (2.62 g, 38.5 mmol, 1.5 eq) in DMF (50 mL) at rt. The resulting 
solution was stirred for 16 h. Then, additional triisopropylsilyl chloride (594 mg, 3.08 
mmol, 0.66 mL, 0.2 eq) was added and the resulting solution was stirred for a further 2 
h at rt. The reaction mixture was concentrated in a hard vacuum, then diluted with 
EtOAc (200 mL) and washed with HCl (2 M, 2 x 50 mL), water (3 x 20 mL), dried 
(MgSO4) and the solvent was evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica with 9:1 hexane – 
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EtOAc as eluent gave a 2:1 mixture (by 
1
H NMR) of alcohols 136/135 (3.60 g, 12.6 
mmol, 82%). 
Lab Book Reference: JCS-3-79 
 
4-(((Triisopropylsilyl)oxy)methyl)cyclohexanone 139 
 
Triisopropylsilyl chloride (0.31 mL, 276 mg, 1.43 mmol, 1.5 eq) was added to a stirred 
solution of ketone 129 (122 mg, 0.95 mmol, 1.0 eq) and imidazole (162 mg, 2.38 mmol, 
2.5 eq) in CH2Cl2 (3 mL) at rt. After 16 h, MeOH (2 mL) was added and the resulting 
solution was stirred for a further 1 h. The solvent was evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on 
silica with 8:2 hexane – EtOAc as eluent gave protected ketone 139 (240 mg, 0.84 
mmol, 89%) as a colourless oil, RF (8:2 hexane – EtOAc) 0.50; IR (ATR) 2942, 2891, 
2865, 1716 (C=O), 1463, 1383, 1366, 1329, 1247, 1202, 1168, 1120, 1103, 1067, 996, 
920, 881, 826, 789, 750, 679, 658, 597, 497, 463 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
3.60 (d, J = 6.5 Hz, 2H, CH2OR), 2.44–2.28 (m, 4H, 2 x CH2C(O)), 2.14–2.06 (m, 2H, 
2 x CHAHB), 2.00–1.87 (m, 1H, CH), 1.46 (dddd, J = 13.0, 13.0, 13.0, 5.0 Hz, 2H, 2 x 
CHAHB), 1.11–1.02 (m, 21H, Si(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) δ 212.5 (C=O), 
67.4 (CH2OR), 40.7 (CH2C(O)), 39.2 (CH), 29.3 (CH2), 18.2 (CH3), 17.8 (CH(CH3)2); 
MS (ESI) 307 [(M+Na)
+
, 100]; HRMS m/z calcd for C16H32O2Si (M+Na)
+
 307.2064, 
found 307.2064 (-0.1 ppm error). 
Lab Book Reference: JCS-7-84 
 
Anhydrous DMSO (31.3 mg, 28 μL, 0.40 mmol, 1.25 eq) was added to a stirred solution 
of oxalyl chloride (48.7 mg, 32 μL, 0.38 mmol, 1.2 eq) in anhydrous CH2Cl2 (3 mL) 
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under N2 at –78 °C. The resulting solution was stirred at the same temperature for 10 
min, followed by the dropwise addition of 135 (91 mg, 0.32 mmol, 1.0 eq) in CH2Cl2 (1 
mL). After 30 m, Et3N (162 mg, 0.22 mL, 1.6 mmol, 5 eq) was added dropwise and the 
resulting solution was allowed to warm to rt over 1 h. The reaction mixture was diluted 
with CH2Cl2 (30 mL), washed with HCl(aq) (2M, 2 x 10 mL), water (1 x 10 mL), dried 
(MgSO4) and the solvent evaporated under reduced pressure to give ketone 139 (83 mg, 
0.29 mmol, 91%) as a pale yellow oil. 
Lab Book Reference: JCS-3-77 
 
Anhydrous DMSO (47.9 mg, 44 μL, 0.61 mmol, 1.25 eq) was added to a stirred solution 
of oxalyl chloride (74.6 mg, 49 μL, 0.59 mmol, 1.2 eq) in anhydrous CH2Cl2 (5 mL) 
under N2 at –78 °C. The resulting solution was stirred at the same temperature for 10 
min, followed by the dropwise addition of 136 (141 mg, 0.49 mmol, 1.0 eq) in CH2Cl2 
(1 mL). After 30 m,  Et3N (248 mg, 0.34 mL, 2.45 mmol, 5 eq) was added dropwise and 
the resulting solution was allowed to warm to rt over 1 h. The reaction mixture was 
diluted with CH2Cl2 (30 mL), washed with HCl(aq) (2M, 2 x 10 mL), water (1 x 10 mL), 
dried (MgSO4) and the solvent evaporated under reduced pressure to give ketone 139 
(139 mg, 0.49 mmol, Quantitative) as a pale yellow oil. 
Lab Book Reference: JCS-3-78 
 
DMSO (1.13 g, 1.03 mL, 14.5 mmol, 1.15 eq) was added dropwise over 5 min to a 
stirred solution of oxalyl chloride (1.76 g, 1.17 mL, 13.8 mmol, 1.1 eq) in anhydrous 
CH2Cl2 (100 mL) under N2 at –78 °C. The resulting solution was stirred at the same 
temperature for 10 min, followed by the dropwise addition of a 2:1 mix of 136/135 
(3.60 g, 12.6 mmol, 1.0 eq) dissolved in CH2Cl2 (10 mL). After 30 min, Et3N (6.36 g, 
8.76 mL, 62.85 mmol, 5 eq) was added dropwise over 5 m and the resulting solution 
was allowed to warm to rt over 1 h. The reaction mixture was  diluted with CH2Cl2 (30 
mL), washed with HCl(aq) (2M, 2 x 50 mL), water (1 x 20 mL), dried (MgSO4) and the 
solvent evaporated under reduced pressure to give the crude product. The residues were 
distilled under vacuum (approx. 140°C at 0.8 mbar) to give ketone 139 (2.57 g, 9.04 
mmol, 72%) as a colourless oil. 
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Lab Book Reference: JCS-3-82 
 
A 2:1 mixture of 136/135 (3.30 g, 11.5 mmol, 1.0 eq) in CH2Cl2 (5 mL) was added to a 
stirred solution of DMP (5.12 g, 12.1 mmol, 1.05 eq) in anhydrous CH2Cl2 (50 mL) 
under N2 at rt. The resulting solution was stirred at the same temperature for 1 hour 
before being quenched with aqueous NaHCO3 (50 mL). The biphasic mixture was 
stirred rapidly for 3 hours and the precipitated solids were removed by filtration through 
celite. The layers were separated and the aqueous layer extracted with CH2Cl2 (3 x 20 
mL). The combined organic layers were dried (MgSO4) and the solvent evaporated 
under reduced pressure to give the crude product. The residues were distilled under 
vacuum to give ketone 139 (2.67 g, 9.39 mmol, 82%) as a colourless oil. 
Lab Book Reference: JCS-3-93 
 
2-Hydroxy-4-methylcyclohexanone 145/146  
 
4-methylcyclohexanone (1.0 g, 8.92 mmol, 1.10 mL, 1.0 eq) was added dropwise to a 
stirred solution of Me3SiCl (3.88 g, 35.7 mmol, 4.53 mL, 4.0 eq), Et3N (4.51 g, 44.6 
mmol, 6.22 mL, 5.0 eq) and NaI (2.67 g, 17.8 mmol, 2.0 eq) in dry MeCN (20 mL) at rt 
under N2. The resulting solution was heated at 45 °C for 16 h. Then, the solvent, excess 
Me3SiCl and Et3N were evaporated under reduced pressure. The residues were then 
triturated with dry hexane (3 x 30 mL), filtered through celite and the solvent was 
evaporated under reduced pressure to give the crude product. Purification by Kugelrohr 
distillation under reduced pressure gave the intermediate racemic silyl enol ether (1.19 g, 
6.46 mmol, 72%) as a colourless oil which was used immediately. 
1
H NMR (400 MHz, 
CDCl3) δ 4.84-4.81 (m, 1H, HC=CH2), 2.15-1.94 (m, 3H, CH2 + CH), 1.75-1.57 (m, 3H, 
CH2 + CH), 1.37-1.24 (m, 1H, CH), 0.96 (d, J = 6.5 Hz, 3H, CH3), 0.19 (s, 9H, SiMe3). 
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m-CPBA (821 mg of a 77% sample, dissolved in 10 mL of CH2Cl2, dried over MgSO4 
and diluted to 20 mL,  3.56 mmol, 1.1 eq) was added dropwise over 15 min to a stirred 
solution of this silyl enol ether (615 mg, 3.35 mmol, 1.0 eq) and NaHCO3 (546 mg, 6.50 
mmol, 1.94 eq) in dry CH2Cl2 (5 mL) at 0 °C under N2. The reaction was allowed to 
warm to rt over the course of 2 h and stirred for a further 14 h. Then, HCl(aq) (2 M, 20 
mL) was added and stirred vigorously for 2 h at rt before the layers were separated and 
the aqueous layer extracted with CH2Cl2 (3 x 10 mL). The combined organic extracts 
were washed with K2CO3(aq) (5% w/w, 1 x 10 mL), dried (MgSO4) and the solvent 
evaporated under reduced pressure to give the crude product which contained a 57:43 
mixture of diastereomeric keto-alcohols 145/146 (by 
1
H NMR spectroscopy of the crude 
reaction mixture). Purification by flash column chromatography on silica eluting with 
9:1-7:3 hexane - EtOAc as eluent gave a 50:50 mixture of diastereomeric keto-alcohols 
(by 
1
H NMR spectroscopy of the isolated material) 145/146 (176 mg, 1.37 mmol, 41%) 
as a white solid, mp 90.5–103.1 °C; RF (7:3 petroleum ether – EtOAc) 0.21; IR (ATR) 
3381 (O-H), 2924, 1963, 1724 (C=O), 1454, 1377, 1310, 1272, 1250, 1209, 1162, 1134, 
1060, 1026, 987, 919, 840, 806, 751, 670, 529, 503 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 
(1:1 mix of inseparable diastereoisomers) δ 4.30 (dd, J = 11.5, 6.5 Hz, 0.5H, CHOH), 
4.14 (ddd, J = 12.0, 7.0, 1.0 Hz, 0.5H, CHOH), 3.57 (br s, 0.5H, OH), 3.46 (br s, 0.5H, 
OH), 2.62-2.32 (m, 3H, CH2 + CH), 2.27-2.17 (m, 1H, CH), 2.07-1.96 (m, 1H, CH), 
1.90-1.83 (m, 1H, CH), 1.72-1.64 (m, 1H, CH), 1.22 (d, J = 7.0 Hz, 1.5H, CH3), 1.00 (d, 
J = 6.5 Hz, 1.5H, CH3); 
13
C NMR (100.6 MHz, CDCl3) (mix of diastereoisomers) δ 
212.1 (C=O), 211.8 (C=O), 74.4 (CHOH), 71.9 (CHOH), 44.7 (CH2), 42.2 (CH2), 38.5 
(CH2), 35.6 (CH2), 35.3 (CH2), 33.1 (CH2), 30.3 (CH), 27.4 (CH), 21.1 (CH3), 18.0 
(CH3); MS (ESI) m/z 279 [(M2+Na)
+
, 100]; HRMS m/z calcd for C14H24O4 (M2+Na)
+
 
279.1567, found 279.1556 (+3.8 ppm error).  
Lab Book Reference: JCS-5-39 and JCS-5-40 
 
Sodium 2-iodobenzenesulfonate hydrate 149 
176 
 
 
NaNO2 (2.09 g, 30.3 mmol, 1.05 eq) in H2O (10 mL) was added dropwise over 1 h to a 
stirred solution of aniline-2-sulfonic acid (5.0 g, 28.9 mmol, 1.0 eq) in HCl(aq) (6M, 20 
mL) at 0 °C. After 1 h, NaI (4.76 g, 31.2 mmol, 1.1 eq) in H2O (10 mL) was added 
dropwise over 10 m and the reaction mixture was stirred at the same temperature for 1 h. 
The reaction mixture was then allowed to warm to rt over 1 h, then heated to 50 °C for 
12 h. Then, the reaction mixture was cooled to 0 °C and the solids were removed by 
filtration. The retentate was recrystallized from EtOH to give 149 as a brown crystalline 
solid (2.37 g, 7.31 mmol, 25%), IR (ATR) 3510 (O-H), 3440 (O-H), 1643, 1563, 1428, 
1231, 1194, 1137, 1104, 1058, 1033, 1004, 761, 750, 733, 706, 647, 597, 550, 495 cm
-1
; 
1
H NMR (400 MHz, D2O) δ 8.11 (d, J = 7.0 Hz, 1H, H4), 7.99 (dd, J = 8.0, 2.0 Hz, 1H, 
H1), 7.50 (ddd, J = 8.0, 8.0, 1.5, Hz, 1H,H2), 7.21 (ddd, J = 8.0, 8.0, 1.5 Hz, 1H, H3); 
13
C NMR (100.6 MHz, D2O) δ 144.7 (CSO3Na), 142.1 (CH4), 132.4 (CH1), 128.5 (CH2), 
128.3 (CH3), 90.9 (CI). 
Spectroscopic data consistent with literature values.
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Lab Book Reference: JCS-5-23 
 
3-Allyl-4-(((triisopropylsilyl)oxy)methyl)cyclohexanone 164/165 
 
Allylmagnesium chloride (0.14 mL of a 0.2 M solution in THF, 0.284 mmol, 4.0 eq) 
was added dropwise over 5 m to a solution of copper (I) iodide (0.71 mL of a 0.2 M 
solution in SMe2, 0.142 mmol, 2.0 eq) and THF (4 mL) at –78 °C. After 30 min, enone 
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117 (20 mg, 0.071 mmol, 1.0 eq) dissolved in THF (1 mL) was added dropwise over 5 
min. The resulting solution was allowed to stir at the same temperature for 2 h before 
being quenched by the addition of aqueous NH4Cl (sat. 2 mL). The reaction mixture 
was allowed to warm to rt and was diluted with EtOAc (60 mL) and washed with a mix 
of NH4Cl (sat. 3 mL) and water (7 mL) three times, dried (MgSO4) and the solvent was 
evaporated under reduced pressure to give the crude product which contained a 65:35 
mix of diastereomeric ketones 164/165 (by 
1
H NMR of the crude product). Purification 
by flash column chromatography with 19:1 to 9:1 hexane – EtOAc as eluent gave a 
65:35 mix of ketones 164/165 (14.5 mg, 44.7 μmol, 63%) as a colourless oil, IR (ATR) 
2938, 2925, 2866, 1717 (C=O), 1463, 1113, 995, 914, 882, 680 cm
-1
; 
1
H NMR (400 
MHz, CDCl3) δ 5.78–5.65 (m, 1H, HC=CH2), 5.08–5.00 (m, 2H, HC=CH2), 3.86–3.80 
(m, 0.7H, CH2OR), 3.78–3.73 (m, 1.4H, CH2OR), 2.47–2.24 (m, 4H, 2 x CH2), 2.18–
2.06 (m, 3H, CH2 and CH), 1.98–1.90 (m, 1H, CH), 1.87–1.65 (m, 2H, CH2), 1.11–1.02 
(m, 21H, Si(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) (Major) δ 212.5 (C=O), 135.2 
(HC=CH2), 117.6 (HC=CH2), 64.7 (CH2OR), 45.6 (CH2C(O)), 42.1 (CH), 40.6 
(CH2C(O)), 38.2 (CH), 38.0 (CH2), 28.7 (CH2), 18.2 (CH3), 12.1 (HC(CH3)2); (Minor) δ 
212.5 (C=O), 136.4 (HC=CH2), 117.1 (HC=CH2), 63.5 (CH2OR), 44.9 (CH2C(O)), 40.7 
(CH), 39.8 (CH2C(O)), 38.0 (CH), 33.7 (CH2), 25.5 (CH2), 18.2 (CH3), 12.1 
(HC(CH3)2); MS (ESI) m/z 325 [(M+H)
+
, 5], 347 [(M+Na)
+
, 100]; HRMS m/z calcd for 
C19H36O2Si (M+Na)
+
 347.2377, found 347.2375 (-0.3 ppm error).  
Lab Book Reference: JCS-5-80 
 
1-Allyl-4-(((triisopropylsilyl)oxy)methyl)cyclohex-2-enol 166 and 167 
 
Allyl magnesium chloride (0.14 mL of a 2.0 M solution in THF, 0.28 mmol, 4.0 eq) was 
added dropwise over 5 min to a stirred solution of CuI (6.8 mg, 36 μmol, 0.5 eq) in THF 
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(6.8 mL) at –78 °C under N2. After 30 m, a solution of enone 117 (20 mg, 71 μmol, 1.0 
eq) in dry THF (1 mL) was added dropwise over 5 min and stirred at the same 
temperature for 2 h. Then, NH4Cl(aq) (sat. 1 mL) was added and the reaction mixture 
was allowed to warm to rt over 10 m. The reaction mixture was diluted with EtOAc (50 
mL) and washed with H2O/NH4Cl(aq) (20 mL), dried (MgSO4) and the solvent 
evaporated under reduced pressure to give the crude product which contained a 3:1 
mixture of 166/167 (by 
1
H NMR spectroscopy of the crude reaction mixture). 
Purification by flash column chromatography on silica eluting with 9:1 hexane – EtOAc 
as eluent gave 167 (7.6 mg, 0.023 mmol, 33%) as a colourless oil, RF (9:1 hexane – 
EtOAc) 0.27; IR (ATR) 3388 (O–H), 2921, 2865, 1493, 1463, 1453, 1382, 1249, 1107, 
1068, 1012, 994, 912, 881, 787, 759, 659, 696, 681, 539 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 5.93-5.81 (m, 2H, HC=CH2 and C(OH)HC=CH), 5.71–5.67 (m, 1H, 
C(OH)HC=CH), 5.16-5.09 (m, 2H, HC=CH2), 3.63–3.54 (m, 2H, CH2OR), 2.32-2.29 
(m, 2H, allylic CH2), 2.27-2.18 (m, 1H, allylic CH), 1.80-1.70 (m, 2H, CH2), 1.52-1.41 
(m, 2H, CH2), 1.08-1.02 (m, 21H, OSi(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) 133.8 
(HC=CH2), 132.7 (C(OH)HC=CH), 132.4 (C(OH)HC=CH), 118.7 (HC=CH2), 69.4 
(C(OH)), 67.2 (CH2OR), 46.9 (allylic CH2), 39.4 (allylic CH), 34.7 (CH2), 22.0 (CH2), 
18.2 (CH3), 12.1 (CH(CH3)2); MS(ESI) 347 [(M+Na)
+
, 100]; HRMS m/z calcd for 
C19H36O2Si (M+Na)
+
 347.2377, found 347.2368 (+2.2 ppm error), and 166 (17.3 mg, 
0.053 mmol, 75%), RF (9:1 hexane – EtOAc) 0.17; IR (ATR) 3385 (O–H), 2941, 2926, 
2865, 1463, 1453, 1383, 1249, 1104, 1069, 1011, 996, 911, 881, 786, 755, 697, 681, 
657, 644 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 5.94–5.82 (m, 1H, HC=CH2), 5.75 (dd, J = 
10.0, 3.0 Hz, 1H, C(OH)HC=CH), 5.64 (dd, J = 10.0, 2.0 Hz, 1H, C(OH)HC=CH), 
5.18–5.09 (m, 2H, HC=CH2), 3.60–3.50 (m, 2H, CH2OR), 2.37–2.24 (m, 3H, allylic 
CH2 and allylic CH), 1.89–1.78 (m, 2H, C(OH)CH2), 1.63–1.48 (m, 2H, CH2), 1.14–
1.02 (m, 21H, Si(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) 133.8 (HC=CH2), 133.8 
(C(OH)HC=CH), 130.8 (C(OH)HC=CH), 118.9 (HC=CH2), 70.3 (COH), 66.5 
(CH2OR), 46.2 (allylic CH2), 38.5 (allylic CH), 34.0 (CH2), 22.5 (CH2), 18.2 (CH3), 
12.1 (HC(CH3)2); MS (ESI) m/z 347 [(M+Na)
+
, 100]; HRMS  m/z calcd for C19H36O2Si 
(M+Na)
+
 347.2377, found 347.2367 (+2.7 ppm error). 
Lab Book Reference: JCS-5-60 
 
179 
 
1-Allyl-2-iodo-4-(((triisopropylsilyl)oxy)methyl)cyclohex-2-enol 173 and 174 
 
Allylmagnesium chloride (16 μL of a 1.7 M solution in THF, 27 μmol, 0.95 eq) was 
added in one portion to a stirred solution of iodo-enone 175 (11.6  mg, 28 μmol, 1.0 eq) 
in THF (2 mL) at 0 °C under N2. After 30 mins, HCl(aq) (2 M, 10 mL) was added and 
the reaction mixture was diluted with EtOAc (50 mL) and the layers separated. The 
organic layer was washed with brine (1 x 10 mL), dried (MgSO4) and the solvent 
evaporated to give the crude product which contained a 1:2 mix of diastereomeric 
alcohols 176/173 (by 
1
H NMR of the crude mixture). Purification by flash column 
chromatography on silica with 9:1 hexane – EtOAc gave alcohol 176 (2.9 mg, 6.4 μmol, 
23%), RF (9:1 hexane – EtOAc) 0.32;  IR (ATR) 3458 (O–H), 2924, 2864, 1463, 1384, 
1365, 1116, 1000, 919, 882, 790, 982 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 6.66 (br s, 
1H, IC=CH), 5.81–5.68 (m, 1H, HC=CH2), 5.21–5.12 (m, 2H, HC=CH2), 3.63–3.51 (m, 
2H, CH2OSi), 2.42 (d, J = 8.0 Hz, 2H, CH2CH=CH2), 2.03–1.70 (m, 5H, 2 x CH2 and 
CH), 1.11–1.00 (m, 21H, Si(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) 144.2 (IC=CH), 
133.1 (HC=CH2), 119.1 (HC=CH2), 73.4 (COH), 66.1 (CH2OSi), 48.3 (CH2), 43.9 (CH), 
32.9 (CH2), 29.9 (CH2), 18.2 (CH3), 12.1 (CHMe2); MS (ESI) m/z 473 [(M+Na)
+
, 100]; 
HRMS m/z calcd for C19H35IO2Si (M+Na)
+
 473.1343, found  473.1322 (+4.4 ppm error) 
and alcohol 173 (2.3 mg, 5.1 μmol, 18%), RF (9:1 hexane – EtOAc) 0.27; IR (ATR) 
3459 (O–H), 2925, 2865, 1462, 1384, 1117, 998, 916, 884, 687 cm-1; 1H NMR (400 
MHz, CDCl3) 6.49 (d, J = 3.0 Hz, 1H, IC=CH), 5.88–5.76 (m, 1H, HC=CH2), 5.18–5.09 
(m, 2H, HC=CH2), 3.60–3.51 (m, 2H, CH2OSi), 2.52–2.33 (m, 3H, CH2 and CHAHB), 
2.23–2.15 (m, 1H, CH), 1.92–1.70 (m, 3H, CH2 and CHAHB), 1.10–1.00 (m, 21H, 
Si(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) 142.7 (IC=CH), 133.0 (HC=CH2), 119.1 
(HC=CH2), 73.5 (COH), 66.0 (CH2OSi), 45.6 (CH2), 43.4 (CH), 32.6 (CH2), 29.9 (CH2), 
18.1 (CH3), 12.1 (CHMe2); MS (ESI) material degraded during analysis, and a 22:78 
mix of diastereomeric alcohols 176/173 (6.2 mg, 13.8 μmol, 49%, combined total yield 
of 90%). 
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Lab Book Reference: JCS-6-23 
 
Allylmagnesium chloride (0.48 mL of a 1.7 M solution in THF, 0.81 mmol, 1.2 eq) was 
added dropwise over 2 mins to a stirred solution of iodo-enone 175 (281 mg, 0.68 mmol, 
1.0 eq) in THF (3 mL) at 0 °C under N2. After 30 mins, HCl(aq) (2 M, 10 mL) was added 
and the reaction mixture was diluted with EtOAc (50 mL). The layers were separated 
and the organic layer was washed with brine (1 x 10 mL), dried (MgSO4) and the 
solvent evaporated under reduced pressure to give the crude product which contained a 
1:2 mix of diastereomeric alcohols 176/173 (by 
1
H NMR of the crude product). 
Purification by flash column chromatography gave a 1:2 mix of alcohols 176/173 (260 
mg, 0.57 mmol, 84%). 
Lab Book Reference: JCS-6-33 
 
2-Iodo-4-(((triisopropylsilyl)oxy)methyl)cyclohex-2-enone 175 
 
Iodine (106 mg, 0.42 mmol, 1.2 eq) was added to a stirred solution of enone 117 (100 
mg, 0.35 mmol, 1.0 eq), K2CO3 (58 mg, 0.42 mmol, 1.2 eq) and DMAP (850 μg, 7 μmol, 
2 mol%)  in THF/H2O (1.4 mL, 1:1 v/v) at 0 °C in one portion. The resulting solution 
was allowed to warm to room temperature over 16 h with stirring. Then, EtOAc (50 mL) 
was added and the resulting solution was washed with Na2S2O3 (5% w/w, 1 x 20 mL), 
HCl (2M, 1 x 20 mL), dried (MgSO4) and evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography eluting with 9:1 petroleum 
ether – EtOAc gave 175 (39 mg, 95 μmol, 27%) as a pale yellow oil, RF (19:1 hexane – 
EtOAc) 0.27; IR (ATR) 2941, 2890, 2864, 1690 (C=O), 1586, 1462, 1417, 1382, 1309, 
1249, 1182, 1114, 1098, 1068, 995, 919, 881, 802, 781, 719, 680, 659, 526 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 7.78 (d, J = 2.5 Hz, 1H, C=CH), 3.72 (dddd, J = 10.0, 10.0, 
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10.0, 6.5 Hz, 2H, CH2OSi), 2.82 (16.5, 4.5, 4.5 Hz, 1H, CHAHBC(O)), 2.77–2.69 (m, 1H, 
CHAHBC(O)), 2.61–2.51 (m, 1H, ½ CH2), 2.19–2.10 (m, 1H, ½ CH2), 1.93–1.81 (m, 1H, 
CH), 1.16–1.03 (m, 21H, Si(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) δ 192.6 (C=O), 
161.1 (IC=CH), 104.5 (IC=CH), 65.5 (CH2OSi), 44.0 (CH2C(O)), 35.8 (CH2), 25.8 
(CH), 18.2 (CH3), 12.1 (CH(CH3)2); MS (ESI) m/z 431 [(M+Na)
+
, 100]; HRMS m/z 
calcd for C16H29IO2Si (M+Na)
+
 431.0874, found 431.0855 (+4.4 ppm error).   
Lab Book Reference: JCS-6-1, JCS-5-93 
 
Iodine (91 mg, 0.36 mmol, 2.0 eq) in CHCl3 (1 mL) and pyridine (1 mL) was added 
over 5 m to a stirred solution of enone 117 (50 mg, 0.177 mmol, 1.0 eq) and DMAP (4.3 
mg, 35μmol, 0.2 eq) in CHCl3 (1 mL) and pyridine (1 mL) at 0 °C. The resulting 
solution was allowed to warm to rt over 16 h before being diluted with EtOAc (50 mL) 
and washed with HCl(aq) (2 M, 2 x 10 mL), Na2S2O3 (10% w/w, 20 mL) and water (20 
mL), dried (MgSO4) and the solvent evaporated under reduced pressure to give the 
crude product. Purification through a small plug of silica with 100 mL of 9:1 hexane – 
EtOAc as eluent gave iodo-enone 175 (62 mg, 0.15 mmol, 86%) as a pale yellow oil.  
Lab Book Reference: JCS-6-21  
 
Iodine (449 mg, 1.77 mmol, 2.0 eq) in CHCl3 (5 mL) and pyridine (5 mL) was added to 
a stirred solution of enone 117 (250 mg, 0.885 mmol, 1.0 eq) and DMAP (21 mg, 0.177 
mmol, 2.0 eq) in CHCl3 (5 mL) and pyridine (5 mL) at 0 °C under N2. The resulting 
solution was allowed to warm to rt over 16 h before being diluted with EtOAc (150 mL), 
washed with HCl (2M, 2 x 50 mL), Na2S2O3 (10% w/w, 1 x 50 mL), dried (MgSO4) and 
the solvent evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 9:1 hexane – EtOAc as eluent gave iodo-
enone 175 (281 mg, 0.68 mmol, 77%) as a pale yellow oil.  
Lab Book Reference: JCS-6-31 
 
2-Iodocyclohex-2-enone 177 
182 
 
 
Iodine (15 g, 59 mmol, 1.9 eq) were added to a stirred solution of DMAP (254 mg, 2.08 
mmol, 0.07 eq) in CHCl3/pyridine (1:1 v/v, 40 mL) at 0 °C. To this solution was added 
cyclohexenenone (3 g, 3.02 mL, 31.2 mmol, 1.0 eq) in one portion and the reaction 
mixture was removed from the cooling bath and allowed to warm to rt. After 16 h, the 
reaction mixture was diluted with EtOAc (150 mL) and washed with HCl(aq) (2 M, 3 x 
30 mL), Na2S2O3 (10% w/w, 30 mL), dried (MgSO4) and the solvent evaporated under 
reduced pressure to give the crude product. Purification by flash column 
chromatography on silica gave iodo-enone 177 (5.86 g, 26.4 mmol, 85%) as a waxy, 
yellow solid, RF (9:1 hexane – EtOAc) 0.19; 
1
H NMR (400 MHz, CDCl3) δ 7.77 (dd, J 
= 4.5, 4.5 Hz, 1H, IC=CH), 2.66 (dd, J = 7.0, 7.0 Hz, 2H, C(O)CH2), 2.44 (ddd, J = 6.0, 
6.0, 4.5 Hz, 2H, CH2CH=CI), 2.08 (dddd, J = 6.0, 6.0, 6.0, 6.0 Hz, 2H, CH2); 
13
C NMR 
(100.6 MHz, CDCl3) δ 192.3 (C=O), 159.6 (IC=CH), 104.0 (IC=CH), 37.4 (CH2), 30.1 
(CH2), 23.0 (CH2). 
Spectroscopic data consistent with literature values.
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Lab Book Reference: JCS-6-41 
 
1-Allyl-2-iodocyclohex-2-enol 178 
 
Allylmagnesium chloride (3.04 mL of a 1.7 M solution in THF, 5.18 mmol, 1.15 eq) 
was added dropwise over 5 mins to a stirred solution of iodo-enone 177 (1.0 g, 4.50 
mmol, 1.0 eq) in THF (20 mL) at 0 °C under N2. After 10 m, HCl(aq) (2 M, 12 mL) was 
added and the reaction mixture was diluted with EtOAc (150 mL). The layers were 
separated and the organic layer washed with brine (10 mL), dried (MgSO4) and the 
183 
 
solvent evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 9:1 hexane – EtOAc gave 178 (0.87 g, 3.29 
mmol, 73%) as a colourless oil, RF (hexane – EtOAc) 0.28; 
1
H NMR (400 MHz, CDCl3) 
δ 6.55 (dd, J = 4.0, 4.0 Hz, 1H, IC=CH), 5.83–5.71 (m, 1H, HC=CH2), 5.19–5.15 (m, 
1H, HC=CHAHB), 5.14–5.12 (m, 1H, HC=CHAHB), 2.44–2.40 (m, 2H, CH2), 2.08–1.97 
(m, 2H, CH2), 1.90–1.83 (m, 2H, CH2), 1.79–1.65 (m, 2H, CH2); 
13
C NMR (100.6 MHz, 
CDCl3) δ 142.0 (IC=CH), 133.0 (CH=CH2), 119.1 (CH=CH2), 111.9 (IC=CH2), 73.1 
(COH), 47.3 (CH2), 34.3 (CH2), 29.8 (CH2), 19.0 (CH2). 
Spectroscopic data consistent with literature values.
145 
Lab Book Reference: JCS-6-44 
 
3-Allylcyclohexanone 179 
 
TiCl4 (1.13 g, 0.66 mL, 5.98 mmol, 1.15 eq) was added dropwise over 5 min to a stirred 
solution of cyclohexenone (0.5 g, 5.20 mmol, 0.50 mL, 1.0 eq) in CH2Cl2 (10 mL) at –
78 °C under N2. After 5 min, allyltrimethylsilane (0.65 g, 0.91 mL, 5.72 mmol, 1.10 eq) 
was added and stirred for 1.5 h. The reaction mixture was then warmed to –30 °C and 
held there for 30 min. TLC analysis showed the presence of starting material. The 
reaction mixture was re-cooled to –78 °C and a further aliquot of TiCl4 (1.13 g, 0.66 mL, 
5.98 mmol, 1.15 eq) and allyltrimethylsilane (0.65 g, 0.91 mL, 5.72 mmol, 1.10 eq) was 
added and stirred for a further 1.5 h. The reaction mixture was allowed to warm to room 
temperature and stirred for 2 h, then, citric acid (aq. 10% w/w, 10 mL) was added and 
the reaction mixture was diluted with EtOAc (50 mL). The layers were separated and 
the organic layer washed with citric acid (aq. 10% w/w, 2 x 10 mL), dried (MgSO4) and 
the solvent evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 9:1 to 8:2 hexane – EtOAc gradient elution 
gave 179 (223 mg, 1.61 mmol, 31%) as a pale yellow oil of reasonable purity, RF (9:1 
hexane – EtOAc) 0.25; IR (ATR) 3076, 2926, 2865, 1709 (C=O), 1640, 1447, 1420, 
184 
 
1345, 1310, 1287, 1224, 1182, 1056, 995, 959, 912, 866, 752, 665, 618, 597, 516 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.79–5.67 (m, 1H, HC=CH2), 5.06–4.99 (m, 2H, 
HC=CH2), 2.44–2.31 (m, 2H, CH2), 2.29–2.19 (m, 1H, CH), 2.13–1.97 (m, 4H, CH2 
and CH2), 1.94–1.79 (m, 2H, CH2), 1.70–1.57 (m, 1H, CH), 1.41–1.28 (m, 1H, CH); 
13
C 
NMR (100.6 MHz, CDCl3) δ 212.0 (C=O), 135.8 (HC=CH2), 117.0 (HC=CH2), 47.9 
(CH2), 41.5 (CH2), 40.9 (CH2), 38.9 (CH), 31.0 (CH2), 25.3 (CH2); MS (ESI) m/z 161 
[(M+Na)
+
, 100]; HRMS m/z calcd for C9H14NaO (M+Na)
+
 161.0937, found 161.0940 (-
1.9 ppm error). 
Lab Book Reference: JCS-6-58 
 
TiCl4 (1.13 g, 0.66 mL, 5.98 mmol, 1.15 eq) was added dropwise over 5 min to a stirred 
solution of cyclohexenone (0.5 g, 5.20 mmol, 0.50 mL, 1.0 eq) in CH2Cl2 (10 mL) 
at     –78 °C under N2. After 5 min, allyltrimethylsilane (0.65 g, 0.91 mL, 5.72 mmol, 
1.10 eq) was added and stirred for 3 h. Citric acid(aq) (10% w/w, 10 mL) was added 
dropwise at –78 °C and the reaction mixture was allowed to warm to room temperature. 
The reaction mixture was diluted with EtOAc (50 mL) and the layers seperated. The 
combine organic layers were dried (MgSO4) and the solvent evaporated under reduced 
pressure to give the crude product. Purification by flash column chromatography on 
silica with 9:1 to 8:2 hexane – EtOAc gradient elution gave 179 (0.47 g, 3.41 mmol, 
66%) as a colourless oil. 
Lab Book Reference: JCS-6-62 
 
3-Allyl-2-(2-Methylpropylidene)cyclohexanone 187 
 
TiCl4 (0.57 g, 3.0 mmol, 0.33 mL, 1.15 eq) was added dropwise over 1 m to a stirred 
solution of cyclohexenone (0.25 g, 0.25 mL, 2.60 mmol, 1.0 eq) in CH2Cl2 (5 mL) at –
185 
 
78 °C under N2. After 2 min, allyltrimethylsilane (0.33 g, 0.46 mL, 2.86 mmol, 1.1 eq) 
was added dropwise over 5 m and the resulting solution was stirred at the same 
temperature for 2 h. Then, isobutylene oxide (0.56 mL, 448 mg, 6.24 mmol, 2.4 eq) was 
added over 2 min, followed by the immediate addition of TiCl4 (1.14 g, 0.66 mL, 6.0 
mmol, 2.3 eq). The temperature was raised to –45 °C. After 2 h, HCl(aq) was added (2 M, 
20 mL) and the reaction mixture was diluted with EtOAc (50 mL). The layers were 
separated and the organic layer washed with HCl(aq) (2 M, 20 mL), dried (MgSO4) and 
the solvent evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica gave with 95:5 hexane – EtOAc as eluent gave 
187 (52 mg, 0.27 mmol, 10%) as a colourless oil, RF (9:1 hexane – EtOAc) 0.32; IR 
(ATR) 3076, 2958, 2931, 2868, 1687 (C=O), 1616, 1465, 1448, 1414, 1383, 1362, 1305, 
1246, 1139, 1097, 1076, 1040, 996, 910, 838, 826, 684, 636, 593, 560, 497 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 6.22 (d, J = 10.5 Hz, 1H, C=CH), 5.77–5.66 (m, 1H, 
HC=CH2), 5.06–4.98 (m, 2H, HC=CH2), 2.60–2.46 (m, 2H, CH2), 2.34–2.26 (m, 1H, 
CH), 2.20–2.00 (m, 2H, CH2), 1.93–1.64 (m, 5H, CH2), 1.02 (d, J  = 7.0 Hz, 3H, CH3), 
0.98 (d, J = 7.0 Hz, 3H, CH3); 
13
C NMR (100.6 MHz, CDCl3) δ 203.1 (C=O), 145.2 
(C=CH), 138.6 (C=CH), 136.3 (HC=CH2), 116.8 (HC=CH2), 40.5 (CH2), 39.0 (CH2), 
35.9 (CH), 27.4 (CH2), 26.9 (CH), 22.7 (CH3), 22.4 (CH3), 18.8 (CH2); MS (ESI) m/z 
193 [(M+H)
+
, 10], 215 [(M+Na)
+
, 100]; HRMS m/z calcd for C13H20O (M+Na)
+
 
215.1406, found 215.1413 (-3.0 ppm error). 
Lab Book Reference: JCS-6-76 
 
3-Allyl-2-(1-hydroxy-2-methylpropyl)cyclohexanone 188/189, (1R,3R,5R,9R)-3-
chloro-9-((R)-1-hydroxy-2-methylpropyl)bicyclo[3.3.1]nonan-1-ol 190, 
(1R,3R,5R,9S)-3-chloro-9-((S)-1-hydroxy-2-methylpropyl)bicyclo[3.3.1]nonan-1-ol 
191 and (1R,4S,5S,9S)-4-chloro-9-((S)-1-hydroxy-2-
methylpropyl)bicyclo[3.3.1]nonan-1-ol 192 
 
186 
 
 
TiCl4 (0.66 mL, 1.14 g, 6.0 mmol, 1.15 eq) was added over 30 seconds to a stirred 
solution of cyclohexenone (0.50 mL, 0.50 g, 5.2 mmol, 1.0 eq) in CH2Cl2 (10 mL) at –
78 °C under N2. After 30 seconds, allyltrimethylsilane (0.92 mL, 0.66 g, 5.8 mmol, 1.1 
eq) was added over 30 seconds and the resulting solution was stirred at the same 
temperature for 3 h. Then, isobutylene oxide (1.12 mL, 0.91 g, 12.6 mmol, 2.4 eq) was 
added in one portion, followed by the immediate addition of TiCl4 (1.32 mL, 2.28 g, 
12.0 mmol, 2.3 eq). The resulting solution was allowed to stir at –78 °C for 3 h. Then, 
NaHCO3(aq) (sat. 20 mL) was added and the reaction mixture was diluted with EtOAc 
(100 mL). NaHCO3(aq) (sat. 30 mL) was added and the layers were separated. The 
organic layer was washed with additional NaHCO3(aq) (sat. 20 mL), dried (MgSO4) and 
evaporated under reduced pressure to give the crude product which contained a 80:20 
mixture of diastereomeric keto-alcohols 188/189 (by 
1
H NMR of the crude reaction 
mixture. Purification by flash column chromatography on silica using 8:2 to 7:3 
hexane – EtOAc gradient elution gave a 78:22 mixture of keto-alcohols 188/189 (448 
mg, 2.13 mmol, 41%) as a colourless oil, RF (7:3 hexane – EtOAc) 0.32; IR (ATR) 3458 
(O–H), 2959, 2931, 2871, 1696 (C=O), 1468, 1388, 1367, 1336, 1309, 1279, 1249, 
1211, 1173, 1139, 1065, 1043, 994, 913, 857, 793, 769, 748, 641, 618, 601, 538, 501 
cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.81–5.63 (m, 1H, HC=CH2), 5.09–4.98 (m, 2H, 
HC=CH2), 3.83 (ddd, J = 11.0, 7.0, 3.5 Hz, 0.23 H, CHOH), 3.55 (br s, 0.78 H, OH), 
3.44–3.36 (m, 0.22 H, OH), 3.30 (ddd, J = 11.0, 8.5, 3.0 Hz, 0.78 H, CHOH), 2.67 (d, J 
= 11.0 Hz, 0.78 H, C(O)CH), 2.43–2.25 (m, 4.22 H, C(O)CH and 2 x CH2) 2.18–2.08 
(m, 2H, CH2) 2.06–1.79 (m, 3H, CH2 and CH) 1.76–1.62 (m, 1H, HC(CH3)2), 0.99–0.94 
(m, 3H, HC(CH3)A(CH3)B), 0.88 (d, J = 6.5 Hz, 0.66 H, HC(CH3)A(CH3)B), 0.80 (d, J = 
6.5 Hz, 2.34 H, HC(CH3)A(CH3)B); 
13
C NMR (100.6 MHz, CDCl3) (Major): 216.2 
(C=O), 135.1 (HC=CH2), 117.7 (HC=CH2), 75.6 (CHOH), 56.1 (C(O)CH), 42.8 (CH2), 
40.9 (CH), 37.5 (CH2), 32.1 (CH), 29.8 (CH2), 26.1 (CH2), 20.1 (CH3), 19.2 (CH3); 
(Minor) δ 214.3 (C=O), 136.5 (HC=CH2), 117.1 (HC=CH2), 74.9 (CHOH), 59.8 
(C(O)CH), 41.1 (CH2) 37.6 (CH2), 37.4 (CH), 31.4 (CH), 25.2 (CH2), 22.8 (CH2), 20.6 
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(CH3), 15.2 (CH3); MS (ESI) m/z 233 [(M+Na)
+
, 100]; HRMS m/z calcd for C11H22O2 
(M+Na)
+
 233.1512, found 233.1511 (+0.4 ppm error), chlorinated diol 190 (59 mg, 0.24 
mmol, 4.6%) as a white, crystalline solid, mp 145.5–147.5 °C; RF (7:3 hexane – EtOAc) 
0.29; IR (ATR) 3234 (O–H), 2916, 1468, 1347, 1313, 1285, 1230, 1198, 1124, 1075, 
986, 938, 889, 860, 832, 804, 737, 661, 597, 576, 542, 521 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 4.68–4.58 (m, 1H, CHCl), 4.09 (d, J = 10.0 Hz, 1H, CHOH), 4.00 (br s, 1H, 
OH), 2.89 (br s, 1H, OH), 2.31 (d, J = 9.0 Hz, 2H, (Cl)CCH2C(OH)), 2.15 (br s, 1H, 
CH), 1.99 (ddd, J = 14.0, 7.0, 2.0 Hz, 1H, CHAHB), 1.91–1.82 (m, 2H, CHAHB and 
CH(CH3)2), 1.80–1.58 (m, 7H, 3 x CH2 and CH), 1.05 (d, J = 7.0 Hz, 3H, (CH3)A), 0.87 
(d, J = 7.0 Hz, 3H, (CH3)B); 
13
C NMR (100.6 MHz, CDCl3) δ 75.5 (CHOH), 74.3 
(COH), 55.6 (CHCl), 48.4 ((Cl)CCH2C(OH)), 41.6 (CH2), 37.1 (CH2), 34.2 (CH), 31.9 
(CH2), 28.7 (C(CH3)A(CH3)B), 22.8 (CH2), 20.2 ((CH3)A), 13.5 ((CH3)B); MS (ESI) m/z 
269 [(M+Na)
+
, 100], 271 [(M+Na)
+
, 25]; HRMS m/z calcd for C13H23O2
35
Cl (M+Na)
+
 
269.1279, found 269.1280 (-0.6 ppm error), chlorinated diol 191 (113 mg, 0.46 mmol, 
8.8%) as a white, crystalline solid, mp 138.0–140.5°C; RF (7:3 hexane – EtOAc) 0.23; 
IR (ATR) 3234 (O–H), 2952, 2920, 2870, 1472, 1445, 1384, 1366, 1351, 1316, 1303, 
1289, 1266, 1224, 1197, 1178, 1130, 1116, 1088, 1068, 1011, 985, 966, 933, 917, 881, 
860, 829, 806, 786, 731, 662, 608, 598, 574, 542, 518 cm
-1
; 
1
H NMR (400 MHz, CDCl3) 
δ 4.69–4.59 (m, 1H, CHCl),  4.03 (d, J = 10.0 Hz, 1H, CHOH), 3.74 (OH), 2.95 (OH), 
2.44–2.38 (m, 1H, (Cl)CCHAHBC(OH)), 2.28–2.21 (m, 1H, CHACHB), 2.19–2.13 (m, 
1H, CH), 2.05–1.62 (m, 10H, 3 x CH2, (Cl)CCHAHBC(OH), CHAHB, CH(CH3)A(CH3)B 
and (OH)CCH), 1.03 (d, J = 7.0 Hz, 3H, (CH3)A), 0.88 (d, J = 7.0 Hz, 3H, (CH3)B); 
13
C 
NMR (100.6 MHz, CDCl3) δ 75.0 (CHOH), 74.0 (C(OH)), 55.2 (CHCl), 53.0 
((Cl)CCHAHBC(OH)), 48.4 ((OH)CCH), 44.3 (CHAHB), 34.2 (CH), 33.8 (CH2), 28.8 
(CH(CH3)A(CH3)B), 23.9 (CH2), 22.1 (CH2), 20.3 ((CH3)A), 13.6 ((CH3)B); MS (ESI) 
MS (ESI) m/z 269 [(M+Na)
+
, 100], 271 [(M+Na)
+
, 25]; HRMS m/z calcd for 
C13H23O2
35
Cl (M+Na)
+
 269.1279, found 269.1272 (+2.7 ppm error), and chlorinated 
diol 192 (10.3 mg, 42 μmol, 0.81%) as a white, crystalline solid, mp 188.0–191.0 °C; RF 
(7:3 hexane – EtOAc) 0.13; IR (ATR) 3271 (O–H), 2924, 2866, 1737, 1471, 1456, 1368, 
1354, 1310, 1286, 1259, 1244, 1228, 1211, 1179, 1129, 1101, 1081, 1067, 1008, 991, 
934, 922, 909, 867, 846, 743, 715, 691, 661, 597, 585, 559, 530, 492 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) 4.36–4.32 (m, 1H, CHCl), 4.09 (dd, J = 10.0, 1.5 Hz, CHOH), 3.45 
(br s, 1H, OH), 3.19 (br s, 1H, OH), 2.50–2.37 (m, 1H, (OH)CCH), 2.36–2.30 (m, 2H, 
CH2), 2.13–2.00 (m, 3H, CH2 and CHAHB), 1.92–1.68 (m, 6H, CHAHB, 
188 
 
CH(CH3)A(CH3)B, and 2 x CH2), 1.43–1.36 (m, 1H, CH), 1.04 (d, J = 7.0 Hz, 3H, 
((CH3)A), 0.93 (d, J = 7.0 Hz, 3H, ((CH3)B); 
13
C NMR (100.6 MHz, CDCl3) δ 75.1 
(CHOH), 73.1 (COH), 64.2 (CHCl), 42.3 (CH), 41.8 (CH), 37.6 (CH2), 34.0 (CH2), 32.4 
(CH2), 28.5 (CH(CH3)A(CH3)B), 23.4 (CH2), 20.9 (CH2), 20.3 ((CH3)A), 13.2 ((CH3)B); 
MS (ESI) m/z 269 [(M+Na)
+
, 100], 271 [(M+Na)
+
, 25]; HRMS m/z calcd for 
C13H23O2
35
Cl (M+Na)
+
 269.1279, found 269.1284 (-1.8 ppm error). 
 
Method For Growing Crystals of 190-192 
A solid sample of 190 (approx. 5 mg) was placed in a small glass vial and dissolved in 
the minimum quantity of EtOAc (approx. 0.05 mL) and placed upright in a sealed 
vessel containing pentane (approx. 20 mL). After 24 h, crystals suitable for X-Ray 
analysis had formed on the inner vial. The same procedure was used for growing 
crystals of diols 191 and 192 
Lab Book Reference: JCS-6-84 
 
3-Allyl-2-(1-hydroxy-2-methylpropyl)cyclohexanone 188/189 
 
TiCl4 (0.66 mL, 1.14 g, 6.0 mmol, 1.15 eq) was added over 10 s to a stirred solution of 
cyclohexenone (0.50 mL, 0.50 g, 5.2 mmol, 1.0 eq) in CH2Cl2 (10 mL) under N2 at –78 
°C. After 30 s, allyltrimethylsilane (0.92 mL, 0.66 g, 5.8 mmol, 1.1 eq) was added 
dropwise over 2 m. After 3 h, the temperature was reduced to –116 °C (N2(l)/EtOH), 
followed by the dropwise addition of isobutylene oxide (1.12 mL, 0.91 g, 12.6 mmol, 
2.4 eq) over 2 m. The resulting solution was stirred at the same temperature for 1 h 
before being quenched by the addition of NaHCO3(aq) (sat. 20 mL) and diluted with 
EtOAc (100 mL). NaHCO3(aq) (sat. 30 mL) was added and the layers were separated. 
The organic layer was washed with NaHCO3(aq) (sat. 20 mL), dried (MgSO4) and the 
189 
 
solvent evaporated under reduced pressure to give the crude product which contained an 
87:13 mix of diastereomeric keto alcohols 188/189 (by 
1
H NMR of the crude reaction 
mixture). Purification by flash column chromatography on silica with 9:1 to 7:3 
hexane – EtOAc as eluent gave a mixture of keto alcohols 188/189 (549 mg, 2.61 mmol, 
50%, 86:14 dr) as a colourless oil. Chlorinated diols 190, 191 and 192 were not 
observed.  
Lab Book Reference: JCS-6-86 
 
TiCl4 (0.66 mL, 1.14 g, 6.0 mmol, 1.15 eq) was added over 10 s to a stirred solution of 
cyclohexenone (0.50 mL, 0.50 g, 5.2 mmol, 1.0 eq) in CH2Cl2 (10 mL) under N2 at –78 
°C. After 30 s, allyltrimethylsilane (0.92 mL, 0.66 g, 5.8 mmol, 1.1 eq) was added 
dropwise over 2 m. After 3 h, isobutylene oxide (0.56 mL, 0.45 g, 6.3 mmol, 1.2 eq) 
was added dropwise over 2 m. The reaction vessel was then placed into an ice bath and 
stirred at the same temperature for 3 h before being quenched with NaHCO3(aq) (sat. 10 
mL) and diluted with EtOAc (60 mL). The layers were separated and organic layer was 
washed with NaHCO3(aq) (sat. 3 x 25 mL), dried (MgSO4) and the solvent evaporated 
under reduced pressure to give the crude product which contained an 88:12 mix of 
diastereomeric keto alcohols 188/189 (by 
1
H NMR of the crude reaction mixture). 
Purification by flash column chromatography on silica with 8:2 to 75:25 hexane – 
EtOAc as eluent gave a 91:9 mixture of keto alcohols 188/189 (839 mg, 4.0  mmol, 
80%, 91:9 dr) as a colourless oil. Chlorinated diols 190, 191 and 192 were not observed.  
Lab Book Reference: JCS-7-3 
 
8-Hydroxy-7-methyl-3,4,4a,5,8,8a-hexahydronaphthalen-1(2H)-one 193 
 
190 
 
Hoveyda-Grubbs 2
nd
 generation catalyst (12 mg, 0.019 mmol, 0.1 eq) was added in one 
portion to a stirred solution of aldol product 198 (40 mg, 0.19 mmol, 1.0 eq) in CH2Cl2 
(5 mL) at rt under N2. After 3 h, the solvent was evaporated under reduced pressure to 
give the crude product. Purification by flash column chromatography on silica with 7:3 
hexane–EtOAc as eluent gave decalin 193 (21 mg, 0.12 mmol, 61%), mp 62.5–63.5 °C; 
RF (7:3 hexane–EtOAc) 0.21; IR (ATR) 3341 (O–H), 2967, 2925, 2886, 2866, 2854, 
1702 (C=O), 1463, 1452, 1430, 1378, 1343, 1328, 1308, 1281, 1262, 1202, 1180, 1168, 
1160, 1119, 1093, 1076, 1062, 1037, 1019, 958, 939, 897, 857, 841, 811, 780, 579, 523, 
489 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.41–5.37 (m, 1H, C=CH), 4.41 (d, J = 9.5 Hz, 
1H, CHOH), 3.24 (br s, 1H, CHOH), 2.49–2.42 (m, 1H, CH), 2.40–2.29 (m, 1H, CH), 
2.25–2.17 (m, 1H, CH), 2.16–2.03 (m, 2H, 2 x CH), 2.00–1.93 (m, 1H, CH), 1.92–1.85 
(m, 1H, CH), 1.84–1.77 (m, 1H, CH), 1.76–1.73 (m, 3H, CH3), 1.70–1.63 (m, 1H, CH), 
1.53–1.45 (m, 1H, CH); 13C NMR (100.6 MHz, CDCl3) δ 214.3 (C=O), 135.5 (C=CH), 
122.2 (C=CH), 69.0 (CHOH), 58.6 (C(O)CHCH(OH)), 42.1 (CH2), 39.0 (CH), 33.3 
(CH2), 31.9 (CH2), 25.6 (CH2), 19.1 (CH3); MS (ESI) m/z 203 [(M+Na)
+
, 100]; HRMS 
m/z calcd for C11H16O2 (M+Na)
+
 203.1043, found 203.1039 (+2.0 ppm error).  
Lab Book Reference: JCS-7-11 
 
Grubbs 2
nd
 generation catalyst (10 mg, 12 μmol, 0.05 eq) was added in one portion to a 
stirred solution of aldol product 198 (50 mg, 0.24 mmol, 1.0 eq) in CH2Cl2 (10 mL) at rt 
under N2. After 90 mins, the solvent was evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 7:3 hexane–
EtOAc as eluent gave decalin 193 (41 mg, 0.23 mmol, 95%) as a white solid.  
Lab Book Reference: JCS-7-46 
 
Grubbs 2
nd
 generation catalyst (31 mg, 36 μmol, 0.05 eq) was added in one portion to a 
stirred solution of aldol product 198 (150 mg, 0.72 mmol, 1.0 eq) in CH2Cl2 (30 mL) at 
rt under N2. After 90 mins, the solvent was evaporated under reduced pressure to give 
the crude product. Purification by flash column chromatography on silica with 7:3 
hexane–EtOAc as eluent gave decalin 193 (115 mg, 0.64 mmol, 89%) as a white solid.  
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Lab Book Reference: JCS-7-51 
 
Method for growing crystals of 193: 
A solid sample of 193 (approx. 5 mg) was placed in a small glass vial and dissolved in 
the minimum quantity of iPrOH (approx. 0.05 mL) and placed upright in a sealed vessel 
containing water (approx. 10 mL). After 24 h, crystals suitable for X-Ray analysis had 
formed on the inner vial. 
Lab Book Reference: JCS-7-44 
 
(4R,8S,8S)-8-hydroxy-7-methyl-3,4,4,5,8,8-hexahydronaphthalen-1(2H)-one 194 
 
Grubbs 2
nd
 generation catalyst (10 mg, 12 μmol, 0.05 eq) was added in one portion to a 
stirred solution of aldol product 197 (50 mg, 0.24 mmol, 1.0 eq) in CH2Cl2 (10 mL) at rt 
under N2. After 90 mins, the solvent was evaporated under reduced pressure to give the 
crude product. Purification by flash column chromatography on silica with 7:3 hexane–
EtOAc as eluent gave decalin 194 (29 mg, 0.16 mmol, 67%) as a pale yellow oil, RF 
(7:3 hexane – EtOAc) 0.26; IR (ATR) 3535 (O–H), 2929, 2865, 1695 (C=O), 1449, 
1374, 1336, 1317, 1299, 1241, 1206, 1179, 1146, 1124, 1091, 1080, 1039, 1016, 969, 
931, 891, 868, 840, 805, 780, 710, 535 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.56–5.51 
(m, 1H, C=CH), 4.32 (br s, 1H, CHOH), 3.25 (d, J = 3.0 Hz, 1H, CHOH), 2.47–2.41(m, 
1H, CH), 2.40–2.34 (m, 1H, 0.5 x CH2), 2.30–2.22 (m, 1H, 0.5 x CH2), 2.19–2.11 (m, 
2H, CH2), 2.11–2.02 (m, 1H, 0.5 x CH2), 2.02–1.94 (m, 1H, 0.5 x CH2), 1.92–1.82 (m, 
1H, 0.5 x CH2), 1.82–1.78 (m, 3H, CH3), 1.76–1.69 (m, 1H, CH), 1.50–1.38 (m, 1H, 0.5 
x CH2); 
13
C NMR (100.6 MHz, CDCl3) δ 214.6 (C=O), 134.0 (C=CH), 124.7 (C=CH), 
66.3 (CHOH), 56.3 (C(O)CH), 42.6 (C(O)CH2), 34.1 (CH2), 33.4 (CH), 32.0 (CH2), 
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25.7 (CH2), 21.4 (CH3); MS (ESI) m/z 203 [(M+Na)
+
, 100]; HRMS m/z calcd for 
C11H16O2 (M+Na)
+
, 203.1043, found 203.1043 (-0.2 ppm error). 
Lab Book Reference: JCS-7-46 
 
(2S,3R)-3-Allyl-2-((R)-1-hydroxy-2-methylallyl)cyclohexanone 198 and (2S,3R)-3-
Allyl-2-((S)-1-hydroxy-2-methylallyl)cyclohexanone 197 
 
TiCl4 (1.14 g, 0.66 mL, 6.0 mmol, 1.15 eq) was added dropwise over 5 m to a stirred 
solution of cyclohexenone (0.5 g, 0.5 mL, 5.2 mmol, 1.0 eq) in CH2Cl2 (10 mL) at –78 
°C under N2. After 5 min, allyltrimethylsilane (0.66 g, 0.92 mL, 5.8 mmol, 1.1 eq) was 
added dropwise over 5 min and the resulting solution was stirred at the same 
temperature for 3 h. Then, methacrolein (0.44 g, 0.51 mL, 6.24 mmol, 1.2 eq) was 
added dropwise over 5 m and the reaction mixture was stirred at the same temperature 
for a further 2 h. NaHCO3(aq) (sat. 30 mL) was added at –78 °C and the reaction mixture 
was allowed to warm to rt over 5 m before being being diluted with EtOAc (150 mL) 
and the layers separated. The organic layer was washed with NaHCO3(aq) (sat. 3 x 25 
mL), dried (MgSO4) and the solvent evaporated under reduced pressure to give the 
crude product which contained a 40:60 ratio of diastereomeric alcohols 197/198 (by 
1
H 
NMR of the crude mixture. The presence of the remaining 2 possible diastereoisomers 
was not observed). Purification by flash column chromatography on silica with 7:3 
hexane – EtOAc as eluent gave 197 (198 mg, 0.95 mmol, 18%) as a colourless oil, RF 
(7:3 hexane – EtOAc) 0.3; IR (ATR) 3423 (O–H), 3075, 2928, 1697 (C=O), 1641, 1450, 
1374, 1308, 1236, 1107, 1028, 995, 907, 762 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.77–
5.65 (m, 1H, HC=CH2), 5.06–4.97 (m, 3H, C=CH2 and C=CHAHB), 4.90–4.87 (m, 1H, 
C=CHAHB),  4.50 (dd, J = 6.0, 6.0 Hz, 1H, CHOH), 2.47–2.36 (m, 3H, CH2/CH), 2.32–
2.15 (m, 3H, CH2/CH), 2.06–1.95 (m, 2 H, CH2/CH), 1.94–1.76 (m, 2H, CH2/CH), 1.72 
(s, 3H, CH3); 
13
C NMR (100.6 MHz, CDCl3) δ  213.9 (C=O), 145.6 (C=CH2), 136.2 
193 
 
(HC=CH2), 117.3 (H2C=C), 113.5 (H2C=CH), 75.4 (CHOH), 58.3 (C(O)CH), 41.4 
(CH2), 38.1 (CH2), 37.1 (CH2), 26.7 (CH2), 22.9 (CH2), 18.2 (CH3); MS (ESI) m/z 231 
[(M+Na)
+
, 100]; HRMS m/z calcd for C13H20O2 (M+Na)
+
 231.1356, found 231.1350 
(+2.4 ppm error), and 198 (110 mg, 0.53 mmol, 10%) as a colourless oil, RF (7:3 
hexane – EtOAc) 0.15; IR (ATR) 3334 (O–H), 3078, 2967, 2922, 2870, 1711 (C=O), 
1642, 1439, 1374, 1339, 1308, 1246, 1229, 1164, 1132, 1100, 1042, 1028, 1016, 992, 
964, 860, 836, 772. 725, 673, 637, 593, 564, 513, 487, 466 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 5.80–5.68 (m, 1H, HC=CH2), 5.12–4.94 (m, 4H, HC=CH2 and C=CH2), 4.36 
(dd, J = 7.0, 7.0 Hz, 1H, CHOH), 2.66–2.63 (1H, C(CO)CH), 2.51–2.41 (m, 2H, 
CH2/CH), 2.40–2.32 (m, 1H, CH2/CH), 2.28–2.19 (m, 1H, CH2/CH), 2.17–2.11 (m, 1H, 
CH2/CH), 2.10–1.77 (m, 4H, CH2/CH), 1.71 (s, 3H, CH3); 
13
C NMR (100.6 MHz, 
CDCl3) δ 214.8 (C=O), 145.6 (C=CH2), 135.4 (HC=CH2), 117.7 (C=CH2), 112.9 
(HC=CH2), 74.4 (CHOH), 57.3 (C(O)CH), 41.2 (CH2), 39.7 (CH), 37.6 (CH2), 27.6 
(CH2), 24.5 (CH2), 18.1 (CH3); MS (ESI) m/z 231 [(M+Na)
+
, 100]; HRMS m/z calcd for 
C13H20O2 (M+Na)
+
 231.1356, found 231.1358 (-1.1 ppm error), and a 1:3 mixture of 
diasteromeric alcohols 197/198 (0.54 g, 2.59 mmol, 50%) in a combined overall yield of 
78%.  
Lab Book Reference: JCS-7-8 
 
(4S,8S,8S)-8-(methoxymethoxy)octahydronaphthalen-1(2H)-one 199 
 
Methoxymethyl chloride (64 μL, 68 mg, 0.84 mmol, 30 eq) was added in one portion to 
a stirred solution of decalin 193 (5 mg, 27.8 μmol, 1.0 eq) and DIPEA (0.22 mL, 162 
mg, 1.25 mmol, 45 eq) in CH2Cl2 (0.25 mL) at rt. After 3 h and 45 m, MeOH (1 mL) 
was added and the reaction mixture was stirred at rt overnight. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 7:3 hexane–EtOAc as eluent gave 199 (1.4 mg, 
6.2 μmol, 22%) as a pale yellow oil, RF (7:3 hexane–EtOAc) 0.32; IR (ATR) 2924, 2858, 
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1714 (C=O), 1451, 1366, 1306, 1205, 1186, 1151, 1079, 1030, 966, 925 cm
-1
; 
1
H NMR 
(400 MHz, CDCl3) δ 5.54 (d, J = 5.5 Hz, 1H, C=CH), 4.91 (d, J = 7.0 Hz, 1H, 
OCHAHBOMe), 4.67 (d, J = 7.0 Hz, OCHAHBOMe), 4.51 (d, J = 8.0 Hz, CH(OMOM)), 
3.35 (s, 3H, OCH3), 2.63 (dd, J = 12.5, 8.5 Hz, 1H, C(O)CH), 2.46–2.40 (m, 2H, CH2), 
2.14–2.03 (m, 2H, CH2), 2.00–1.81 (m, 2H, CH2), 1.76–1.72 (br s, 3H, CH3), 1.72–1.62 
(m, 3H, CH2 + CH); 
13
C NMR (100.6 MHz, CDCl3 211.3 (C=O), 134.3 (C=CH), 124.6 
(C=CH2), 97.4 (OCH2OMe), 74.5 (CHOMOM), 58.8 (C(O)CH), 56.3 (OCH3), 42.8 
(CH2), 41.7 (CH), 33.0 (CH2), 32.9 (CH2), 27.3 (CH2), 20.4 (CH3); MS (ESI) m/z 247 
[(M+Na)
+
, 100]; HRMS m/z calcd for C13H20O3 (M+Na)
+
 247.1305, found 247.1307 (-
1.4 ppm error). 
Lab Book Reference: JCS-7-47 
 
Methoxymethyl chloride (0.24 mL, 257 mg, 3.20 mmol, 5 eq) was added in one portion 
to a stirred solution of decalin 193 (115 mg, 0.64 mmol 1.0 eq) and DIPEA (1.10 mL, 
827 mg, 6.40 mmol, 10 eq) in CH2Cl2 (3 mL) at rt. After 6 h and 20 min, MeOH (2 mL) 
was added and the reaction mixture was stirred at rt overnight. The solvent was 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 7:3 hexane–EtOAc as eluent gave 199 (123 mg, 
0.55 mmol, 86%) as a pale yellow oil. 
Lab Book Reference: JCS-7-52 
 
(4R,8S,8S)-8-(Methoxymethoxy)-7-methyl-3,4,4,5,8,8-hexahydronaphthalen-1(2H)-
one 200 
 
Methoxymethyl chloride (0.32 mL, 340 mg, 4.22 mmol, 2.0 eq) was added to a stirred 
solution of decalinone 194 (381 mg, 2.11 mmol, 1.0 eq) and DIPEA (1.10 mL, 818 mg, 
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6.33 mmol, 3.0 eq) in CH2Cl2 (3 mL) at rt under N2. The resulting solution was allowed 
to stir at the same temperature for 16 h. Then, MeOH (2 mL) was added and stirred for a 
further 16 h. The solvent was evaporated under reduced pressure to give the crude 
product. Purification by flash column chromatography on silica eluting with 8:2 
hexane – EtOAc gave protected decalinone 200 (131 mg, 0.58 mmol, 28%) as a 
colourless oil, RF (8:2 hexane – EtOAc) 0.30; IR (ATR) 2923, 2823, 1707 (C=O), 1448, 
1371, 1341, 1319, 1276, 1245, 1208, 1180, 1149, 1128, 1092, 1025, 980, 920, 893, 871, 
776, 704, 617, 596, 533 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.51–5.47 (m, 1H, C=CH), 
5.02 (d, J = 7.0 Hz, 1H, OCHAHBOMe), 4.58 (d, J = 7.0 Hz, 1H, CHAHBOMe), 4.19 (d, 
J = 2.5 Hz, 1H, CHOMOM), 3.34 (s, 3H, OMe), 2.46 (ddddd, J = 16.0, 2.0, 2.0, 2.0, 2.0 
Hz, 1H, CHAHB), 2.37–2.17 (m, 3H, CHAHB, CHCHD and CH), 2.09–2.02 (m, 1H, 
C(O)CH), 2.01–1.92 (m, 2H, CHEHF and CHGHH), 1.88–1.65 (m, 5H, CHCHD, CH3 and 
CHEHF), 1.43–1.29 (m, 1H, CHGHH); 
13
C NMR (100.6 MHz, CDCl3) δ 210.1 (C=O), 
134.0 (C=CH), 125.2 (C=CH), 98.7 (OCH2OMe), 74.2 (CHOMOM), 56.4 (C(O)CH), 
55.8 (OMe), 41.8 (CHAHB), 34.2 (CHCHD), 32.1 (CH), 31.7 (CHGHH), 23.8 (CHEHF), 
21.6 (CH3); MS (ESI) m/z 247 [(M+Na)
+
, 100]; HRMS m/z  calcd for C13H20O3 
(M+Na)
+
 247.1305, found 247.1301 (+1.3 ppm error). 
Lab Book Reference: JCS-7-83 
 
(4R,8S,8S)-8-(methoxymethoxy)-7-methyl-2-(phenylselanyl)-3,4,4,5,8,8-
hexahydronaphthalen-1(2H)-one 206/207 and (4R,8S,8S)-8-(methoxymethoxy)-7-
methyl-2,2-bis(phenylselanyl)-3,4,4,5,8,8-hexahydronaphthalen-1(2H)-one 208 
 
nBuLi (0.62 mL of a 2.47 M soln in hexanes, 1.54 mmol, 2.0 eq) was added dropwise 
over 2 m to a stirred solution of diisopropylamine (0.18 mL, 129 mg, 1.28 mmol, 2.5 eq) 
in THF (2 mL) under N2 at –78 °C. After 30 min, decalinone 200 (115 mg, 0.51 mmol, 
1.0 eq) in THF (2 mL) was added dropwise over 5 min and the resulting solution was 
stirred at the same temperature for 1 h. Then, phenylselenium bromide (361 mg, 1.53 
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mmol, 3.0 eq) was added in THF (2 mL) over 30 s and the resulting solution was stirred 
at the same temperature for 2 h before being quenched with K2CO3 (10% w/w, 3 mL), 
diluted with EtOAc (70 mL), washed with K2CO3 (10% w/w, 2 x 20 mL), dried 
(MgSO4) and the solvent evaporated under reduced pressure to give the crude product 
which contained a 60:40 mixture of diastereomeric selenides 206/207 (by 
1
H NMR of 
the crude reaction mixture). Purification by flash column chromatography on silica with 
9:1 hexane – EtOAc as eluent gave an 85:15 mix of diastereomeric selenides 206/207 
(19 mg, 50.3 μmol, 10%) as a yellow oil, RF (8:2 hexane – EtOAc) 0.31; IR (ATR) 3052, 
2921, 2871, 1688 (C=O), 1670, 1576, 1474, 1436, 1351, 1291, 1260, 1238, 1215, 1169, 
1146, 1110, 1095, 1079, 1061, 1028, 999, 923, 859, 812, 795, 745, 735, 690, 672, 660, 
622, 552, 531, 472 cm
-1
; 
1
H NMR (400 MHz, CDCl3) (Major) δ 7.55–7.51 (m, 2H, m-
PhH), 7.30–7.24 (m, 3H, p-PhH and o-PhH), 5.59–5.54 (m, 1H, C=CH), 4.81 (d, J = 6.5 
Hz, 1H, OCHAHBOMe), 4.50 (d, J = 6.5 Hz, 1H, OCHAHBOMe), 4.47 (d, J = 8.5 Hz, 
1H, CHOMOM), 3.99–3.96 (m, 1H, CHSePh), 3.50 (dd, J = 13.0, 8.5 Hz, 1H, C(O)CH), 
3.29 (s, 3H, OCH3), 2.32–2.16 (m, 2H, CH2A), 2.11–1.98 (m, 2H, CH2B), 1.79–1.68 (m, 
6H, CH3, CH2C and CH); 
1
H NMR (Minor, some signals unassigned) δ 7.79–7.74 (m, 
2H, m-PhH), 7.43–7.33 (m, 3H, p-PhH and o-PhH), 5.73 (d, J = 6.0 Hz, 1H, C=CH), 
4.70 (d, J = 6.5 Hz, 1H, CHAHBOMe), 4.59 (d, J = 6.5 Hz, 1H, CHAHBOMe), 3.04 (s, 
3H, OCH3), 1.71 (s, 3H, CH3); 
13
C NMR (100.6 MHz, CDCl3) (Major) δ 208.2 (C=O), 
134.5 (C=CH), 134.2 (m–Ph), 129.4 (o–Ph), 128.8 (i–Ph), 128.1 (p-Ph), 124.6 (C=CH), 
97.4 (OCH2OMe), 74.2 (CHOMOM), 56.4 (OCH3), 53.7 (C(O)CH), 51.1 (CHSePh), 
41.2 (CH), 32.6 (CH2B), 32.4 (CH2A), 29.1 (CH2C), 20.6 (CH3); 
13
C NMR signals 
unobservable for minor diastereoisomer; MS (ESI) m/z 403 [(M+Na)
+
, 100]; HRMS m/z 
calcd for C19H24O3
80
Se (M+Na)
+
 403.0784, found 403.0799 (-4.1 ppm error), doubly 
substituted 208 (54 mg, 0.10 mmol, 20%) as a yellow solid, mp 126–128 °C; RF (8:2 
hexane – EtOAc) 0.39; IR (ATR) 2921, 1699 (C=O), 1578, 1477, 1438, 1371, 1344, 
1294, 1265, 1211, 1191, 1151, 1079, 1040, 1023, 921, 849, 810, 791, 739, 690, 670, 
598, 543, 459 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 7.78–7.72 (m, 4H, m–PhH), 7.44–
7.30 (m, 6H, o–PhH and p-PhH), 5.54–5.50 (m, 1H, C=CH), 4.83 (d, J = 6.5 Hz, 1H, 
OCHAHBOMe), 4.35 (d, J = 6.5 Hz, 1H, OCHAHBOMe), 4.37–4.32 (underneath doublet 
at 4.35, 1H, CHOMOM), 3.75 (dd, J = 13.5, 8.5 Hz, 1H, C(O)CH), 3.37 (s, 3H, OCH3), 
2.46–2.36 (m, 1H, CHAHB), 2.07–1.98 (m, 3H, CHAHB and CH2), 1.78 (m, 4H, CH3 and 
CH), 1.67–1.60 (m, 1H, CHAAHBB), 1.28–1.24 (m, 1H, CHAAHBB); 
13
C NMR (100.6 
MHz, CDCl3) δ 204.9 (C=O), 138.2 (m-Ph), 136.8 (m-Ph), 134.8 (C=CH), 129.6 (p-Ph), 
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129.13 (p-Ph), 129.07 (o-Ph), 128.8 (o-Ph), 127.9 (i-Ar), 127.4 (i-Ar), 124.0 (C=CH), 
98.9 (OCH2OMe), 75.9 (CHOMOM), 64.5 (C(SePh)2), 56.6 (OCH3), 54.4 (C(O)CH), 
41.0 (CHAHB), 40.4 (CH), 32.6 (CH2), 30.2 (CHAAHBB), 20.7 (CH3); MS (ESI) m/z 559 
[(M+Na)
+
, 100]; HRMS m/z calcd for C19H24O3
80
Se (M+Na)
+
 559.0266, found 
559.0279 (-1.3 ppm error) and a 62:38 mix of selenides 206/207 (60:40 dr) and doubly 
substituted 208 (24 mg).  
Lab Book Reference: JCS-7-80 
 
(4R,8S,8S)-8-methoxy-7-methyl-3,4,4,5,8,8-hexahydronaphthalen-1(2H)-one 209 
 
Iodomethane (0.17 mL, 397 mg, 2.8 mmol, 8.3 eq) was added in one portion to a stirred 
suspension of decalin 194 (60 mg, 0.336 mmol, 1.0 eq) and silver (I) oxide (642 mg, 2.8 
mmol, 8.3 eq) in MeCN (1 mL) at rt. After 24 h, a further portion of iodomethane (0.34 
mL, 792 mg, 5.6 mmol, 16.6 eq) and silver(I) oxide (1.28 g, 5.6 mmol, 16.6 eq) was 
added. After 3 d, a further portion of iodomethane (0.5 mL, 1.16 g, 8.24 mmol, 24.4 eq) 
was added and the resulting solution was stirred at rt for 2 d before the solvent and 
excess reagent were evaporated under reduced pressure to give the crude product. 
Purification by flash column chromatography on silica with 8:2 hexane – EtOAc as 
eluent gave methylated decalin 209 (13.7 mg, 70.5 μmol, 21%) as a colourless oil, RF 
(8:2 hexane – EtOAc) 0.34; IR (ATR) 2924, 2824, 1709 (C=O), 1448, 1371, 1340, 1318, 
1278, 1245, 1216, 1179, 1130, 1092, 1061, 1042, 974, 915, 893, 873, 835, 775, 616, 
531 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.48–5.43 (m, 1H, C=CH), 3.94 (d, J = 2.5 Hz, 
CHOMe), 3.62 (s, 3H, OMe), 2.49 (ddddd, J = 16.0, 2.5, 2.5, 2.5, 2.5 Hz, 1H, 
CHeqHaxC(O)), 2.30–1.91 (m, 7H, CHeqHax, 2 x CH and 2 x CH2), 1.86–1.72 (m, 5H, 
CH3 and CH2); 
13
C (100.6 MHz, CDCl3) δ 210.2 (C=O), 134.6 (C=CH), 124.2 (C=CH), 
76.0 (CHOMe), 61.5 (OCH3), 56.3 (C(O)CH), 41.8 (C(O)CH2), 34.2 (CH2), 32.4 (CH), 
31.6 (CH2), 23.7 (CH2), 24.4 (CH3); MS (ESI) m/z 217 [(M+Na)
+
, 100]; HRMS m/z 
198 
 
calcd for C12H18O2 (M+Na)
+
 217.1199, found 217.1197 (+2.6 ppm error), and RSM (32 
mg, 0.18 mmol, 53%) as a colourless oil. 
Lab Book Reference: JCS-7-74 
 
(S)-1-((1S,2R)-2-Allyl-6-oxocyclohexyl)-2-methylallyl 4-nitrobenzoate 210  
 
Para-nitrobenzoyl chloride (53 mg, 0.29 mmol, 3.0 eq) was added in one portion to a 
stirred solution of alcohol 197 (20 mg, 0.096 mmol, 1.0 eq) in pyridine (3 mL) at rt. 
After 16 h, a further portion of para-nitrobenzoyl chloride (353 mg, 1.90 mmol, 20 eq) 
was added and the resulting solution was stirred at rt for a further 16 h. Then, the 
reaction mixture was diluted with EtOAc (150 mL) and washed with HCl(aq) (2 M, 30 
mL), water (2 x 20 mL), K2CO3(aq) (10% w/w, 2 x 20 mL), dried (MgSO4) and the 
solvent evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 7:3 hexane – EtOAc as eluent gave 210 (30 
mg, 84.0 μmol, 87%) as a bright yellow oil, RF (7:3 hexane – EtOAc) 0.47; IR (ATR) 
2926, 1724 (C=O), 1710 (C=O), 1608, 1526 (N–O), 1451, 1410, 1378, 1347, 1319, 
1267 (N–O), 1097, 1014, 916, 872, 850, 783, 718, 565, 505 cm-1; 1H NMR (400 MHz, 
CDCl3) δ 8.31 (d, J = 9.0 Hz, 2H, o-ArH-NO2), 8.20 (d, J = 9.0 Hz, 2H, m-ArH-NO2), 
6.02 (d, J = 9.5 Hz, 1H, CHOCOAr), 5.73–5.62 (m, 1H, HC=CH2), 5.11–4.96 (m, 4H, 
HC=CH2 and C=CH2), 2.83 (br d, J = 9.5 Hz, 1H, C(O)CH), 2.49–2.39 (m, 1H, 
CHAHBC(O)), 2.37–2.29 (m, 1H, CHAHBC(O), 2.21–2.03 (m, 4H, CH2 and 2 x CH), 
1.97–1.83 (m, 2H, CH2), 1.80 (s, 3H, CH3), 1.66–1.57 (m, 2H, CH2); 
13
C NMR (100.6 
MHz, CDCl3) 210.2 (C=O), 163.8 (CO2Ar), 150.8 (i-ArNO2), 140.9 (p-ArNO2), 135.8 
(HC=CH2), 135.4 (C=CH2), 130.9 (o-Ar-NO2), 123.8 (m-Ar-NO2), 117.4 (HC=CH2), 
116.2 (C=CH2), 77.4 (HCOCOAr), 57.4 (C(O)CH), 40.5 (C(O)CH2), 37.3 (CH), 37.1 
(CH2), 25.1 (CH2), 22.4 (CH2), 17.3 (CH3); MS (ESI) 380 [(M+Na)
+
, 100]; HRMS m/z 
calcd for C20H23NO5 (M+Na)
+
 380.1468, found 380.1460 (+ 2.7 ppm error). 
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Lab Book Reference: JCS-7-15 
                           
 (R)-1-((1S,2R)-2-allyl-6-oxocyclohexyl)-2-methylallyl 4-nitrobenzoate 211 
 
Para-nitrobenzoyl chloride (56 mg, 0.28 mmol, 3.0 eq) was added in one portion to a 
stirred solution of alcohol 198 (21 mg, 0.10 mmol, 1.0 eq) in pyridine (3 mL) at rt. After 
16 h, a further portion of para-nitrobenzoyl chloride (373 mg, 2.0 mmol, 20 eq) was 
added and the resulting solution was stirred at rt for a further 16 h. Then, the reaction 
mixture was diluted with EtOAc (150 mL) and washed with HCl(aq) (2 M, 30 mL), water 
(2 x 20 mL), K2CO3(aq) (10% w/w, 2 x 20 mL), dried (MgSO4) and the solvent 
evaporated under reduced pressure to give the crude product. Purification by flash 
column chromatography on silica with 7:3 hexane – EtOAc as eluent gave 211 (27 mg, 
76 μmol, 75%) as a bright yellow oil, RF (7:3 hexane – EtOAc) 0.42;  IR (ATR) 2937, 
1722 (C=O), 1716 (C=O), 1608, 1526 (N–O), 1439, 1411, 1347, 1320, 1268 (N–O), 
1171, 1100, 1051, 1014, 995, 943, 915, 873, 859, 841, 784, 718, 600, 567, 506 cm
-1
; 
1
H 
NMR (400 MHz, CDCl3) δ 8.27–8.23 (m, 2H, 2 x o-ArH-NO2), 8.16–8.12 (m, 2H, 2 x 
m-ArH-NO2), 5.99 (d, J = 10.5 Hz, 1H, CHOCOAr), 5.75–5.62 (m, 1H, CH=CH2), 
5.27–5.04 (m, 4H, CH=CH2 and C=CH2), 2.77 (d, J = 10.5 Hz, 1H, C(O)CH), 2.61 (ddd, 
J = 14.0, 12.5, 7.0 Hz, 1H, CH), 2.31–2.24 (m, 1H, CH), 2.13–1.83 (m, 6H, 3 x CH2), 
1.74 (s, 3H, CH3), 1.66–1.58 (m, 2H, CH2); 
13
C NMR (100.6 MHz, CDCl3) δ 211.5 
(C=O), 163.8 (CO2Ar), 150.8 (i-ArNO2), 139.9 (p-ArNO2), 135.5 (HC=CH2), 135.3 
(C=CH2), 131.0 (o-ArNO2), 123.7 (m-ArNO2), 118.0 (HC=CH2), 117.9 (C=CH2), 78.9 
(HCOCOAr), 56.0 (C(O)CH), 39.3 (C(O)CH2), 37.8 (CH), 37.1 (CH2), 24.8 (CH2), 22.5 
(CH2), 16.9 (CH3); MS (ESI) m/z 380 [(M+Na)
+
, 100]; HRMS m/z calcd for C20H23NO5 
(M+Na)
+
 380.1468, found 380.1461 (+2.2 ppm error). 
Lab Book Reference: JCS-7-14 
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(1S,4R,8S,8R)-7-methyl-1,2,3,4,4a,5,8,8a-octahydronaphthalene-1,8-diol 212 and 
(1R,4R,8S,8R)-7-methyl-1,2,3,4,4a,5,8,8a-octahydronaphthalene-1,8-diol 213 
 
NaBH4 (13 mg, 0.35 mmol, 5.8 eq) was added in one portion to a stirred solution of 
decalinone 194 (11 mg, 60 μmol, 1.0 eq) in MeOH (1 mL) at rt. After 3 h, the reaction 
was diluted with EtOAc (30 mL) and washed with HCl(aq) (2 M, 1 x 5 mL), dried 
(MgSO4) and the solvent evaporated under reduced pressure to give the crude product 
which contained a 63:37 mix of diastereomeric alcohols 212 and 213 respectively. 
Purification by flash column chromatography on silica using 7:3 to 1:1 hexane–EtOAc 
gradient elution gave 212 (7 mg, 38 μmol, 63%) as a colourless oil, RF (1:1 hexane – 
EtOAc) 0.33; IR (ATR) 3307 (O–H), 2926, 2864, 1417, 1357, 1326, 1274, 1172, 1125, 
1107, 1086, 1045, 1001, 939, 661, 597 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.53–5.49 
(m, 1H, C=CH), 4.32–4.27 (m, 1H, CHOH), 4.08 (d, J = 3.0 Hz, 1H, CH(OH)C=CH), 
2.26–2.16 (m, 1H, CH(OH)CH), 2.05–1.95 (m, 1H, CH/CH2), 1.92–1.84 (m, 1H, 
CH/CH2), 1.79–1.77 (m, 3H, CH3), 1.71–1.55 (m, 2H, CH/CH2), 1.54–1.41 (m, 2H, 
CH/CH2), 1.34–1.23 (m, 2H, CH/CH2), 1.07–0.93 (m, 1H, CH/CH2); 
13
C NMR (100.6 
MHz, CDCl3) δ 134.7 (C=CH), 125.7 (C=CH), 73.7 (CHOH), 70.3 (CH(OH)C=CH), 
45.8 (CH(OH)CH), 34.0 (CH2), 33.9 (CH2), 33.8 (CH2), 24.9 (CH), 21.2 (CH2), 19.4 
(CH3); MS (ESI) m/z 205 [(M+Na)
+
, 100]; HRMS m/z calcd for C11H18O2 (M+Na)
+
 
205.1199, found 205.1193 (+2.2 ppm error) and diol 213 (4.1 mg, 22.5 μmol, 37%) as a 
white solid, mp 113.0–116.0 °C; RF (1:1 hexane – EtOAc) 0.17; IR (ATR) 3323 (O–H), 
2923, 2858, 1449, 1400, 1109, 1046, 1008, 920, 847, 793 cm
-1
; 
1
H NMR (400 MHz, 
CDCl3) δ 5.55–5.51 (m, 1H, C=CH), 4.15 (d, J = 3.5 Hz, 1H, HC=CCHOH), 3.81 (ddd, 
J = 10.5, 10.5, 4.5 Hz, 1H, CHOH), 2.16–2.12 (m, 1H, CHAHB), 2.06–1.99 (m, 1H, 
CHCHD), 1.81 (m, 3H, CH3), 1.79–1.71 (m, 3H, CHEHF, CHGHF and CHAHB), 1.46–1.31 
(m, 4H, CHCHD, 2 x CH, CHEHF), 1.03–0.93 (m, 1H, CHGHF); 
13
C NMR (100.6 MHz, 
CDCl3) δ 134.7 (C=CH), 125.1 (C=CH), 70.2 (CHOH), 68.8 (HC=CCHOH), 51.0 
201 
 
(CH(OH)CH), 35.5 (CHCHD), 33.3 (CHAHB), 33.1 (CHGHF), 30.0 (CH), 23.7 (CHEHF), 
21.5 (CH3); MS (ESI) m/z 205 [(M+Na)
+
, 100]; HRMS m/z calcd for C11H18O2 (M+Na) 
205.1199, found 205.1192 (+3.1 ppm error). 
Lab Book Reference: JCS-7-50 
 
Method for growing crystals of 213: 
The entirety of 213 (4 mg) was placed in a small glass vial and dissolved in the 
minimum quantity of EtOAc (approx. 0.05 mL) and placed upright in a sealed vessel 
containing pentane (approx. 20 mL). After 24 h, crystals suitable for X-Ray analysis 
had formed on the inner vial. 
Lab Book Reference: JCS-7-50 
 
(R)-1-((1S,6R)-6-Allyl-2-((triisopropylsilyl)oxy)cyclohex-2-en-1-yl)-2-methylprop-2-
en-1-ol 214 
 
Triisopropylsilyl triflate (0.30 mL, 1.10 mmol, 10 eq) was added in one portion to a 
stirred solution of keto-alcohol 198 (21 mg, 0.11 mmol, 1 eq) in pyridine (3 mL) at rt. 
After 16 h, the reaction mixture was diluted with EtOAc (60 mL), washed with HCl(aq) 
(2M, 1 x 50 mL), water (2 x 50 mL), NaHCO3 (sat. 50 mL), dried (MgSO4) and the 
solvent evaporated under reduced pressure to give the crude product. Purification by 
flash column chromatography on silica with 9:1 hexane – EtOAc as eluent gave 214 
(16.7 mg, 0.046 μmol, 42%) as a colourless oil, RF (9:1 hexane – EtOAc) 0.44; IR 
(ATR) 3529 (O–H), 3074, 2943, 2927, 2894, 2867, 1736, 1716, 1666, 1641, 1494, 1463, 
1437, 1415, 1383, 1368, 1331, 1317, 1289, 1274, 1246, 1191, 1167, 1069, 1012, 995, 
970, 899, 881, 823, 767, 682, 657, 555, 506, 465 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 
202 
 
5.79–5.68 (m, 1H, SiOC=CH), 5.04–4.87 (m, 5H, HC=CH2 and C=CH2), 4.18 (d, J = 
10.0 Hz, 1H, CHOH), 3.97 (br s, 1H, OH), 2.06–1.97 (m, 5H, 2 x CH2 and CH), 1.71 (s, 
3H, CH3), 1.64–1.50 (m, 2H, CH2), 1.42–1.34 (m, 1H, CH), 1.14–1.04 (m, 21H, 
Si(iPr)3); 
13
C NMR (100.6 MHz, CDCl3) δ 151.0 (COSi(iPr)3), 145.6 (C=CH2), 137.5 
(HC=CH2), 116.3 (C=CH2), 114.4 (HC=CH2), 103.6 (HC=COSi(iPr)3), 81.8 (CHOH), 
45.1 (HOHCCH), 37.0 (CH2), 21.8 (CH2), 19.9 (CH2),  18.2 (HC(CH3)2), 16.1 
(HC(CH3)2), 12.7 (CH3); MS (ESI) m/z 387 [(M+Na)
+
, 100]; HRMS m/z calcd for 
C22H40O2Si (M+Na)
+
 387.2690, found 387.2685 (+1.7 ppm error). 
Lab Book Reference: JCS-7-33 
 
 (2S,3R)-3-allyl-2-((R)-1-(methoxymethoxy)-2-methylallyl)cyclohexanone 217 
 
Chloromethylmethyl ether (0.32 mL, 348 mg, 4.4 mmol, 30 eq) was added dropwise to 
a stirred solution of aldol product 198 (30 mg, 0.14 mmol, 1.0 eq) and DIPEA (0.75 mL, 
560 mg, 4.4 mmol, 30 eq) in CH2Cl2 (3 mL) at rt. The resulting solution was stirred at rt 
for 16 h before the addition of EtOH (3 mL). After 2 h at rt, the solvent was evaporated 
under reduced pressure to give the crude product. Purification by flash column 
chromatography on silica with 9:1 to 8:2 hexane – EtOAc gradient elution gave 216 (29 
mg, 0.11 mmol, 80%) as a colourless oil, RF (7:3 hexane – EtOAc) 0.34; IR (ATR) 3075, 
2936, 1714 (C=O), 1641, 1439, 1376, 1309, 1249, 1221, 1153, 1091, 1052, 1024, 912, 
767, 718, 629, 576, 509 cm
-1
; 
1
H NMR (400 MHz, CDCl3) δ 5.70–5.58 (m, 1H, 
HC=CH2), 5.12–4.98 (m, 4H, HC=CH2 and C=CH2), 4.59 (d, J = 7.0 Hz, 1H, 
OCHAHBOMe), 4.51 (d, J = 11.0 Hz, 1H, CHOMOM), 4.37 (d, J = 7.0 Hz, 1H, 
OCHAHBOMe), 3.25 (s, 3H, OCH3), 2.65 (ddd, J = 13.0, 13.0, 7.0 Hz, 1H, C(O)CHAHB), 
2.50 (br d, J = 11.5 Hz, 1H, C(O)CH), 2.34–2.26 (m, 1H, C(O)CHAHB), 2.07–1.77 (m, 
6H, CH/CH2), 1.59 (s, 3H, CH3), 1.55–1.48 (m, 1H, 0.5 x CH2); 
13
C NMR (100.6 MHz, 
CDCl3) δ 212.8 (C=O), 141.1 (C=CH2), 140.0 (HC=CH2), 118.0 (C=CH2), 117.4 
203 
 
(C=CH2), 93.0 (OCH2OMe), 80.4 (HCOMOM), 56.7 (C(O)CH), 56.0 (OCH3), 38.8 
(C(O)CH2), 37.8 (CH), 37.0 (CH2), 24.4 (CH2), 22.6 (CH2), 15.8 (CH3); MS (ESI) m/z 
275 [(M+Na)
+
, 100], HRMS m/z calcd for C15H24O3 (M+Na)
+
 275.1618, found 
275.1616  (+0.5 ppm error).  
Lab Book Reference: JCS-7-35 
 
Allyllithium  
 
Allyl phenol ether (0.69 mL, 671 mg, 5 mmol, 1 eq) was added over 3 h via syringe 
pump to a vigorously stirred suspension of lithium metal (208 mg, 30 mmol, 6 eq) in 
Et2O (10 mL) at 0 °C under argon. The resulting solution was stirred for a further 2 h at 
0 °C, then titrated against a solution of 2-hydroxybenzaldehyde phenylhydrazone (49 
mg, 0.23 mmol, 0.61 mL of allyllithium required, 0.38 M, 4.05 mmol, 81%). 
JCS-6-50 
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List Of Abbreviations 
Ac   Acetyl 
Aq   Aqueous 
 
Bn  Benzyl 
Boc  Tertiary-butyloxycarbonyl 
Botc  Tertiary-butyloxythiocarbonyl 
br    Broad 
Bu   Butyl 
Bz  Benzoyl 
 
CIPE  Complex induced proximity effect 
cm
-1
  Wavenumber 
CSP-HPLC Chiral stationary phase high pressure liquid chromatography 
 
δ  Chemical shift 
d  Doublet 
DMAP  4-Dimethylaminopyridine 
DMF  Dimethylformamide 
DMSO  Dimethylsulfoxide 
dr  Diastereomeric ratio 
 
E
+
  Electrophile 
ESI  Electrospray ionisation 
eq  Equivalents 
er  Enantiomeric ratio 
Et  Ethyl 
 
g  Gram(s) 
 
h  Hour 
HRMS  High resolution mass spectrometry 
Hz  Hertz 
205 
 
 
iPr  Isopropyl 
IR  Infrared 
 
J   Coupling constant in hertz 
 
LDA  Lithium diisopropylamide 
LiHMDS Lithium hexamethyldisilazide 
 
M  Molar 
M
+
  Parent ion 
m  Multiplet 
mCPBA meta-chloroperbenzoic acid 
Me  Methyl 
mg  Milligram 
min  Minutes 
mL  Millilitre 
mol  Mole 
MOM  Methoxymethyl ether 
mp  Melting point 
MS  Mass spectrometry 
Ms  Mesyl 
m/z  Mass to charge ratio 
 
nBu  Normal-butyl 
NCS  N-chlorosuccinimide 
NMR  Nuclear magnetic resonance 
 
Ph  Phenyl 
PMB  para-methoxybenzyl 
ppm  Parts per million 
Pr  Propyl 
 
R  Undefined group 
206 
 
 RF  Retention factor 
RSM  Recovered starting material 
rt  Room temperature 
 
s  Singlet 
sBu  Secondary-butyl 
 
TBS  Tertiary-butyldimethylsilyl 
TBDMS Tertiary-butyldimethylsililyl 
TIPS  Triisopropylsilyl 
tBu  Tertiary-butyl 
TFA  Trifluoroacetic acid 
THF  Tetrahydrofuran 
TLC  Thin layer chromatography 
TMEDA N,N,N',N'-tetramethylethylenediamine 
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